D: Format & Structure Total Attributes,B: Business Total Attributes,total_attributes,title,F: Technical Metadata Missing Count,F: Technical Metadata Total Attributes,C: Coverage & Detail Missing Count,C: Coverage & Detail Total Attributes,missing_attributes,id,publisher,E: Attribution Total Attributes,A: Summary Total Attributes,B: Business Missing Count,A: Summary Missing Count,E: Attribution Missing Count,pid,D: Format & Structure Missing Count
5,9,42,KPIC,7,7,10,10,38,0056a5c8-4f98-4e9e-b74a-bd498be71c0d,,3,7,8,6,3,11dee486-22d2-4cf4-a955-512249e61645,5
5,9,42,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - Wales,6,7,10,10,38,00a784aa-ea3a-4a57-9612-81b0745e0763,,3,7,8,6,3,602cbc9b-0113-4712-8c4a-0efe8d86b77c,5
5,9,42,Mental Health Inpatient and Day Case - Scottish Morbidity Record (SMR04),6,7,10,10,38,00e1b694-3072-4d25-ab2d-a1de59629ae3,,3,7,8,6,3,24de9d1a-1f48-4c10-b8fc-a3bd7449e191,5
5,9,42,National Paediatric Diabetes Audit - Parent and Patient Recorded Experience measures,7,7,2,10,19,00ffee70-43d6-4a81-8568-32b0b6d9e39c,ALLIANCE > HQIP,3,7,5,0,3,b0979e07-3331-408f-853b-5eeba80ce8f9,3
5,9,42,PTCL Biobank,7,7,2,10,11,0121c132-5be6-414e-853b-885ff301854f,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,19fa25a7-c15d-441c-b635-ad49043e7a96,2
5,9,42,Human Developmental Biology Resource (HDBR),7,7,2,10,11,01470238-7a17-47a5-a131-17178ba26a0a,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,399a6d67-7577-4476-a3b6-4bbceb5a8ff7,2
5,9,42,BathTAP Switching Cohort 2,6,7,10,10,38,01a5c44c-c2fd-4c1e-856e-9875ee1beafa,,3,7,8,6,3,ea1aca1f-6ddb-44a0-b530-0645a26b2bee,5
5,9,42,UK Biobank,6,7,10,10,38,01eb52c3-3f21-4e31-8b27-5e70327543b2,,3,7,8,6,3,,5
5,9,42,Cam-UroOnc Biorepository,7,7,2,10,11,0315886c-f34a-4f1d-8f76-2dfa80a6e949,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,21044030-1cd5-46b1-b072-c9959fd330b4,2
5,9,42,The Leicester City and County Chronic Kidney Disease Cohort,7,7,8,10,28,039c0b29-63f6-4ce9-8d89-87012a52e44f,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,3,7,7,0,3,4dfec37d-dd24-465f-85ea-30209aff3a26,4
5,9,42,"4 Country ChrOnic: estimating respiratory disease burden in adults, South India",7,7,2,10,14,03abf37c-41b2-4ff3-9c09-2cfea438526a,HUB > BREATHE,3,7,2,0,2,2f1244b8-7cbf-4fa3-8534-433efd769d48,2
5,9,42,National Asthma and COPD Audit (NACAP): Adult Asthma secondary care clinical,6,7,10,10,38,03b7acd5-ecfe-4cd6-a6dc-bf9e3f98c772,,3,7,8,6,3,becd2624-9a01-4f01-bcf8-56e94545a49a,5
5,9,42,NIHR BioResource: Consent records,6,7,10,10,38,03cdf92e-b6ea-4e1d-a861-e9da4372ed36,,3,7,8,6,3,1fb479b1-98d4-4d7b-91a2-8368ce3dc77c,5
5,9,42,COVIDsortium,6,7,3,10,21,03fb3b18-4419-44f7-a035-9ddfecfcadfc,OTHER > UNIVERSITY COLLEGE LONDON,3,7,7,1,3,529f126b-660c-4c31-aeb2-765dac1d9df0,1
5,9,42,SOLUS,7,7,10,10,33,0477b06f-cbed-4949-982e-ce248a47ed1a,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,3,7,9,0,3,e653b264-3e44-4ed1-a376-86df45db7f72,5
5,9,42,North West London COVID-19 Patient Level Situation Report (NWL COVID19 SITREP),6,7,1,10,7,04f22c93-53df-440a-a71a-50d6827450bc,HUB > DISCOVER NOW,3,7,0,0,0,ed08c844-343e-44fa-a02d-3ad5ecf25184,0
5,9,42,NIHR IBD BioResource: Sample holding,6,7,10,10,38,04f28919-aa6c-4beb-b186-0ad0043c1c6c,,3,7,8,6,3,f2af20f9-af84-40ce-8a07-7d095948653e,5
5,9,42,National Asthma and COPD Audit Programme (NACAP):COPD and adult asthma secondary care organisational dataset,7,7,8,10,29,04fb4aac-415b-4493-986b-65bbef5214d3,ALLIANCE > HQIP,3,7,7,0,3,1982d9ef-890a-41ff-a86a-de61d65aaa09,5
5,9,42,Bowel Screening Wales,6,7,0,10,6,05716e41-9842-4c07-8ddd-af9f9231e056,ALLIANCE > SAIL,3,7,0,0,0,9f29d47e-4e9a-41b8-b7bc-5ef3570294ef,0
5,9,42,COVID-19 Shielded People list,6,7,0,10,6,05a0baf4-72ea-4e02-b4fb-64c37bb1eb0e,ALLIANCE > SAIL,3,7,0,0,0,dc22db56-8791-4e96-9ce6-6b6a58b1241f,0
5,9,42,INCA Trial,7,7,2,10,11,0664f988-276e-4268-af43-1986a3101f38,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,edd55990-a616-4a9c-a4a2-38af136a349b,2
5,9,42,HCV Research UK,7,7,2,10,11,069c213c-eb04-463e-a300-7614c03cf623,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,01492322-9b33-41cc-9f51-484024e45878,2
5,9,42,"OMOP dataset: Hospital COVID patients: severity, acuity, therapies, outcomes",6,7,0,10,7,06dee089-8c10-4a8b-aa94-7cb699dc3c80,HUB > PIONEER,3,7,0,0,1,0eb789bb-0047-46ac-83ff-631f31e98da0,0
5,9,42,Millennium Clinical Events,7,7,10,10,33,0711cc7e-80d5-4781-a1ab-2637ea176ceb,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,3,7,9,0,3,5f45bcd1-970b-44ba-8ae2-0fb49b85ffa9,5
5,9,42,Prospective Observation of Fibrosis in the Lung Clinical Endpoints,7,7,0,10,6,0715a950-3999-46d8-a646-6496866638a1,HUB > BREATHE,3,7,0,0,0,bb8de9d2-cc38-4c40-b104-ffd167f64f76,0
5,9,42,COVID-19 Sequence Data,6,7,10,10,38,077a21b9-5c5a-4c68-a9f0-b4fa3384aead,,3,7,8,6,3,602cbc9b-0113-4712-8c4a-0efe8d86b77c,5
5,9,42,Cancer Network Information System (CNIS / CANISC),6,7,10,10,38,0786f8b9-77b1-4bc4-8464-28c664298adb,,3,7,8,6,3,da91f0eb-1761-485b-8b7f-9121b6a1d004,5
5,9,42,The impact of COVID on hospitalised patients with COPD; a dataset in OMOP,6,7,2,10,14,07e3ac82-a38d-45f3-9933-07439f6a761d,HUB > PIONEER,3,7,3,1,1,323dc330-aad9-472a-b579-ab66f5f75906,1
5,9,42,Breast Test Wales (SBTW),6,7,10,10,38,084ab1d8-78f6-4c04-b829-6891c6463ca9,,3,7,8,6,3,8b9efd45-f56d-4aa3-b2b8-c66ff3813a2b,5
5,9,42,Careers Wales dataset,6,7,2,10,12,08846261-45f0-4bcf-9801-fe785dcef1c9,ALLIANCE > SAIL,3,7,1,1,1,e4004e0e-6adb-4b11-82c2-af0caf61d751,1
5,9,42,Klang Asthma Cohort,7,7,10,10,38,089a0dd5-b2bd-4152-8033-d53552fe2c80,,3,7,8,6,3,a2eddb27-c8bd-42ae-94f8-2a3026220da3,5
5,9,42,National Joint Registry - Primary Shoulder Replacement dataset,6,7,10,10,38,08bffe91-46aa-4718-ab3a-9e9b60353ea2,,3,7,8,6,3,0e903b9e-a329-478a-937c-480eecee4996,5
5,9,42,Tayside Pathology,6,7,10,10,38,08d1a4f5-92b0-4142-a38d-8bac734086e8,,3,7,8,6,3,419e5a82-2d82-48a7-a8f3-a83e64a54e92,5
5,9,42,NHS Tayside and Fife Accident & Emergency Dataset (ISD/National),6,7,10,10,38,0910383a-44d6-4652-98da-550df7204416,,3,7,8,6,3,750063ea-6bfd-4492-9748-2a18080cf6ea,5
5,9,42,The acute presentation of pregnant women to non-maternity Emergency departments,6,7,2,10,15,0942304f-8b91-4258-af9c-3a1801c7e79f,HUB > PIONEER,3,7,3,1,2,86632207-1e57-4272-b178-ea069a13cae1,1
5,9,42,National Cardiac Audit Programme - National Heart Failure Audit,7,7,10,10,38,0969dc51-1ab9-469a-8b35-3ec63f30fa89,,3,7,8,6,3,834618f3-0c6d-4ed2-abae-39208c6b3080,5
5,9,42,ICON9 Trial,7,7,2,10,11,097cc6bd-ce98-47ec-a73d-5d2c250f2697,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,1fdf266c-d5d8-418d-a423-81265da540a2,2
5,9,42,National Joint Registry - Revision Hip Replacement dataset,6,7,10,10,38,09d1cc0f-4b4d-4525-853a-012ece4a1ab2,,3,7,8,6,3,4b8286e2-c4e4-4db4-8fd9-5f1c8b4e56de,5
5,9,42,Development of ELISA and Rapid Testing Kits for COVID-19,7,7,10,10,38,09f04291-670d-4db0-a3e4-7e0d84555231,,3,7,8,6,3,6b2aca2c-b03a-44ba-80a1-883b744421b6,5
5,9,42,Lothian Birth Cohort 1921 (LBC1921),7,7,10,10,38,0a137eec-4288-400b-8c47-0275319c9f09,,3,7,8,6,3,df288318-6663-417d-9870-666e75920bed,5
5,9,42,Pathology Data from WRRS,6,7,0,10,6,0abfceb7-5a56-4559-b0d4-88326e0331a3,ALLIANCE > SAIL,3,7,0,0,0,48ef8f54-9606-4e6f-9256-3cc07ffd10b8,0
5,9,42,Pathology Data from WRRS (PATH) - Legacy,6,7,10,10,38,0ac16d3d-5ca8-4e25-ad46-ce8e03a04e17,,3,7,8,6,3,48ef8f54-9606-4e6f-9256-3cc07ffd10b8,5
5,9,42,Census 2011 E&W - Household structure for COVID-19 models,6,7,2,10,13,0ac9438e-da8d-4488-bdc6-8285d1401b1d,NCS > OFFICE FOR NATIONAL STATISTICS,3,7,2,0,2,2f66bcf9-e626-4e8d-bc6e-2d3958e709d8,1
5,9,42,Mental Health Dataset (MHDS) for CPRD GOLD,6,7,10,10,38,0af73a56-5683-4072-99c0-01c84355d0d0,,3,7,8,6,3,d5c0cc93-3347-46f0-b8dd-f44e82718e38,5
5,9,42,Determinants of Adolescent Social Wellbeing & Health (DASH),7,7,10,10,38,0b06a5c0-f015-4ce6-bf53-cab304334ae0,,3,7,8,6,3,9d242d12-2d2e-4941-93e4-9ec40d239dd1,5
5,9,42,HPB Biobank,7,7,2,10,11,0b7ea326-fc05-4aca-a962-3f93128b91d1,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,ebe6c9dd-fb95-4301-a929-c21b8077753a,2
5,9,42,Welsh Demographic Service Dataset (WDSD),6,7,10,10,38,0b835c3e-9968-4f12-8aad-c4f10a7d460f,,3,7,8,6,3,8a8a5e90-b0c6-4839-bcd2-c69e6e8dca6d,5
5,9,42,Patient Episode Dataset for Wales (PEDW),6,7,10,10,38,0bffc029-b739-4974-8855-8912a152834a,,3,7,8,6,3,4c33a5d2-164c-41d7-9797-dc2b008cc852,5
5,9,42,Teleconsultation in remote rural India: management of COPD and Asthma,7,7,2,10,12,0c219a61-a1d6-4c5b-bec2-3537454e4137,HUB > BREATHE,3,7,2,0,2,de496590-26b3-4e74-bc5e-1ff5c83f5b43,0
5,9,42,Tissue Access for Patient Benefit (TAPb),7,7,2,10,11,0c50801d-1079-4879-b608-5e8f112b313f,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,35985f8e-f01a-41cc-a9e2-30299d3d6eed,2
5,9,42,Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II),7,7,2,10,10,0c78d1cf-4ba6-44f4-adcf-16c15142d8fb,HUB > BREATHE,3,7,2,0,0,25bc9862-5b6c-4dda-80b2-46642d9e518a,0
5,9,42,Substance Misuse Dataset (SMDS),6,7,10,10,38,0c8fcf41-177b-4ca8-a01f-d86ca8bd5a03,,3,7,8,6,3,291c0dd4-0988-42d2-8e0b-878a892add57,5
5,9,42,Mental Health Services Data Set - Community,7,7,5,10,20,0c98200b-48b5-418a-b8d0-a7708abc1f39,ALLIANCE > NHS DIGITAL,3,7,1,0,3,f3bb6a68-2c32-40a7-9a79-61a718068893,5
5,9,42,"Problem, Diagnosis and Procedures",6,7,10,10,38,0cd32bab-357b-4ea2-bba0-eca90b7b36e9,,3,7,8,6,3,51b41359-1558-48df-9950-88f75ca6ac4c,5
5,9,42,NIHR IBD BioResource: NHS Trust data,7,7,10,10,38,0d65fabc-6cb0-4a77-a01d-cb341b0b053c,,3,7,8,6,3,ae1898da-7fe5-4fe0-b10d-9f06cdec1735,5
5,9,42,The Cleft Collective,7,7,2,10,10,0d6ab9af-c43b-490d-b39c-2d72de46a661,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,12288034-00a4-47a8-a779-1cf7a55270e4,2
5,9,42,MRC Brain Banks Network,7,7,2,10,11,0d70b5c8-da5d-49c5-8ff5-0bdc7b5f6306,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,6f1b9a4e-2367-47f1-a985-3ed9bf3a7211,2
5,9,42,Leeds NIHR Biomarker Research Tissue Bank,7,7,2,10,11,0d79e0d8-9b3d-4450-9c34-0539673dc9a5,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,8648d251-6186-4383-82fc-c036a87c3842,2
5,9,42,Renal Register – PHS National Dataset,6,7,10,10,38,0ddb1d67-e0b9-4b08-898c-9957a09d7e69,,3,7,8,6,3,32edd77d-533c-423f-b045-937507f8505d,5
5,9,42,Real Time Data Network (RTDN),6,7,3,10,15,0ddcb454-2372-4180-9ba0-a7e1896d4fe2,HUB > DATA-CAN,3,7,3,1,1,616c4488-65a5-4608-a187-0c6bc78b359a,1
5,9,42,Cancer Registration Data,6,7,3,10,16,0e07413c-892c-4f06-bd22-2a917eb5c905,ALLIANCE > NHS DIGITAL,3,7,3,1,2,2ed7bbbc-80db-46c2-a45b-632dda40794b,1
5,9,42,Mental Health Minimum Dataset v4 (Sensitive) Episodes,6,7,4,10,19,0e6e6ed5-ab81-4d7f-b06a-768bf33357ca,ALLIANCE > NHS DIGITAL,3,7,1,0,3,29c61f09-c4a1-425f-9bbc-888c23d99516,5
5,9,42,"Cancer and cerebrovascular events: frequency, cancer types and outcomes",6,7,10,10,38,0e9e034a-913a-4764-8615-961c3647b268,,3,7,8,6,3,ae3fd121-141d-466b-b002-06c3959116d0,5
5,9,42,Cardamon Clinical Trial Samples,7,7,2,10,11,0ecedaa2-e8f5-4eb2-ad3f-fc2ce433fc36,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,c0dcceca-c8cf-4269-a0e0-0c18b6ba2de1,2
5,9,42,Better Rx BRIT2 Patient GP Dataset,6,7,10,10,38,0efcd6ce-4e7a-4f8e-8903-1a987ec76b1c,,3,7,8,6,3,656b2c22-9e57-4f15-9b3c-1969da6495ca,5
5,9,42,National Cardiac Audit Programme -  Congenital Heart Disease Audit (NCHDA),7,7,10,10,38,0f1a2789-e8b3-4e36-9622-65d76cebff26,,3,7,8,6,3,2b640175-725a-465f-9aec-6794e6d27791,5
5,9,42,UKALL14 Trial,7,7,2,10,11,0faa4c3e-edf5-4ae8-9b26-c59c98e26b57,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,b5533cb5-0c59-495b-9b11-3c401daeb958,2
5,9,42,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Events,6,7,4,10,19,0fc61ace-397d-4489-9e62-77f88082e775,ALLIANCE > NHS DIGITAL,3,7,1,0,3,9c8bd383-b117-4167-a25c-9e15fa5ec1c6,5
5,9,42,"National Audit of Dementia - spotlight audit on  psychotropic medication, 2019",7,7,10,10,38,1045ca85-0c8f-453b-9da3-778144cf3744,,3,7,8,6,3,949d9d7a-a3f1-480a-8563-3fb024300561,5
5,9,42,COVID-19 Test Trace and Protect (CTTP),6,7,10,10,38,1046cc4d-bd35-43de-a156-80bddb3eb415,,3,7,8,6,3,c0fc84af-aeab-4c7e-aa0b-8264baff55d9,5
5,9,42,NHS 111 Dataset (NHSO),6,7,10,10,38,108d652d-3afb-4001-8ae6-b5a42e8b2daa,,3,7,8,6,3,3d6b69dc-cb3c-4b9a-bdea-a798e7d5b5cf,5
5,9,42,Quality of Life of Colorectal Cancer Survivors: Patient Reported Outcomes (GOLD),6,7,10,10,38,1096dcb8-2a9d-49bb-a455-35e657c1e1a2,,3,7,8,6,3,61a607a9-b404-41e0-a52e-0c6d0ce8c2be,5
5,9,42,Antimicrobial prescribing surveillance data during the COVID-19 pandemic,6,7,10,10,38,10bd5205-5d7d-4d77-baef-4a6237ce7c75,,3,7,8,6,3,a95beeb8-9316-442c-8699-22fc4b2170e5,5
5,9,42,Bangladesh Asthma Hajj Study,7,7,10,10,38,112db000-f69f-47a4-8dd7-db7b6d839e68,,3,7,8,6,3,27e1ffc7-5804-40e2-83e2-93f570906127,5
5,9,42,UK SARS-CoV-2 viral sequencing data (COG-UK) - Lineage/Variant Data - NI,6,7,10,10,38,115109e7-9a35-420f-831e-0707bc96375c,,3,7,8,6,3,3d2d9c5e-6111-4583-a6db-07affd628f1e,5
5,9,42,National Maternity and Perinatal Audit Organisational Survey 2019,7,7,8,10,28,1199f5b5-99f0-4aae-9769-ab754f05dcdb,ALLIANCE > HQIP,3,7,7,0,3,01ad25ed-8cde-43d7-bc77-d8cc3d165df4,4
5,9,42,2019 UK Parkinson's Audit - Occupational therapy,6,7,10,10,38,125202ff-1d00-4f8e-96e1-1d5a310ab326,,3,7,8,6,3,9890eee9-44d4-49f7-8674-16c05a5f82e0,5
5,9,42,Lighthouse,6,7,10,10,38,126b50ad-d0c8-4c75-a477-69420d4601b4,,3,7,8,6,3,62903826-acfc-4d60-9010-cd70b4f556c1,5
5,9,42,NIHR IBD BioResource: SNP imputation data,7,7,10,10,38,12d62b02-2167-407d-acdb-6ddb9d251d36,,3,7,8,6,3,7dee2bd6-733a-4b2e-a942-7f9eaf8ebbc2,5
5,9,42,UK primary Sjogren's syndrome Registry,7,7,2,10,11,12dba445-dfa9-46af-abc0-5bd3701061a7,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,38fe1a10-ebf9-4dc1-8c35-2e7b33b1f6b5,2
5,9,42,"Cataract surgery and visual outcomes at QE Hospital, Birmingham, UK",6,7,10,10,38,131ccbe5-28dc-4abf-8a44-05f470d1be1d,,3,7,8,6,3,4352ef1c-67d7-4f2e-b256-1efaac61dacd,5
5,9,42,Tayside Radiology,6,7,10,10,38,135f2650-ea0c-4cad-80ac-c86449a176a8,,3,7,8,6,3,af10ec29-1866-4726-b33f-3948afe182f2,5
5,9,42,Manchester Eye Tissue Repository,7,7,2,10,11,1406c52a-e5d6-4c57-883d-62e405eb604a,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,47fc8f03-eba1-4efa-ae3e-148a76b56517,2
5,9,42,COPDMAP Consortium,7,7,5,10,14,1450ff1a-4526-4a6e-b9e9-25969878449d,HUB > BREATHE,3,7,2,0,0,bcbc41cb-99f7-482e-ba3d-561164abbd4e,1
5,9,42,Optimum Patient Care Research Database,7,7,3,10,17,145916c8-d3ca-4465-a719-93dd0770a6e4,HUB > BREATHE,3,7,3,0,2,e3ca35c1-b2e2-4479-adf1-6a78b1c8c088,3
5,9,42,National Asthma and COPD Audit  (NACAP): secondary care  – CYP asthma (org),6,7,10,10,38,147576e2-b445-4d36-aecc-d604302bd34e,,3,7,8,6,3,3efd9b30-1f84-48c0-a3e0-402ecb5c7724,5
5,9,42,Cystic Fibrosis Patient Sweat Tests,6,7,0,10,6,148ebbaa-28f4-42e0-a27f-8587e516c3bf,ALLIANCE > CYSTIC FIBROSIS TRUST,3,7,0,0,0,34f0c2bd-d42e-4441-a89b-e0e384f12afa,0
5,9,42,Practice postcode linked deprivation measures for CPRD GOLD,6,7,10,10,38,14a90909-997f-4676-ae52-e19c01670e23,,3,7,8,6,3,3326d554-ca11-4dc6-aff0-c5b314442d27,5
5,9,42,Active Adult Survey,6,7,0,10,6,15805559-2115-4822-b91f-635de36fb289,ALLIANCE > SAIL,3,7,0,0,0,1eb67fd5-33f6-49dd-a43d-854fff9f25f5,0
5,9,42,UHB 2020 Winter Society of Acute Medicine Benchmarking Audit,6,7,2,10,12,1584af1e-9683-4727-8c9b-9bea8beaa68d,HUB > PIONEER,3,7,2,1,0,5bf9bf39-3cd7-4a54-994b-9914405f945e,1
5,9,42,Health and Employment After Fifty (HEAF),7,7,10,10,38,15aebc30-1e52-4a36-8b17-f9801f35f649,,3,7,8,6,3,ea2d54a2-a6d4-4e82-b2e4-95184f00bbdc,5
5,9,42,GENOMICS ENGLAND 100K QUICK VIEW,6,7,0,10,6,15efea36-d022-495c-a5b6-90f51631a643,GENOMICS ENGLAND,3,7,0,0,0,4cc5ed33-3190-4f80-953b-cabd5a2b1c7c,0
5,9,42,COVID-19 Clinical Information Network (CO-CIN),6,7,1,10,11,1638cce2-12f5-410b-9624-86d2f407c502,ALLIANCE > ISARIC 4C,3,7,2,0,1,84336be3-23bd-466e-b29b-df48db897665,1
5,9,42,MFT Biobank,7,7,2,10,10,16445ebd-bd45-4ded-a7ae-05f33f676598,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,d17efe5d-325f-4fcf-b25e-87d1f6269bea,2
5,9,42,Cambridge Blood and Stem Cell Biobank,7,7,2,10,11,167cc04b-23b8-4a9e-9ff9-6c8e07d6a561,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,c51ab59a-33ce-4145-a642-7f3f96bca545,2
5,9,42,2019 UK Parkinson's Audit - Physiotherapy,6,7,10,10,38,16d40748-66f1-4fc3-bdb3-7c8103cadeb7,,3,7,8,6,3,27690c58-a5da-4359-909a-8e19ff6ca463,5
5,9,42,Suspected Cancer Pathway Daily (SPCD),6,7,10,10,38,16f11980-e2e7-4f79-8e33-39ba4dc3547f,,3,7,8,6,3,9ea2f685-d6c2-49fe-a0e2-735910584d67,5
5,9,42,ARIA Medonc,7,7,10,10,33,172242ce-a1c5-4915-9c71-686f6e7d5789,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,3,7,9,0,3,88eb839c-bc51-45f0-b15e-ea89bba9ffca,5
5,9,42,Demography,6,7,10,10,38,177c34b4-b74a-406a-a73a-4250d1fb9c1b,,3,7,8,6,3,b88c2b24-b75d-4d28-9391-2dbac1605a17,5
5,9,42,UHB 2019 Summer Society of Acute Medicine Benchmarking Audit,6,7,2,10,12,1785cc1a-ace0-4980-8352-5977b2b72969,HUB > PIONEER,3,7,2,1,0,5acfadf9-21a7-4517-a1b2-620d20469611,1
5,9,42,Rural-Urban classification for CPRD GOLD,6,7,10,10,38,17c58f15-93ab-4239-b05a-6b9ea82f6f37,,3,7,8,6,3,a7d8c6a8-0825-4e73-8f29-3d76194d7114,5
5,9,42,IoN Trial,7,7,2,10,11,17cd75a2-e2b5-440c-89b1-22c9f3b03a03,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,e10a660d-b84c-475f-abd4-024dd1af7a5d,2
5,9,42,CPRD GOLD,6,7,10,10,38,185c4410-cea3-4bac-a192-1e1dd8842872,,3,7,8,6,3,a29feafa-7bdd-44e9-b977-c9d26425e67f,5
5,9,42,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - England,6,7,10,10,38,18e2ce4c-b0a0-4f2b-a12c-0d18bb1a165a,,3,7,8,6,3,9a36f3f8-3b7e-4e61-8993-b9cc2734fcb8,5
5,9,42,GENOMICS ENGLAND 100K BIOINFORMATICS DATA,6,7,0,10,6,1900af1a-bd21-4157-ac48-203eec682073,ALLIANCE > GENOMICS ENGLAND,3,7,0,0,0,98999c67-0133-4f11-be95-b84ee5727c84,0
5,9,42,Improving Access to Psychological Therapies Data Set,6,7,10,10,38,19525c5f-92ee-41b6-bb79-673624b27bdd,,3,7,8,6,3,bcf6e5ce-986d-4b84-9c9c-69de966e8bbd,5
5,9,42,COVID-19 Consolidated Deaths (CDDS),6,7,10,10,38,199b8c9f-baf2-4eb8-a8fe-783f58eceb2e,,3,7,8,6,3,70e37f44-5c3e-4c83-a42a-89b3476d1d45,5
5,9,42,3CN (Cirrhosis Cohort),7,7,10,10,38,1a2ecd43-745f-4a67-acd6-27023f1f9c5b,,3,7,8,6,3,2fea047c-ae65-43d5-a1e3-43447981c165,5
5,9,42,UK real-world lymphoid tissue bank,7,7,2,10,10,1a412ff0-6275-4cab-a485-bb76befc7afe,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,c9f82f86-79e1-4067-932f-5e6dc939006d,2
5,9,42,Cystic Fibrosis Patient CFQ-R,6,7,0,10,6,1a4b65e9-5241-4081-9cbb-43a8c8c6ea3b,ALLIANCE > CYSTIC FIBROSIS TRUST,3,7,0,0,0,9cf5dbd3-a109-4e8d-b1bb-7e4126bd887f,0
5,9,42,"Diabetic Eye Screening: the Birmingham, Solihull and Black Country Data Set",6,7,10,10,38,1bafa55c-5616-47db-8ac8-798038146254,,3,7,8,6,3,36886b21-12ff-45e7-82bc-fb5308c12450,5
5,9,42,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - contextual data,7,7,8,10,28,1bbcb128-dd3e-4f56-81d5-17df2dab3c52,ALLIANCE > HQIP,3,7,7,0,3,4559a14f-563d-4fd2-93ae-27c6c0fd891e,4
5,9,42,Deaths General Registrar Office – National Records Scotland,6,7,10,10,38,1c524f7c-ee22-4bdc-877b-8dddc03e3aa2,,3,7,8,6,3,5362cfea-d554-43ba-916a-4460da39cc0c,5
5,9,42,Sero-surveillance to monitor the trend of SARS-CoV-2 infection in rural India,7,7,10,10,38,1ca52b96-27d9-491a-b5f0-5787852d39d2,,3,7,8,6,3,185e9c5c-e686-4174-bcba-5e2f584b5cbb,5
5,9,42,Asthma self-management behaviour in Bangladesh and Pakistan,7,7,4,10,17,1cb397d5-a86d-4354-b1f7-565b7ef5054b,HUB > BREATHE,3,7,4,1,0,3b378225-48e1-45fa-b62d-fc4ed4b39bec,2
5,9,42,Labour Force Survey (Person),6,7,10,10,38,1cc3dc2c-adf3-4c66-ab7b-cfc00388a6a8,,3,7,8,6,3,8c60a308-1e47-4a0c-8b69-9259f05338cb,5
5,9,42,Tayside Microbiology: Tests,6,7,10,10,38,1d2acc70-0e2d-4601-bbbb-569a49bfaa5b,,3,7,8,6,3,826be5be-9977-49f9-b6d1-83ed9de08ebe,5
5,9,42,Critical Care Dataset,6,7,0,10,6,1d46f920-e253-4e7d-a72a-843d068d3c69,ALLIANCE > SAIL,3,7,0,0,0,1789286a-deaf-49df-88cd-660e92934af6,0
5,9,42,Mental Health Services Data Set - Service Users,7,7,5,10,20,1d5e3b05-8ce3-4f80-ae3a-f6031ad8cf69,ALLIANCE > NHS DIGITAL,3,7,1,0,3,f48ad0a1-f90c-4a81-8c04-b23f2d8baf7a,5
5,9,42,ICNARC - Intensive Care National Audit and Research Centre for QResearch,6,7,10,10,38,1dc6e88f-d2de-41ab-8e40-a708dc453cdf,,3,7,8,6,3,0e6aaabb-0efc-4a69-a9a7-aa98888c04bd,5
5,9,42,Somerset Cancer Registry,7,7,10,10,32,1e465797-5e54-4667-9120-d373e75be64f,ALLIANCE > BARTS HEALTH,3,7,8,0,3,3ec5f1c4-95c0-4b1d-899b-399cec32ad49,5
5,9,42,UK Renal Registry - CKD and AKI on Dialysis Dataset,6,7,10,10,38,1e875c15-4a99-4c3e-9621-e4ebf594469f,,3,7,8,6,3,b7152f21-0f2c-4ed9-a013-51e725242f94,5
5,9,42,Emergency Care Data Set (ECDS),6,7,10,10,38,1f6118ce-4051-4ba6-b13e-63dca0032d8d,,3,7,8,6,3,7749d90e-dd7a-4697-8a9c-666491c64a0c,5
5,9,42,COVID-19 Shielded People List (CVSP),6,7,10,10,38,1fd6e7d5-266a-4c79-b492-7045910cd291,,3,7,8,6,3,dc22db56-8791-4e96-9ce6-6b6a58b1241f,5
5,9,42,Sentinel Stroke National Audit Programme Clinical Dataset,7,7,8,10,28,203cc8b4-7711-4d1f-9213-af982d6cff28,ALLIANCE > HQIP,3,7,7,0,3,059a6495-a7d5-435b-8e2b-806c6ccccf2e,4
5,9,42,Moorfields Eye Image Dataset Release 001,6,7,1,10,7,208f79dc-2294-4370-8f16-0d0f7bec9d10,HUB > INSIGHT,3,7,0,0,0,6bfe44ef-9532-4986-b8a2-9c2cda4a89cc,0
5,9,42,CovPall - Survey of Palliative Care Services,6,7,10,10,38,20e2a770-d086-4b17-858f-805bd53d18c7,,3,7,8,6,3,8ba190b7-4c29-4558-a256-50e1f2242874,5
5,9,42,South London and Maudsley NHS Foundation Trust (SLaM) Clinical Record Interactive Search (CRIS) platform,7,7,0,10,6,21cd4b8e-f4f5-44a6-83eb-b7799e98ba55,ALLIANCE > SLaM,3,7,0,0,0,a25a9892-9141-4e78-8415-945ba73da11e,0
5,9,42,NIHR BioResource: Returned datasets,7,7,10,10,38,21d1277b-baf8-4fb8-826e-3f4910d18098,,3,7,8,6,3,261bcf76-8621-4f0d-b2e6-310993d73daa,5
5,9,42,NHS 111 Dataset,6,7,3,10,13,22173802-db99-475e-b95e-d69798734077,ALLIANCE > SAIL,3,7,1,1,1,3d6b69dc-cb3c-4b9a-bdea-a798e7d5b5cf,1
5,9,42,SAIL Dementia e-Cohort (SDEC),6,7,10,10,38,226b52f4-1be8-46c2-86a4-261eb48ec542,,3,7,8,6,3,f48b7c05-6a44-480c-84c6-4f7a684f29f8,5
5,9,42,QTL Programme at MRC HGU,7,7,2,10,10,22739526-317f-4b0e-a23b-ece0c859958f,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,351cc017-caff-4303-8a48-1aa1b90fce2b,2
5,9,42,Children's Cancer and Leukaemia Group (CCLG) Tissue Bank,7,7,2,10,11,227fe0ea-d76e-4c14-a33e-ca255380937d,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,c232fa07-5d28-4bdc-b540-1ad8d933c5f9,2
5,9,42,University of Liverpool - GCP Laboratory Facility,7,7,2,10,11,22974866-44c7-4176-9c51-6b57a1dda39d,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,029b7f0f-911e-46ce-837f-031959f067da,2
5,9,42,CDE Encounters,7,7,10,10,31,22aecb42-9ea3-4d60-b392-d3cdd0a806f8,ALLIANCE > BARTS HEALTH,3,7,7,0,3,3598723f-62fb-4377-9a8b-b264ced1aabd,5
5,9,42,GENOMICS ENGLAND 100K RARE DISEASE & COMMON,6,7,0,10,6,239e8253-a997-4676-8940-16b74a004365,GENOMICS ENGLAND,3,7,0,0,0,3f2b37f1-e8f7-42e5-83c4-fc9e1c58725d,0
5,9,42,NHS Tayside and Fife Accident & Emergency Dataset (PHS/National),6,7,10,10,38,23d790f2-de80-4c7a-b57a-03c8467c54e9,,3,7,8,6,3,750063ea-6bfd-4492-9748-2a18080cf6ea,5
5,9,42,SWIFT-RTB,7,7,2,10,11,24f2374a-e804-434e-a805-e29b332b0693,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,d387ed7c-14fa-49e2-8ced-df0f9372eb88,2
5,9,42,Intensive Care National Audit and Research Centre - Covid19,6,7,2,10,11,2550f814-0849-4d19-b83e-edef46b157fb,ALLIANCE > SAIL,3,7,1,1,0,add6226b-0f21-439a-84a6-51dc26cdc425,1
5,9,42,DOLORISK,6,7,10,10,38,260f4fb2-b40a-4e20-888d-1e3c9c2ddd8e,,3,7,8,6,3,0a467180-a898-44d8-a586-ca4762de362e,5
5,9,42,Mental Health Minimum Dataset v4 (Non-Sensitive) Episodes,6,7,4,10,19,263ad0a8-ae90-4c1d-85d6-c3d2470eb2b7,ALLIANCE > NHS DIGITAL,3,7,1,0,3,2964d1b0-2630-468a-82c1-00f5ac901b3d,5
5,9,42,Mental Health Minimum Dataset v2.6 (Sensitive),6,7,4,10,19,263f28a4-9835-4856-b1c3-0a0d4085f207,ALLIANCE > NHS DIGITAL,3,7,1,0,3,dc37fcd6-1e68-46e5-b73d-4896e069746a,5
5,9,42,Arden Tissue Bank,7,7,2,10,9,263f4ce3-7ccf-45c3-9d41-c1f5ed14cc81,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,62fdfd1c-f195-49cc-b3a1-7d9fd2cc8e1b,1
5,9,42,Welsh Dispensing Dataset (WDDS),6,7,10,10,38,268d54cf-189e-46ea-8f0e-71ad8907bea3,,3,7,8,6,3,50ef6443-ed4b-40f9-97fb-1cfd53be6579,5
5,9,42,Child Health Systems Programme - 27-30Months Review,6,7,10,10,38,26ac9d75-df76-49e5-ba41-d4c0e83a8765,,3,7,8,6,3,d2d57b7f-95d8-425f-b2fd-cc9aff05e659,5
5,9,42,Scottish Human Papillomavirus Archive,7,7,2,10,8,270b55a8-a9ee-44ee-8db6-eb214e721eea,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,4883530f-1c8d-49aa-886e-ea3b958772ea,0
5,9,42,"Deeply phenotyped sepsis patients within hospital: onset, treatments & outcomes",6,7,2,10,13,273e091c-d0b3-4529-9cd2-4bc1a1b6195a,HUB > PIONEER,3,7,3,1,0,38ff49e2-dffa-4103-87a8-386f9f424d22,1
5,9,42,Unified Cohorts Research Network,7,7,8,10,25,274238a8-ec06-4ee4-83ae-a419a925d43b,HUB > BREATHE,3,7,5,0,2,cffcf30d-cedb-421b-a5dc-6726633cb99a,4
5,9,42,NIHR IBD BioResource: SNP chip data,6,7,10,10,38,27a97f1b-e7ac-4723-87db-0a4d9e3ed4b6,,3,7,8,6,3,3c749cfc-4008-4916-b64f-969d6a754c0f,5
5,9,42,SIMD,6,7,10,10,38,2879b7f9-9bf1-4c6d-88cb-fade32b0ec3f,,3,7,8,6,3,5e1ee577-f1d1-48ae-861e-6a5f2f510773,5
5,9,42,Cholecystectomy and post-operative complications from over 9000 surgical cases,6,7,10,10,38,2887c7b4-66d4-404c-a352-83fcff441568,,3,7,8,6,3,4abba8ec-9a67-4334-91fc-e624173f3055,5
5,9,42,DENDRITE Dataset,7,7,10,10,32,29de7178-dcf3-4859-bd96-ca6d944db5f8,ALLIANCE > BARTS HEALTH,3,7,8,0,3,31920b14-d114-410f-8255-522e6451c44e,5
5,9,42,Treatment of Bangladeshi children with severe pneumonia,7,7,10,10,38,2a17a802-a2da-4bfc-8571-b2015350eed4,,3,7,8,6,3,2f4c56b3-ca6a-4b30-a7f0-d83e68192c5b,5
5,9,42,National Audit of Care at the End of Life - Quality Survey,6,7,10,10,38,2a4ef602-0485-47d2-a6f7-9e2ccf849a5d,,3,7,8,6,3,51a8dfba-5c94-48bd-9c68-3707f0ebc2a2,5
5,9,42,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Records,6,7,4,10,19,2a725f9d-c4a9-4c89-aa37-b3c25cc83389,ALLIANCE > NHS DIGITAL,3,7,1,0,3,7c2b435c-5442-4a05-9b8d-08024ec57c30,5
5,9,42,National Asthma and COPD Audit (NACAP): COPD secondary care clinical dataset,6,7,10,10,38,2a826781-0f58-44d6-89f3-7d899eb3cd45,,3,7,8,6,3,85b4dc84-88f4-4740-80fa-fa1eb04a0ae6,5
5,9,42,Millennium Cohort Study,6,7,0,10,7,2b09ea87-5b22-4049-b7dd-de0889699115,ALLIANCE > SAIL,3,7,0,0,1,a380bd6b-009f-4b78-b638-ba9ee62be2eb,0
5,9,42,Leeds-IQVIA Collaboration,6,7,3,10,13,2b40a784-79ea-4403-a4bd-0950a7a36a6c,HUB > DATA-CAN,3,7,1,1,1,00b897c7-d50d-486a-af1b-bd94821b58f7,1
5,9,42,Maternity Inpatient and Day Case - Scottish Morbidity Record (SMR02),6,7,10,10,38,2b77663f-c71d-4138-8fad-f45a1f8b1222,,3,7,8,6,3,d47c809f-3da8-4f8a-b1ee-258d21aad530,5
5,9,42,UCL Infection DNA Bank,7,7,2,10,10,2bd45ffb-b22f-4f02-968b-f5ab8f9d6342,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,3e5fb54a-84ec-4888-9a72-4093c6e90dbc,2
5,9,42,MDSBio,7,7,2,10,11,2c3e75c3-141a-4d29-b7f0-0dbe14fb18fd,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,13c71637-144e-4742-8aea-aefb778a360e,2
5,9,42,Millennium Cohort Study Dataset (MCSD),6,7,10,10,38,2ca2a23d-64c3-4691-9289-197436dddfa3,,3,7,8,6,3,a380bd6b-009f-4b78-b638-ba9ee62be2eb,5
5,9,42,Higher Education Statistics Agency (HESA) Student Data,6,7,10,10,38,2cb07157-1c99-48dc-9926-0ad968a09166,,3,7,8,6,3,68b04d3b-17b4-4a04-a8a3-e2a93ed231df,5
5,9,42,GENOMICS ENGLAND 100K NHSD LINKED DATA,6,7,0,10,6,2d4b933d-1c8b-4fde-860e-c324454d28f9,GENOMICS ENGLAND,3,7,0,0,0,14c31b39-f189-4417-bd38-635268495593,0
5,9,42,COVID-19 Vaccination Adverse Reaction,6,7,10,10,38,2d4d0d89-edfb-448a-b95b-a3c0401ebe75,,3,7,8,6,3,080a90e4-4bc6-4153-a4c6-c120eef5ba94,5
5,9,42,IBD NIHR BioResource: NHS Trust data,7,7,4,10,16,2d6e8e68-2fc9-4b9c-a517-c5c5677af225,HUB > GUT REACTION,3,7,3,1,1,ae1898da-7fe5-4fe0-b10d-9f06cdec1735,1
5,9,42,Welsh Cancer Intelligence and Surveillance Unit (WCISU),6,7,10,10,38,2d7a047c-a90f-48e4-82ee-9a8a082a696e,,3,7,8,6,3,368ad790-3ad8-4f93-9a7c-0bfb64dc6015,5
5,9,42,NHS Tayside - A&E drugs given during an A&E visit,6,7,10,10,38,2d9240b4-6f54-4d00-9c2e-d19220c33211,,3,7,8,6,3,acfbef89-344c-49a5-8079-7344f4316e0f,5
5,9,42,Death Registration data for CPRD Aurum,6,7,10,10,38,2dd188f3-0b5c-4cf7-a077-97b78746d254,,3,7,8,6,3,ad8f07ef-a984-449b-8a60-d1dd564cc36d,5
5,9,42,Cafcass England (CAFE),6,7,10,10,38,2e821540-cce6-4b75-94a1-7e210045fe86,,3,7,8,6,3,8ee61578-e298-423a-be22-cb0438023e5c,5
5,9,42,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - NI,6,7,10,10,38,2e98ae87-b10d-4aa0-acec-773a2b028af1,,3,7,8,6,3,3d2d9c5e-6111-4583-a6db-07affd628f1e,5
5,9,42,Patient Episode Dataset for Wales,6,7,0,10,6,2ef8bfd7-3edb-49e0-a1eb-edc181c03e1d,ALLIANCE > SAIL,3,7,0,0,0,4c33a5d2-164c-41d7-9797-dc2b008cc852,0
5,9,42,Community perception on public health measures for COVID-19 prevention/control,7,7,10,10,38,2f9c0340-2116-41f5-bdbd-921561476061,,3,7,8,6,3,6464fb4f-2838-495b-9963-4001204ed166,5
5,9,42,Deaths – National Records Scotland,6,7,10,10,38,2fcd3d4f-773b-4adc-a8cf-c80841c92d51,,3,7,8,6,3,5362cfea-d554-43ba-916a-4460da39cc0c,5
5,9,42,CDE Patient Demographics,6,7,10,10,38,3008933e-6fc1-415c-b2c6-ebb12e8f3b99,,3,7,8,6,3,209d7fae-0521-4d07-8a4d-e0843a46a107,5
5,9,42,Covid-19 UK Non-hospital Antigen Testing Results,6,7,10,10,38,30524e8c-c92c-4f01-84bd-c5593ada3e43,,3,7,8,6,3,f06ec631-77d0-4b12-a21f-f11e7af49ba5,5
5,9,42,Watch and Wait Trial,7,7,2,10,11,30a0ee0e-d9f9-4341-b00c-2fab8f122b5f,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,e46dccbf-484d-45d2-a42a-4d308b87c113,2
5,9,42,COVID-19 Sequence Data (CVSD),6,7,10,10,38,30e1343e-0628-47aa-b4f6-756cdb6e54c6,,3,7,8,6,3,602cbc9b-0113-4712-8c4a-0efe8d86b77c,5
5,9,42,General Acute Inpatient and Day Case - Scottish Morbidity Record (SMR01),6,7,10,10,38,31503f67-c546-4223-aec6-9255263e8b66,,3,7,8,6,3,98cda353-0011-45b2-80ca-4ed24cd084bf,5
5,9,42,Crohn's Disease Metabolic Syndrome & Related Disease Outcomes,7,7,10,10,38,31b487d4-7beb-4eed-82bb-9ebbb8b9c066,,3,7,8,6,3,07a0d0ee-93a0-49ab-801d-a9322875f2cd,5
5,9,42,"A synthetic dataset of 15,000 ""patients"" with Community Acquired Pneumonia (CAP)",6,7,10,10,38,31b7387f-5760-4c82-b320-051b3f18180d,,3,7,8,6,3,a6575d98-0b2b-4c06-b9c6-88c1729257b9,5
5,9,42,Webex Cohort,7,7,10,10,38,320d4c1e-df08-4eaa-ab9f-bd342d1799a0,,3,7,8,6,3,9254f941-db57-4a97-922e-880b84855a21,5
5,9,42,A dataset of hospitalised patients with Sarcoma,6,7,10,10,38,32639ab2-f23c-4d2b-96f8-c2139d50563b,,3,7,8,6,3,6dcd9c0e-d5f8-46f9-9d4a-335943e46c21,5
5,9,42,Cancer Patient Experience Survey (CPES) for CPRD GOLD,6,7,10,10,38,32b56dc6-5731-4976-823b-86ea1625b9ed,,3,7,8,6,3,a4ecb8df-c72f-4018-8f23-e180c28dfdb6,5
5,9,42,Falls and Fragility Fracture Audit  National Hip Fracture clinical dataset,6,7,10,10,38,32f2d582-3b99-44a8-ac30-0a0819fc2523,,3,7,8,6,3,e06b951b-e9d8-4a2c-a51f-1d819f669205,5
5,9,42,Wales Asthma Observatory,6,7,0,10,6,333d92ca-3a32-41bd-8b16-96aee2dc85b1,HUB > BREATHE,3,7,0,0,0,8604bcdc-235a-4c70-b29b-1617396815e6,0
5,9,42,National Bowel Cancer Audit -  Organisational Survey dataset,7,7,10,10,38,3373aa9c-219e-4036-91a5-78bb98e8a7f5,,3,7,8,6,3,4e232aa8-ad56-4d82-adcc-cd06715a5c45,5
5,9,42,TRICON8B,7,7,2,10,11,33e4b8c6-23cc-4c5f-a7a5-8380035b6601,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,ff875c08-58e6-4e33-8ffe-6f51c8364333,2
5,9,42,National Neonatal Research Database,6,7,10,10,38,34396fa9-0691-42a6-9477-e49e3ae854e6,,3,7,8,6,3,67020745-9def-4c6e-b5ac-bb273bd0a20e,5
5,9,42,CPRD Cardiovascular Disease Synthetic Dataset,6,7,10,10,38,3485968c-0ac8-4c90-bfb0-a9faca4a24f9,,3,7,8,6,3,780c0a71-0264-4843-939d-1336eee60d40,5
5,9,42,Emergency Department (eEMS),6,7,10,10,38,349f5326-67b5-4ff8-a9b8-8e6c4e42a9f2,,3,7,8,6,3,2ba72371-1527-4d8d-94e2-f795e45b9f77,5
5,9,42,Rural Payments Wales (RPWD),6,7,10,10,38,34c47ecf-09ff-4f12-afaa-50c785d482c5,,3,7,8,6,3,9dc76035-dd6c-4246-8686-403087ed8890,5
5,9,42,Welsh Ambulance Services NHS Trust (WASD),6,7,10,10,38,3587e2f5-1cf5-4dd3-82ed-c36be7eab130,,3,7,8,6,3,4dd97609-2753-46ed-8066-3482d6dbdb34,5
5,9,42,BRAIN UK,7,7,2,10,10,359006d7-1c6c-43c2-8905-09b016398ae1,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,1c455ad3-af51-4b93-aff4-c5d3dacfa9f4,2
5,9,42,National Audit of Dementia Round 4 - organisational checklist,7,7,10,10,38,3591992f-cfae-4e26-96e7-da80997e81e7,,3,7,8,6,3,0a305b29-cf23-4261-9299-5251e41ee9f0,5
5,9,42,NIHR BioResource: Full Blood Counts,6,7,10,10,38,35919e8c-5cea-4d79-bf3f-e28efec1b686,,3,7,8,6,3,321e3ad6-96b9-4f19-bbc4-d06dfe2a59d5,5
5,9,42,NHS Tayside and Fife Virology,6,7,10,10,38,35cc06b0-3de1-45b0-8d40-9a8da9b77866,,3,7,8,6,3,855a84b2-9d58-4b2b-a450-b6c6d534e403,5
5,9,42,The Malaysian Asthma Hajj Study,7,7,10,10,38,35fde6f6-ff7d-44f0-92fc-1d28b488cbc1,,3,7,8,6,3,8187f77f-65e3-435e-ad7e-d7f22e2fcf80,5
5,9,42,Mental Health Minimum Dataset v3_3.5 (Sensitive),6,7,4,10,19,36047c5f-7d57-4d25-a114-2bcc6c11708f,ALLIANCE > NHS DIGITAL,3,7,1,0,3,c123f74c-0731-428e-b31b-eee2723df54d,5
5,9,42,Exploring the provision of supportive care for patients with COPD in Malaysia,7,7,3,10,17,36e6b617-ecd5-4ae2-87d6-4a00bb2c653a,HUB > BREATHE,3,7,4,0,2,af8cdc87-789e-4bea-9d8b-927aa689d211,2
5,9,42,Glaucoma dataset at University Hospitals Birmingham,6,7,10,10,38,375dae92-2015-478b-b1bc-5de90b6d53a9,,3,7,8,6,3,48c44534-0184-471e-93b8-1385f92c6631,5
5,9,42,Bristol Dental School Saliva Bank,7,7,2,10,10,37687806-bab2-4de8-87a7-844a0061e7f8,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,8d77f0ad-f376-4d61-a97d-5e996c2bbe72,2
5,9,42,UK MND Collections,7,7,2,10,10,381413fe-8808-47f8-b8df-e65baa543ae4,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,89e2d798-c488-4eaf-a50f-a93616093304,2
5,9,42,North West London Pathology (NWL PATH),6,7,1,10,7,38194ca7-57f5-40ff-b463-900e306cd40f,HUB > DISCOVER NOW,3,7,0,0,0,2c5f3ef6-53f8-42e6-a077-8718261df026,0
5,9,42,NIHR Nottingham Digestive Diseases Collection,7,7,2,10,11,38254214-35f1-4564-b7bb-aab331732dab,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,f20bf814-ee80-4e67-ab00-afff884ddbb4,2
5,9,42,Admitted Patient Care Dataset,6,7,10,10,38,382d8665-a580-4ac1-a279-4fa53cb5bcc1,,3,7,8,6,3,b67f0edd-fed2-4d68-a25f-d225759aa3b0,5
5,9,42,Congenital Anomaly Register and Information Service,6,7,0,10,6,38468759-3351-4722-9eeb-4c6dc9fa44ce,ALLIANCE > SAIL,3,7,0,0,0,6fe7e004-eb51-4c7b-9905-1ec9a4827dca,0
5,9,42,National Exercise Referral Scheme (NERS),6,7,10,10,38,38b0da08-c889-4538-95f2-f2f2c1a86919,,3,7,8,6,3,131784c0-769d-4f7b-b7d0-b5f4b89886d4,5
5,9,42,Clinical response thresholds (acuity) in acutely unwell patients: onset-outcome,6,7,2,10,13,391ab58c-3412-4fa0-96f6-fdd5ae380b86,HUB > PIONEER,3,7,3,1,0,a9018475-452b-4864-bbc3-80eda2067820,1
5,9,42,Bridge file: Hospital Episode Statistics to Diagnostic Imaging Dataset,6,7,4,10,19,3935e2fd-0c30-4f56-8388-45a02e0499b4,ALLIANCE > NHS DIGITAL,3,7,1,0,3,2f73575d-23c8-4bb8-87db-115cde076127,5
5,9,42,Optimising the treatment of Bangladeshi adults with severe pneumonia or ARDS,7,7,10,10,38,39445f3f-c05c-4967-81a9-77a34529ad8e,,3,7,8,6,3,224b1065-340b-4c01-842f-d422911d9334,5
5,9,42,Neuropathic Pain Profiling in Retroviral Infection Study (NIPPR),7,7,10,10,38,396e55fb-9a71-4b8c-9e33-2e7179a87d1f,,3,7,8,6,3,41f5c96c-a27a-4015-be50-af967b6c4bac,5
5,9,42,"BRIAN App - Patient data; treatments, PROMs, multi-modal data and demographics",7,7,10,10,38,3a0a0acd-c549-41f4-8188-14235decf473,,3,7,8,6,3,37c82bb7-eaae-4f16-97b6-045373b7ba18,5
5,9,42,Congenital Anomaly Register and Information Service (CARS),6,7,10,10,38,3a0d2dea-32c4-40bc-8ad8-be8cd20440b8,,3,7,8,6,3,6fe7e004-eb51-4c7b-9905-1ec9a4827dca,5
5,9,42,SICSAG Daily (Scottish Intensive Care Audit Group),6,7,10,10,38,3a880d1a-bd02-4d23-bca0-4b6ac45b09f1,,3,7,8,6,3,811a54fb-8b79-442f-8e28-a725a0561a15,5
5,9,42,Annual District Birth Extract,6,7,0,10,6,3ab70331-aa54-4f0d-aa95-ea2b95bed9d5,ALLIANCE > SAIL,3,7,0,0,0,12a77014-4a77-4eb1-8b26-f49689352d1b,0
5,9,42,Emergency Department Data Set,6,7,0,10,6,3abe6b38-e479-4eb3-87d6-ef4803ff88f9,ALLIANCE > SAIL,3,7,0,0,0,75c4dcb8-33bf-43f4-b2bb-db51b6621b2c,0
5,9,42,National Paediatric Diabetes Audit - Parent and Patient Experience measures,6,7,10,10,38,3adb43c7-cc13-423a-9625-8fd571bbcb26,,3,7,8,6,3,b0979e07-3331-408f-853b-5eeba80ce8f9,5
5,9,42,IBD NIHR BioResource: Consent records,6,7,2,10,9,3b0a3b33-dbd5-4cb0-b863-0e1fd80c9a1e,HUB > GUT REACTION,3,7,1,0,0,44ca2cf8-679e-447c-a9eb-55b32159679a,0
5,9,42,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - case note audit,7,7,8,10,28,3b6d2dbe-0241-4c38-9038-2d6ce1e280de,ALLIANCE > HQIP,3,7,7,0,3,24b88d1a-4363-4619-870e-9ba9fc5d09e1,4
5,9,42,CDE Surginet Documentation,7,7,10,10,32,3b752633-8274-4418-b15b-4502bab03935,ALLIANCE > BARTS HEALTH,3,7,8,0,3,4c4bc482-16f5-462f-8daf-51ec6492074d,5
5,9,42,IBD NIHR BioResource: Demographic,6,7,10,10,38,3b8357ac-bf06-44c4-9a43-8e772bec709c,,3,7,8,6,3,b4121feb-f91b-4e20-a19b-fa49c7a5c1c1,5
5,9,42,"Investigations, interventions, and outcomes for acute coronary syndrome",6,7,10,10,38,3b84d205-2175-4c9a-bbe3-d0e24434e625,,3,7,8,6,3,b8f2c611-21d0-424e-a1ed-6976b1c207ec,5
5,9,42,IBD NIHR BioResource: SNP imputation data,7,7,3,10,13,3bb25cba-b4dc-47f1-ab5e-b63f89500612,HUB > GUT REACTION,3,7,1,1,1,7dee2bd6-733a-4b2e-a942-7f9eaf8ebbc2,1
5,9,42,Active Adult Survey Dataset (AASD),6,7,10,10,38,3c14d319-4ff5-42ff-b440-400f099f9b13,,3,7,8,6,3,1eb67fd5-33f6-49dd-a43d-854fff9f25f5,5
5,9,42,Tissue Solutions Ltd,7,7,2,10,10,3c23941a-42a7-4940-b32f-aea743c0dc2a,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,bbcdc352-e0f7-4672-93a7-134bcf5001b1,1
5,9,42,Postponed Admitted Procedures (CAPD),6,7,10,10,38,3c870bf2-acfb-44d1-8437-06ebb3c0993c,,3,7,8,6,3,bff94600-a254-4111-82f7-6167084d81ca,5
5,9,42,Vaccine Adverse Reactions data for QResearch,6,7,10,10,38,3c899660-32e3-4acc-9583-9d8251bd6f80,,3,7,8,6,3,9ad92ce4-7410-4edc-a5ac-2c0c64915f4c,5
5,9,42,North West London Outpatient Care Data (NWL OP),6,7,1,10,7,3d51dc99-c44f-44ff-bdab-da205c5e394e,HUB > DISCOVER NOW,3,7,0,0,0,9f1df859-f1d0-4f1e-959e-affd05138a25,0
5,9,42,Ethical Tissue - University of Bradford,7,7,2,10,11,3db58c78-fc8b-49b2-a847-b43fd0184500,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,fdf9ac68-fc89-4adf-9a73-3a94a9974aef,2
5,9,42,Diagnostic Imaging Dataset,6,7,10,10,38,3e4d27e2-baa8-4bb5-a711-d0b36f1f278c,,3,7,8,6,3,86f46be3-bc29-4820-8363-de6530a94c6f,5
5,9,42,CPRD GOLD ICNARC,6,7,10,10,38,3e923281-bfde-48a8-86fd-73e429cce811,,3,7,8,6,3,0e47bbf0-0d60-4c7c-85a5-543957635471,5
5,9,42,Higher Education Statistics Agency (HESA),7,7,10,10,38,3ed8d3fe-92a3-43bc-9fba-274fb34847af,,3,7,8,6,3,36f54a48-6f0a-4827-a86b-fd677a22a88f,5
5,9,42,mHealth for pneumonia prevention,7,7,10,10,38,3ee4c2af-ff04-4dcf-830e-420e0a21a6d2,,3,7,8,6,3,fc66381e-cc46-4bca-85fc-fc2ee09cc5dd,5
5,9,42,Multiple Sclerosis and Parkinson's Tissue Bank,7,7,2,10,11,3f00330d-1f45-4cab-86c2-e91b7c1a59e9,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,4684d391-a6a7-44f7-bf4b-62b6b693f9fa,2
5,9,42,Outpatient Appointment Dataset,6,7,10,10,38,3f6962d8-1f4c-49b0-80a8-e491d5205827,,3,7,8,6,3,1c27bfbf-c659-42ff-8afe-d58250b49c07,5
5,9,42,Barts Health NHS Trust COVID-19 EHR Extracted Dataset,6,7,3,10,13,3fbef1ac-fa6d-4c72-836d-3a8d8a0f7b08,ALLIANCE > BARTS HEALTH,3,7,2,0,1,d6e8163f-2ab8-4880-bbb6-a174b4a95632,1
5,9,42,The impact of ethnicity and multi-morbidity on C19 hospitalised outcomes,6,7,2,10,13,3fc555e1-3e36-46dc-bef1-2d94d560bcb2,HUB > PIONEER,3,7,3,1,0,cfa1ef13-8ae0-4827-8a0f-9d2df5244725,1
5,9,42,National Paediatric Diabetes Audit - survey of workforce in PDUs,6,7,10,10,38,3fcdcced-e16a-4f04-a521-ffe1047f37cb,,3,7,8,6,3,fe8f8e2c-2f77-464d-9d45-a601cb2f8bf9,5
5,9,42,Cafcass Wales,6,7,0,10,6,3fceb952-0b21-40f4-bd69-fa5cd7ad7df9,ALLIANCE > SAIL,3,7,0,0,0,29a714e1-5289-4362-be24-2848c954344e,0
5,9,42,Estimating Chronic Respiratory Disease burden in adults in Asian LMICs,7,7,10,10,38,3fd2760d-ab12-48ee-8b32-b229aead60a4,,3,7,8,6,3,56130df6-1880-4600-a7a4-afa9a4bcc895,5
5,9,42,Endobase,7,7,10,10,33,40573895-497b-4d47-90e1-6aafe70b93f6,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,3,7,9,0,3,e830b2a5-14d6-4643-a206-619bf5372dc8,5
5,9,42,Domiciliary Social Care Worker [DSCW],6,7,5,10,16,41a667eb-1c84-4665-b0d4-d26405d277c5,ALLIANCE > SAIL,3,7,2,1,1,0e38bbf4-c788-4a1a-9af8-a24821250154,1
5,9,42,Care-seeking practices for childhood pneumonia in non/tribal areas of Pune India,7,7,1,10,13,41ac5dfd-7b23-4f1b-a91e-03e8186e4ab8,HUB > BREATHE,3,7,2,0,2,4346676d-6108-47de-b579-6cef74c6acef,2
5,9,42,Quality of Life of Colorectal Cancer Survivors: Patient Reported Outcomes (Aurum,6,7,2,10,12,41ce265a-c252-45c4-9b80-d764b0737f38,ALLIANCE > CPRD,3,7,1,0,2,bfb90d2b-746d-44a6-a896-4979d73d9276,1
5,9,42,Death Registration Data - Finalised Extracts,6,7,10,10,38,41f6dfe9-d5e2-4641-9953-1589c7d35e07,,3,7,8,6,3,fdfa5116-4f44-457d-99ef-e8c1852aa858,5
5,9,42,National Asthma and COPD Audit (NACAP): secondary care  – CYP asthma (clinical),6,7,10,10,38,425e39b4-cc2b-4a15-851a-a0093ef1e1f8,,3,7,8,6,3,33b36393-3760-40d8-bb98-61806fea5398,5
5,9,42,Mental Health and Learning Disabilities Data Set,6,7,5,10,20,4262e057-6978-4e4c-a05d-c4f328422090,ALLIANCE > NHS DIGITAL,3,7,1,0,3,e9b43936-e700-40c9-8b32-57ed44583f3d,5
5,9,42,Cystic Fibrosis Patient Microbiology Cultures,6,7,0,10,6,42ac7c27-a37b-4081-8a33-51ac077e6a4e,ALLIANCE > CYSTIC FIBROSIS TRUST,3,7,0,0,0,9c1727f6-2032-413f-bf60-470769b2616e,0
5,9,42,Pathology - PATH,6,7,10,10,38,42e4299f-1e06-4e24-ab40-b71949f5cba3,,3,7,8,6,3,48ef8f54-9606-4e6f-9256-3cc07ffd10b8,5
5,9,42,Covid-19 Infection Survey linked with VOA and EPC data,6,7,10,10,38,4330b6ee-f333-4cd8-90b9-0f43f7cb0b67,,3,7,8,6,3,2193ad56-6671-4ecc-9ecf-6da84e23e9fd,5
5,9,42,Welsh Ambulance Services NHS Trust,6,7,0,10,7,45499ef9-daca-4a88-8493-c3c1a92960d0,ALLIANCE > SAIL,3,7,0,0,1,d415a5c5-8432-4a81-937f-12135ade6de7,0
5,9,42,Asthma and COPD: practices and perceptions of GPs in rural India,7,7,1,10,11,458d7f2d-9ba8-4593-862c-14160692d494,HUB > BREATHE,3,7,2,0,2,c15bc3ad-c053-496b-863f-1d54075d5bd4,0
5,9,42,Public Health Research Database (PHRD),6,7,10,10,38,459387f3-c484-441d-9abb-b6ee22df86d2,,3,7,8,6,3,a325f33e-bac8-49af-896f-1e025941dae8,5
5,9,42,Mental Health Minimum Dataset v4 (Sensitive) Events,6,7,4,10,19,46493a09-b3bb-4c0e-b944-82665ee21508,ALLIANCE > NHS DIGITAL,3,7,1,0,3,9c31a2bd-ff3a-4379-a4b8-0b90527a4c38,5
5,9,42,National Paediatric Diabetes Audit - Spotlight survey of workforce in Paediatric Diabetes Units,7,7,8,10,28,46762bdc-42f9-4c92-92fe-9c757083ad33,ALLIANCE > HQIP,3,7,7,0,3,fe8f8e2c-2f77-464d-9d45-a601cb2f8bf9,4
5,9,42,Maternity Indicators Dataset,6,7,0,10,6,46e30817-b19e-40f2-9b06-9611b2985148,ALLIANCE > SAIL,3,7,0,0,0,a0c27454-8cbe-418f-bdae-a85d5e92e9d4,0
5,9,42,Developing and Evaluating Interventions to Improve Asthma Care,7,7,10,10,38,46f6e0d3-412e-4799-8683-1ca649b99eec,,3,7,8,6,3,d57d7956-d13e-49c4-bb31-889b8e560596,5
5,9,42,Sentinel Stroke National Audit Programme Acute Organisational survey dataset,7,7,8,10,28,4710222c-9830-4ae4-8be6-b25c723812e1,ALLIANCE > HQIP,3,7,7,0,3,fe6a4c83-f46f-4f61-8460-e120fdf8d864,4
5,9,42,Tayside Biorepository,7,7,2,10,11,47d22aea-cbe9-47d4-8f65-45861d9c5f6f,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,6ac9b356-00f1-49da-825a-6eb04d18e49d,2
5,9,42,NIHR IBD BioResource: Consent records,6,7,10,10,38,47e26b2b-8be1-4595-a327-a9f00e0d4712,,3,7,8,6,3,44ca2cf8-679e-447c-a9eb-55b32159679a,5
5,9,42,"St Thomas' Hospitals Plasma, serum & DNA Bio bank from patients with antiphospholipid antibodies",7,7,2,10,10,47f57de8-aa71-4df1-af4a-a81e37d4ae8c,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,425f4534-51c4-4f75-8ca0-d7c731dbd903,2
5,9,42,North West London Primary Care Prescriptions Data (NWL PCP),6,7,1,10,7,48182af6-2ccd-44b2-92d5-69cc140e7d67,HUB > DISCOVER NOW,3,7,0,0,0,0fb33df6-ab36-4170-9fad-1eaf35a3a812,0
5,9,42,A granular assessment of the day-to-day variation in emergency presentations,6,7,10,10,38,483be944-b3ea-4037-b22b-4e9ffca3e613,,3,7,8,6,3,ef850406-2993-43ec-80b9-ef504734f2ac,5
5,9,42,National Vascular Registry - Organisational Audit dataset,6,7,10,10,38,483f49ea-07b3-4efb-8bad-0d9af5ed5f0f,,3,7,8,6,3,3c661240-e4d2-456c-a809-133c23f9c469,5
5,9,42,Falls and Fragility Fracture Audit Programme National Audit of Inpatient Falls clinical dataset,7,7,8,10,28,489cb34a-f20d-4fe0-849a-db85f00141f5,ALLIANCE > HQIP,3,7,7,0,3,3c19e2c9-96d5-45f3-9c55-fc3cec762cd7,4
5,9,42,NIHR BioResource: Sample holding,6,7,10,10,38,48deb24e-7a15-48d7-ba2c-c477ae61b55d,,3,7,8,6,3,56993820-96e4-4a1f-9de1-bad53108c201,5
5,9,42,"National Audit of Dementia - spotlight audit on the prescription of psychotropic medication, 2019",7,7,8,10,28,491cc634-05e8-48fe-9018-ffb9e7eed84e,ALLIANCE > HQIP,3,7,7,0,3,949d9d7a-a3f1-480a-8563-3fb024300561,4
5,9,42,Cancer registration data for CPRD Aurum,6,7,10,10,38,4a4f5d83-e8fb-4249-9275-2a42d9f76c53,,3,7,8,6,3,3f3df3be-05a8-42b2-89d9-f731deb7ea66,5
5,9,42,Tayside & Fife Radiology,6,7,10,10,38,4abe1436-3a14-4779-aa03-28929e817411,,3,7,8,6,3,af10ec29-1866-4726-b33f-3948afe182f2,5
5,9,42,Epilepsy 12 - National organisational audit (service descriptor questionnaire) and Trust profile,7,7,8,10,28,4b2fbd88-71c7-4572-99ea-5987a72a0c1a,ALLIANCE > HQIP,3,7,7,0,3,2c737d63-69f4-4a02-8df9-54c1e65e845f,4
5,9,42,South East London Community Health Study (SELCoH),7,7,10,10,38,4b3d70f4-ce62-478b-9ada-0419850d17af,,3,7,8,6,3,cda770e3-0d4d-466f-8102-c56beff04848,5
5,9,42,Systemic Anti-Cancer Therapy Dataset (SACT),6,7,10,10,38,4b59ff6f-2830-4f2b-b35a-623ef4520eb8,,3,7,8,6,3,6c4ed998-0f05-415c-a3e4-42430bb62d24,5
5,9,42,Daily Situation Report Data,6,7,0,10,7,4b6d3344-e73a-4f46-8e9d-fabb85827772,ALLIANCE > SAIL,3,7,0,0,1,c74a9b9e-1fea-4aac-99fd-54e30668e085,0
5,9,42,National Early Inflammatory Arthritis Audit - organisational survey dataset,6,7,10,10,38,4b79bce2-6d1c-448b-969e-56b424f3d57a,,3,7,8,6,3,a9ac99fe-32be-40ef-9509-03e6b2713ddf,5
5,9,42,HES Outpatient data for CPRD Aurum,6,7,10,10,38,4bf36706-8176-4525-a3f4-3b96f68e48de,,3,7,8,6,3,8d3f3e58-be79-4450-b2e3-f5ab8a25fb0e,5
5,9,42,Assessment of ASHA’s workload and its determinants,7,7,10,10,38,4c171540-5caa-42f7-868d-1d4d7b969f11,,3,7,8,6,3,1a02bc11-a378-4f9e-82f9-c52674b388bd,5
5,9,42,"Prevention, detection, treatment: adult lung disease/cancer in rural Tamil Nadu",7,7,1,10,13,4cb9082f-619d-4be2-8d09-641f2c573d38,HUB > BREATHE,3,7,2,0,2,2581994d-5be2-4465-bb62-60c4c97e8e2b,2
5,9,42,Obesity Research Biobank Syndicate (ORBiS),7,7,2,10,11,4cde083a-bf5a-4f57-97c6-38632e10050d,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,264a1987-a8cb-4a83-81e0-70b4c3893b7d,2
5,9,42,National Oesophago-Gastric Cancer Audit - clinical dataset,7,7,8,10,28,4d0c3779-9251-4a4a-9eff-41a47869157f,ALLIANCE > HQIP,3,7,7,0,3,306274ee-a098-43cc-b113-2df8116a8703,4
5,9,42,Paediatric Intensive Care Audit Network - core dataset (admission),7,7,8,10,28,4d1271dd-b256-454b-9b13-be38bef73f15,ALLIANCE > HQIP,3,7,7,0,3,4ca76471-6970-4ad4-87c7-fae77a98cbf5,4
5,9,42,NIHR BioResource: SNP chip data,6,7,10,10,38,4d560a49-6ab2-460c-980f-94d76d1527f2,,3,7,8,6,3,c388676c-a5e5-419c-967c-239c1f0c3c5c,5
5,9,42,POUT-T,7,7,2,10,11,4dd3f23c-44be-4126-aac5-ba655d07855c,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,c6e0e70e-7f23-4a44-a2cf-1d7d87be7808,2
5,9,42,Death Registration data for CPRD GOLD,6,7,10,10,38,4eb62568-e89c-4d85-af0e-095e1e5b8a36,,3,7,8,6,3,1d35e229-13eb-4be1-9dae-4752b6c27c4a,5
5,9,42,"Longitudinal hospital prescribing data for >48,000 deeply phenotyped patients",6,7,10,10,38,4f32f054-0183-4515-8c18-00cd7a5a63af,,3,7,8,6,3,6c8894f0-3675-4e65-baa8-88ce539b3fd1,5
5,9,42,QResearch®,6,7,10,10,38,4f385ff8-109c-4e7e-ad09-ee0021864989,,3,7,8,6,3,777d6ac1-6879-4750-9a85-9e42d28bb8d4,5
5,9,42,Trusted Research Environments for CVD-COVID-UK / COVID-IMPACT,7,7,10,10,38,4f38a842-d30b-41db-9a6e-cd271f8a3392,,3,7,8,6,3,7e5f0247-f033-4f98-aed3-3d7422b9dc6d,5
5,9,42,National Audit of Dementia Round 4 - carer experience survey,7,7,10,10,38,4f3fff58-7c32-4879-8ac2-f3c7641fbb85,,3,7,8,6,3,3b5907da-256d-49a3-b24b-00893afe8bdd,5
5,9,42,"Maternal, Newborn and Infant Clinical Outcome Review Programme - perinatal surveillance dataset",7,7,8,10,28,501b0226-1cbf-4717-8dee-adf189dd0088,ALLIANCE > HQIP,3,7,7,0,3,11deee42-5876-4ebe-acca-e996702e1343,4
5,9,42,National Cardiac Audit Programme - Myocardial Ischaemia National Audit Project (MINAP),7,7,8,10,28,50609a73-30a0-46ca-847d-4a9c1bfec5fc,ALLIANCE > HQIP,3,7,7,0,3,3558f8a1-6d52-4b59-b513-51c068095bc2,4
5,9,42,National Audit of Dementia Round 4 - staff questionnaire,7,7,10,10,38,51221591-a4d4-4b9f-a220-b72d860d99fd,,3,7,8,6,3,ef6e68d6-dcba-410c-943c-26ca21376a3a,5
5,9,42,Looked After Children Wales (LACW),6,7,10,10,38,51ad73b3-dd3e-44ad-b941-0d5d12bcb0cd,,3,7,8,6,3,cfdafacb-48f0-4ad8-9f20-193a5eec2da4,5
5,9,42,The Airwave Health Monitoring Study,6,7,10,10,38,51f9de9e-5fcd-4629-bdfc-7719359a7ec6,,3,7,8,6,3,98bfe17f-be12-47b1-943a-2d3a621b7618,5
5,9,42,ARIA Dataset,7,7,10,10,32,5271131b-ba5b-452d-b230-077094a031c2,ALLIANCE > BARTS HEALTH,3,7,8,0,3,621dd611-adcf-4434-b538-eecdbe5f72cf,5
5,9,42,Respiratory rate counters in paediatric pneumonia diagnosis,7,7,10,10,38,52db3903-e6c1-4f03-b6ee-909967fe3d16,,3,7,8,6,3,beeee4fb-55ab-41b0-9287-33f008e9d6bf,5
5,9,42,Scarred Liver,7,7,10,10,38,53099fb6-18ff-4edc-b76d-225dade94db3,,3,7,8,6,3,17f80626-5adf-4777-9ccf-7f0cd107daa6,5
5,9,42,North West London Adult Social Care Data (NWL ASC),6,7,1,10,7,535a0983-6618-4211-a939-ae2edfe26f9a,HUB > DISCOVER NOW,3,7,0,0,0,de9cf0f5-b26a-4363-9df8-3628a4aa6b6e,0
5,9,42,National Records of Scotland (NRS) - Deaths Data,6,7,10,10,38,53846ac7-61b7-4403-8556-c319d04b546d,,3,7,8,6,3,e600dae2-a83c-4b7a-8d23-af4ac31ca374,5
5,9,42,Ventilatory strategies and outcomes for patients with COVID: a dataset in OMOP,6,7,2,10,15,53b7c446-667b-409e-920e-67cb516de3ae,HUB > PIONEER,3,7,3,2,1,cacba424-6c2c-4b57-8f5b-64e92a78370a,1
5,9,42,Scottish Medical Imaging (SMI) Research Dataset,6,7,10,10,38,53dbbca0-b57d-4f93-8f05-37f626f9a7bc,,3,7,8,6,3,1c49a822-6432-468b-8ba5-6aab534654b9,5
5,9,42,Cervical Screening Wales (SCSW),6,7,10,10,38,542bf16f-baea-4fca-be51-fcef9732494a,,3,7,8,6,3,b32325d7-7f00-4d20-9935-dd02e1bc6932,5
5,9,42,Epilepsy Society Brain and Tissue Bank,7,7,2,10,11,54a7dd45-d6c7-4b4d-801d-2becd2b694f1,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,f13258c3-f85a-4772-b42e-da8a84c5064a,2
5,9,42,HES Outpatients data for QResearch,6,7,10,10,38,555f609d-c48d-431a-98b4-fb4198b5ad79,,3,7,8,6,3,8321071e-88ef-4d7e-8cf8-ab826c00096c,5
5,9,42,RTDS - Radiotherapy treatment data set for QResearch,6,7,10,10,38,5575bf81-2d52-40e3-b95a-7ba43d718965,,3,7,8,6,3,3a65467a-61a1-4801-ba73-1e062de75c85,5
5,9,42,IBD Registry COVID-19,7,7,10,10,38,55b311a8-7162-410c-8cf7-eef1ac9ff544,,3,7,8,6,3,ffdf167b-f3a3-4d78-a228-2865aea90509,5
5,9,42,LBIH Biobank,7,7,2,10,11,567b23fe-abf2-4e2e-88f7-505dfeaa3cde,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,c0318a31-a32c-4d3a-9591-dfe9352bf2b9,2
5,9,42,Assessing the feasibility and effectiveness of introducing pulse oximetry,7,7,10,10,38,567b5d24-07df-4430-8466-4444ecbe86c8,,3,7,8,6,3,2f36b7b3-e50f-459f-a691-f62dde65e2bd,5
5,9,42,TNT: Triple Negative breast cancer Trial,7,7,2,10,11,56f3e791-a204-4f67-a4d0-52803148d71a,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,5f4c825d-d6c3-453e-9667-8cdf2329b6e1,2
5,9,42,Wellcome Sanger Institute: Whole Exome Sequencing,7,7,10,10,38,5727d014-0c5c-4dcb-89c9-ff33e1b680bb,,3,7,8,6,3,cd20517c-2f75-40e9-9ee8-563d32624b55,5
5,9,42,NIHR IBD BioResource: Health and Lifestyle Questionnaire,6,7,10,10,38,57458394-945e-4e6a-abc7-91df0f44cb60,,3,7,8,6,3,18bfe765-5733-41f3-8114-0a1ec2524b5b,5
5,9,42,Coronavirus and the social impacts on Great Britain,6,7,2,10,13,575514e3-6e8f-4218-bd75-ff32742abc52,NCS > OFFICE FOR NATIONAL STATISTICS,3,7,2,0,2,e253257c-48c2-491b-b3b9-205161a16a7e,1
5,9,42,COVID-19 Test results,6,7,0,10,6,57726e95-afe2-4d62-ab1e-81d90eb0ec1d,ALLIANCE > SAIL,3,7,0,0,0,f5f6d882-163d-4ef1-a53e-000fba409480,0
5,9,42,CPRD Aurum ICNARC,6,7,10,10,38,57a2febd-6ff7-402b-9503-b362d476257f,,3,7,8,6,3,d1490c18-b6a0-46a2-915f-d7145f02e36f,5
5,9,42,National Radiotherapy Dataset (RTDS) for CPRD Aurum,6,7,10,10,38,580b029e-4cce-44db-9c76-f8530cf599db,,3,7,8,6,3,9c535c8d-ebac-4212-b602-fc2489df2c92,5
5,9,42,Daily Situation Report Data (DSRD),6,7,10,10,38,58c38549-7b97-427e-94b2-591d700e233b,,3,7,8,6,3,c74a9b9e-1fea-4aac-99fd-54e30668e085,5
5,9,42,Exploration of Pneumonia Related Policy Formation and Implementation in Pakistan,7,7,10,10,38,590e7bb7-a6e3-4f87-af2f-e46943f98ce9,,3,7,8,6,3,e0d00cb7-62e1-4a38-8df6-cf537b59228d,5
5,9,42,Computational Framework to Interpret Chest X-rays and Diagnose Pneumonia,7,7,10,10,38,598ab9d9-04a3-4628-be64-d8f026d266ac,,3,7,8,6,3,cf9bc775-1db7-44e4-9a16-317d5bb063a2,5
5,9,42,National Cardiac Audit Programme - Percutaneous Coronary Interventions (PCI),7,7,10,10,38,59f5b724-234f-401d-a8f5-df35ea9ecdc9,,3,7,8,6,3,ac7016ce-f7a9-4c71-bebb-6af6efa27844,5
5,9,42,HES Patient Reported Outcomes Measures (PROMs) data for CPRD GOLD,6,7,10,10,38,5a108169-4afd-4e02-908b-c65bddc3bd2e,,3,7,8,6,3,2439a88e-d961-4152-a7b5-042097946209,5
5,9,42,National Cardiac Audit Programme - National Adult Cardiac Surgery Audit (NACSA),7,7,10,10,38,5a6009f8-c74a-4e72-b2a1-83be100f7841,,3,7,8,6,3,5f37e3c2-b5ac-43eb-8eba-ac94dbbff103,5
5,9,42,National Joint Registry - Primary Ankle Replacement dataset,6,7,10,10,38,5ad2e0c9-f0ba-4947-90f7-b19431080f83,,3,7,8,6,3,b8d009d0-0163-4aaf-8bd6-ad363c859862,5
5,9,42,Longitudinal C-reactive protein concentrations in COVID-19: an OMOP dataset,6,7,10,10,38,5b456d15-cb68-4944-839c-c25a2986e572,,3,7,8,6,3,597524d4-038e-4fc2-aff9-1c9b87d3e16c,5
5,9,42,North West London Accident and Emergency Data (NWL A&E),6,7,1,10,7,5b9b7964-615b-438a-b151-d2f884a24aee,HUB > DISCOVER NOW,3,7,0,0,0,721db252-8069-433d-bb6d-4b44b243d364,0
5,9,42,VinCaP,7,7,2,10,11,5bb40472-fc5d-4b16-a0a6-d1d42fd1d3e8,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,e57dd7a2-3c5c-4285-8001-8e2589c395e9,2
5,9,42,Cancer registration data for CPRD GOLD,6,7,10,10,38,5c2cd37f-a930-4e92-85a4-76394838ce90,,3,7,8,6,3,e2f5d637-94b3-447b-b7eb-ea957ce449b6,5
5,9,42,International Severe Asthma Registry,7,7,5,10,18,5c7ae78d-53e6-427d-a3a9-52538f8342dc,HUB > BREATHE,3,7,5,0,0,9711e6cc-426c-4cef-afb3-64382f8d7ed4,2
5,9,42,Mental Health Dataset (MHDS) for CPRD Aurum,6,7,10,10,38,5ca0f47a-307f-448e-911c-24e01c79120f,,3,7,8,6,3,48627b2d-f247-4921-9ee1-6c37adfff10d,5
5,9,42,Education Daily Attendance Dataset (EDAD),6,7,10,10,38,5cd5a6a1-f7a2-4d83-a3e3-423495c3a281,,3,7,8,6,3,17056e83-ee5a-4fe7-86e1-f09563256be1,5
5,9,42,National Waiting List Diagnostics,6,7,10,10,38,5ce6905a-8b54-4d6c-9da6-e2d57ce45419,,3,7,8,6,3,e508951d-e118-4217-84a4-722e50fdd400,5
5,9,42,Renal Register – ISD National dataset,6,7,10,10,38,5cf49b5c-bb8d-4ab2-90ce-74d801f7c090,,3,7,8,6,3,32edd77d-533c-423f-b045-937507f8505d,5
5,9,42,Moorfields Ophthalmic Prescription 004,6,7,10,10,38,5d577e70-2b9b-4286-81f3-824978dc3069,,3,7,8,6,3,2ec8d8e3-35bc-4304-83e8-3afed4438cd5,5
5,9,42,NIHR BioResource: Case report form,6,7,10,10,38,5de9d313-fb9f-4dbf-a959-1329062eb1ef,,3,7,8,6,3,4b8675d3-dd87-4cca-804c-aaf0e4ff8140,5
5,9,42,ARIA Radonc,7,7,10,10,33,5e022f8f-4d07-44bb-a87c-43e31200fe1e,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,3,7,9,0,3,59d72237-6969-4f59-9e87-48138978abe8,5
5,9,42,National Joint Registry - Primary Hip Replacement dataset,6,7,10,10,38,5e044863-b792-4256-aa45-3235a6546e39,,3,7,8,6,3,03280e87-6975-4a2a-967d-b332cb788e44,5
5,9,42,North West London Mental Health Data (NWL MH),6,7,1,10,7,5e19a471-64e3-4aa4-ac56-6901d5e39e28,HUB > DISCOVER NOW,3,7,0,0,0,2d3ec99a-a087-4355-8539-5a22cef58910,0
5,9,42,Emergency Department Dataset Daily,6,7,0,10,6,5e2a7277-dc64-499a-b16d-51850d9ad00b,ALLIANCE > SAIL,3,7,0,0,0,fa257aa8-51fc-4eb7-a448-e473fa54686d,0
5,9,42,NHS Tayside and Fife Biochemistry (Lab Data Restructured),6,7,10,10,38,5e442584-9acd-4e8d-9448-5f8f2b937d56,,3,7,8,6,3,10ffac16-d0c2-4d53-ab6a-69a38e283223,5
5,9,42,Moorfields AMD Dataset Release 002,6,7,10,10,38,5e9d4a4b-544c-4739-b079-62f353086fde,,3,7,8,6,3,bf392537-82b4-4d71-ace0-e7bea3b167fb,5
5,9,42,National Cancer Registration and Analysis Service,6,7,10,10,38,5ef3573a-274a-41e1-8f64-9330109d59d1,,3,7,8,6,3,0a852454-ee67-443b-a091-d13499a71b41,5
5,9,42,HES Admitted Patient Care data for QResearch,6,7,10,10,38,5fbc74c1-e305-4697-bb02-1de6585d6113,,3,7,8,6,3,69996d55-ead8-4c8a-a2b6-eb5cdc0e7d75,5
5,9,42,Covid-19 Infection Survey,6,7,10,10,38,5fdfa652-eda8-4709-89e0-02d8412851d4,,3,7,8,6,3,628e9ad9-28c5-4d58-9ec5-04a63be9b4cf,5
5,9,42,North West London population data (NWL POP),6,7,0,10,6,601f1504-2706-405b-94cb-8cd14231f434,HUB > DISCOVER NOW,3,7,0,0,0,1032850f-7631-4d9e-a760-b0532bffd21a,0
5,9,42,"Investigating the impact of frailty, age and illness severity during COVID-19",6,7,10,10,38,602dc3ef-8c76-4ad4-941b-0a39e50481e7,,3,7,8,6,3,108ba1b0-994d-449c-b192-2331698e477d,5
5,9,42,STAMPEDE,7,7,2,10,11,60b148f7-b48c-49c4-9286-b83691cfc7b2,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,71eb0192-1124-4b27-86e4-1139e0047a02,2
5,9,42,Weekly SUS Inpatient Dataset,6,7,10,10,38,61b34cfb-041b-46a3-801d-1932b92795b9,,3,7,8,6,3,3858647c-5161-45dc-ba49-66a4fc4499c2,5
5,9,42,COVID-19 Wastewater data,6,7,10,10,38,61df41f6-6d91-4144-b29d-489dd73c48a1,,3,7,8,6,3,fa9c25eb-1ce0-4f44-b6a6-46ec8caeef40,5
5,9,42,HES Admitted Patient Care data for CPRD Aurum,6,7,10,10,38,62663e36-f8cb-4ca0-9fdf-bca1023726d3,,3,7,8,6,3,ed2de8fe-a204-4a4e-bcfa-9e3ad85e2fee,5
5,9,42,GENOMICS ENGLAND 100K PHE LINKED DATA,6,7,0,10,6,62c01293-83a5-4d4d-9d36-9d7aa2bf120f,GENOMICS ENGLAND,3,7,0,0,0,ea748742-568a-46e2-b603-2fada49024e1,0
5,9,42,Vitamin D supplementation meta-analyses,7,7,8,10,25,62fef8d2-c397-43c3-b14a-69cf89423887,HUB > BREATHE,3,7,5,0,2,2454a964-be58-4d1f-8f9a-ffae9db9129c,4
5,9,42,Intensive Care National Audit and Research Centre - Covid19 (ICNC),6,7,10,10,38,63f5c784-e0ee-46db-bbe5-279164033ed4,,3,7,8,6,3,add6226b-0f21-439a-84a6-51dc26cdc425,5
5,9,42,Tayside Microbiology Lab,6,7,10,10,38,6421830a-148d-4f86-8cd3-cefb5177610c,,3,7,8,6,3,826be5be-9977-49f9-b6d1-83ed9de08ebe,5
5,9,42,Suspected Cancer Pathway Monthly (SPCM),6,7,10,10,38,645168a0-21b1-4e13-85d8-266ad9040af8,,3,7,8,6,3,fcf5a844-f48d-428e-aa06-abe64e66185e,5
5,9,42,Intensive Care National Audit and Research Centre (ICCD),6,7,10,10,38,6456c509-aa71-45de-b4f4-251448e45cbc,,3,7,8,6,3,fa8bf269-4769-491b-b398-fa63137d14ab,5
5,9,42,"Trusted Research Environments for CVD-COVID-UK in England, Scotland, and Wales",7,7,10,10,38,646d65df-fc4c-4680-b949-79ec8f40b406,,3,7,8,6,3,7e5f0247-f033-4f98-aed3-3d7422b9dc6d,5
5,9,42,Civil Registration - Deaths,6,7,10,10,38,649261ce-833f-459e-908c-2ef93c5fed41,,3,7,8,6,3,050163dc-1728-4ac5-a7d9-4dd3ca0ca12a,5
5,9,42,Welsh Cancer Intelligence and Surveillance Unit (WCSU),6,7,10,10,38,658c4030-3a6d-4e67-abea-25601a478861,,3,7,8,6,3,368ad790-3ad8-4f93-9a7c-0bfb64dc6015,5
5,9,42,Diagnostic and Therapy Services Waiting Times,6,7,0,10,7,65c8a30c-de2c-47bf-87e4-18c86e75e54a,ALLIANCE > SAIL,3,7,0,0,1,97896866-ab5e-408a-ac5a-072802db9faf,0
5,9,42,Careers Wales Dataset (CARW),6,7,10,10,38,65ce36d2-f5fa-4a10-b210-b917fbb7c8a5,,3,7,8,6,3,e4004e0e-6adb-4b11-82c2-af0caf61d751,5
5,9,42,Falls and Fragility Fracture Audit  Programme - Inpatient Falls clinical dataset,6,7,10,10,38,65eaa19c-e4b6-4611-922a-4be585a6d348,,3,7,8,6,3,3c19e2c9-96d5-45f3-9c55-fc3cec762cd7,5
5,9,42,Fife Microbiology Lab,6,7,10,10,38,6615ba0a-9bcf-4a3b-8204-283c5e741b2b,,3,7,8,6,3,0c43c0b6-de3a-478b-8190-4da37fbe5ff5,5
5,9,42,Theory of Planned Behaviour Intervention: respiratory disease in South India,7,7,1,10,13,661b27db-38d4-4a9c-ac40-e3146ef12350,HUB > BREATHE,3,7,2,0,2,7d23e729-72b0-4dd1-820d-07697b49acd0,2
5,9,42,interNational Anaplastic Thyroid Cancer Tissue Bank (iNATT),7,7,2,10,11,6620b221-6909-4106-a49e-f1b5820be2f3,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,5ef75d71-73ce-4451-9d7a-a39dd82b712f,2
5,9,42,The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) primary care sentinel network and database,6,7,1,10,7,664513d6-d766-461d-a69e-206a928cd14f,ALLIANCE > ROYAL COLLEGE OF GENERAL PRACTITIONERS,3,7,0,0,0,d5049af5-e351-4b22-8f75-6f3dfc96419b,0
5,9,42,National Asthma and COPD Audit Programme (NACAP): Adult Asthma secondary care clinical dataset,7,7,8,10,28,668eefeb-fb5c-46d8-a052-12fa8da4931b,ALLIANCE > HQIP,3,7,7,0,3,becd2624-9a01-4f01-bcf8-56e94545a49a,4
5,9,42,Scotland Accident and Emergency,6,7,10,10,38,670dbf72-0140-4228-b2de-4ad1ba1c920d,,3,7,8,6,3,05e6752e-3a0b-4809-aa14-207b4761ef60,5
5,9,42,NHS Tayside and Fife Biochemistry,6,7,10,10,38,672a54ba-0b41-4573-adf8-e97158fad9bc,,3,7,8,6,3,10ffac16-d0c2-4d53-ab6a-69a38e283223,5
5,9,42,NHS Tayside and Fife Haematology,6,7,10,10,38,674c290e-36c6-4d9b-a908-a23e89a6745c,,3,7,8,6,3,c294bb01-062b-494e-942b-1efe8cbac3dc,5
5,9,42,National Cardiac Audit Programme - Cardiac Rhythm Management (CRM),7,7,10,10,38,6762c371-8f4a-4511-910a-faf85760eab2,,3,7,8,6,3,3cc81e6c-0c17-4ccd-8202-a9aceb82c989,5
5,9,42,National Waiting List Clock Stops,6,7,10,10,38,67ab8a56-99d7-4951-aacb-5dca0b8ffa35,,3,7,8,6,3,3f073707-50b4-48cf-93b6-76843519a5c0,5
5,9,42,Genetics of Asthma Severity & Phenotypes,7,7,0,10,6,67cd0c2b-3944-4bc4-a03a-4081ee67847f,HUB > BREATHE,3,7,0,0,0,6277abc6-c039-4886-8489-d4a2cdb8190c,0
5,9,42,UK Renal Registry - AKI Lab Alerts Dataset,6,7,10,10,38,682b4d85-732a-4440-922d-07191a604143,,3,7,8,6,3,c38541a7-cf43-4bfd-928d-75613abc8e3f,5
5,9,42,Epilepsy 12 - clinical audit,6,7,10,10,38,68906d25-384c-4152-86b5-50c5170ad94c,,3,7,8,6,3,1fcaf429-8762-454c-b999-c5fdd757b880,5
5,9,42,Tayside & Fife Diabetes – Summary and a range of diabetes related datasets.,6,7,10,10,38,69220bf9-f223-4e88-91c8-8ae8eab9f438,,3,7,8,6,3,49e63323-e564-48ac-9f11-cf77bf0fe20b,5
5,9,42,Business Insights and Conditions Survey (BICS),6,7,10,10,38,693fd389-a3a9-4cc9-9a13-6218d84292fd,,3,7,8,6,3,8e739a01-bcfa-4b75-b7f8-e694ee185f8d,5
5,9,42,HES Diagnostic Imaging Dataset for CPRD Aurum,6,7,10,10,38,697690e1-e766-43be-bf89-244aab0641a8,,3,7,8,6,3,617f9f54-3fb6-40c3-b391-fe51d1fc7c49,5
5,9,42,"Deaths – CHI, Community Health Index",6,7,10,10,38,69833273-2b81-4657-8d80-5bafb2c0834d,,3,7,8,6,3,faf2fc49-d09f-4ea2-a2cb-b1d30fffa406,5
5,9,42,National Asthma and COPD Audit Programme (NACAP): primary care workstream resources,7,7,8,10,28,6a11bc97-b57a-458f-8a3e-98c71221cb5c,ALLIANCE > HQIP,3,7,7,0,3,8a3ec96a-0600-4c6d-8761-9d277f07b9da,4
5,9,42,North West London Patient Index (NWL PI),6,7,1,10,7,6a390359-1e26-470f-a4e5-bfb31a5ed643,HUB > DISCOVER NOW,3,7,0,0,0,1fe1e7bb-ef6e-4d89-9824-bb560afc81f0,0
5,9,42,Mental Health Services Data Set,6,7,3,10,15,6a63513f-92cb-43ce-b0dd-fdb1113150c9,ALLIANCE > NHS DIGITAL,3,7,2,1,2,fa2ec63d-f76d-4555-8fc1-f4bd66e3c60d,1
5,9,42,UHB Linked Diabetic Eye Disease from National Screening to Hospital Eye Care,6,7,10,10,38,6a9a3c4c-95d4-45da-9520-c3b9aceb6d13,,3,7,8,6,3,7c087b3c-cc04-4d3d-894b-7ea5419fa714,5
5,9,42,Synthetic Dataset: Patients at risk of sudden death: hypertrophic cardiomyopathy,6,7,5,10,18,6ae22437-38d7-4c47-b529-e100e15c81ab,HUB > PIONEER,3,7,3,1,2,7b1c1f1a-4fb2-452d-9a3c-7748992b1fa4,1
5,9,42,York Tissue Bank,7,7,2,10,10,6aebcd6d-10c6-44cd-80d6-b5a90791db4f,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,71e898d1-db8c-4887-a605-dd6336b92a34,2
5,9,42,Moorfields AMD Dataset 002,6,7,10,10,38,6af010f2-5973-486f-a44b-ef296455bee6,,3,7,8,6,3,bf392537-82b4-4d71-ace0-e7bea3b167fb,5
5,9,42,National Cancer TRE,6,7,10,10,38,6bbafb1d-09d3-443f-83db-cfd3a58a5e20,,3,7,8,6,3,b5439bc5-8141-4a13-a024-a6db2003b40e,5
5,9,42,Sheffield Brain Tissue Bank (SBTB),7,7,2,10,8,6bc36f07-d55a-4a97-afab-29d93dc65bde,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,bdda7221-7c02-4ced-b7a8-3806a073d981,0
5,9,42,Leicester Respiratory Research Database,7,7,3,10,11,6bca5d27-5b98-45e7-b834-6980ba5db5c9,HUB > BREATHE,3,7,0,0,1,01c3d08c-6948-4059-a027-3437e4f5d53b,1
5,9,42,Leeds Breast Research Tissue Bank,7,7,2,10,11,6bde3902-5d69-4c24-9d10-f84a63efdb22,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,2dc1218d-df5f-4025-826c-cf5ca7d67882,2
5,9,42,Moorfields Eye Image BioResource 001,6,7,10,10,38,6c12c555-c011-4f43-b98f-df0bfaad6b05,,3,7,8,6,3,6bfe44ef-9532-4986-b8a2-9c2cda4a89cc,5
5,9,42,Effects of second-hand smoke on pregnant women: a phenomenological study,7,7,10,10,38,6cae7a61-568d-40b1-984a-1dd9365f9c71,,3,7,8,6,3,4a5c610f-019d-450a-90c5-0fe315027f56,5
5,9,42,National Vascular Registry Audit Carotid Lower Limb Amputation clinical dataset,7,7,8,10,28,6cd16bca-395b-4dbc-a817-15fd55a1a8e8,ALLIANCE > HQIP,3,7,7,0,3,03e77b9d-57b8-44d5-8d64-9b1325958b22,4
5,9,42,DARWIN1 Trial,7,7,2,10,10,6ceec25d-2c8e-4dd7-8f99-2e56ec63c298,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,7f9672fa-dad5-479d-a929-52719e8cc2fa,2
5,9,42,Exploring Personal Preparedness and Self-Protective Measures during COVID-19,7,7,10,10,38,6dd170f2-c9fe-4496-9499-26783d84e3c2,,3,7,8,6,3,680a7d41-0fd1-4b32-a2cd-190e338f8ac7,5
5,9,42,"Introducing pulse oximetry in IMNCI, primary health facilities in Pune India",7,7,2,10,14,6dd62b6b-d832-4c65-a101-20fe9edd75fc,HUB > BREATHE,3,7,2,0,2,dae5b81c-db28-414b-9328-5596632a8732,2
5,9,42,Wales Cancer Bank,7,7,2,10,11,6dd6c679-7c5f-4d8e-b1e4-8f1447425e96,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,37886fb5-d0ae-400f-89eb-78664897bcf2,2
5,9,42,HES Accident and Emergency data for CPRD GOLD,6,7,10,10,38,6e1400af-cdad-4843-b8f2-ccc7d444e833,,3,7,8,6,3,733b1060-f958-4c3e-ab6a-2b87901d9a9a,5
5,9,42,Covid-19 Second Generation Surveillance System,6,7,10,10,38,6e47173e-651a-404e-a0b2-1fa1cbd887b1,,3,7,8,6,3,fede31c6-a9c5-4cfb-9866-9b58b2199cff,5
5,9,42,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - organisational audit,7,7,8,10,28,6e70b32a-dfbc-46d3-9784-479f3f09527e,ALLIANCE > HQIP,3,7,7,0,3,4b33fc6d-3cac-4404-adac-d693328456fa,4
5,9,42,Annual District Death Daily (ADDD),6,7,10,10,38,6e92101b-a660-4854-9a19-040324b6c9b3,,3,7,8,6,3,584bf8c8-d58f-44c6-9b65-e1611144fd54,5
5,9,42,TwinsUK,7,7,10,10,38,6eef1d16-2283-4932-aa6c-c71ae7fa9e3e,,3,7,8,6,3,19b4cd38-3828-4bb1-a980-4f7420658965,5
5,9,42,Intensive Care National Audit and Research Centre,6,7,2,10,11,6f348bdc-21e4-459b-b658-dc839a1e2133,ALLIANCE > SAIL,3,7,1,1,0,fa8bf269-4769-491b-b398-fa63137d14ab,1
5,9,42,National Early Inflammatory Arthritis Audit - patient survey,6,7,10,10,38,6f9a4cb1-7c5a-4671-838a-9554a6491266,,3,7,8,6,3,e87410ec-a819-43db-99d1-f887c977e525,5
5,9,42,"NHS Tayside A&E, Diagnosis dataset during A&E visit",6,7,10,10,38,6fbdc930-be40-4492-ba79-82d06d49b539,,3,7,8,6,3,14a39e96-8ac3-4df3-b42b-07718121c585,5
5,9,42,Covid-19 UK Non-hospital Antibody Testing Results,6,7,10,10,38,6fd8abda-7e49-436c-9131-a1f607569c14,,3,7,8,6,3,a77e52cc-d404-45d6-835f-32e2dc46778a,5
5,9,42,"NHS Tayside A&E, Diagnosis During A&E visit",6,7,10,10,38,6ffc7fd8-732f-4360-b38b-fa94dd75a13d,,3,7,8,6,3,14a39e96-8ac3-4df3-b42b-07718121c585,5
5,9,42,School Workforce Annual Census (SWAC),6,7,10,10,38,7017aede-b38a-4b70-b7b2-aade001d0cc0,,3,7,8,6,3,5692eade-5738-48ed-8527-39be9caaa7b5,5
5,9,42,National Records of Scotland (NRS) - Stillbirth Data,6,7,10,10,38,70491568-676d-43e4-b3c3-b1db4f1ff530,,3,7,8,6,3,dca0c95b-ae7d-4163-8c3b-a881f779df02,5
5,9,42,GoDARTS,6,7,10,10,38,705f86b8-4c2f-4ed5-b792-3a0d49d14c75,,3,7,8,6,3,8ca05f55-af73-42bd-b682-851c2c54a6cc,5
5,9,42,National Waiting List Clock Starts,6,7,10,10,38,708839a0-d003-4917-bbd9-92741f54ab75,,3,7,8,6,3,2b847fd2-0f65-43b7-84e1-10cec99d699e,5
5,9,42,BathTAP Switching Cohort 3,6,7,10,10,38,70ad0b2c-a8dd-4f91-a5b8-adca272bf215,,3,7,8,6,3,a20643c7-ef15-4f7d-9e48-5a9f23a645c1,5
5,9,42,CASPS: A Phase II trial of Cediranib in ASPS patients,7,7,2,10,11,70b4d407-288a-4945-a4d5-506d60715110,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,7dcd5c0a-1922-4fe2-9b7e-090e4c39861b,2
5,9,42,CuT-AsthMa: Culturally tailored school-based intervention for asthma in Malaysia,7,7,10,10,38,70c318c4-b388-4102-924e-5419d44c1679,,3,7,8,6,3,009bcb87-05f3-46e6-8866-7e4df698cb19,5
5,9,42,Moorfields DMO Dataset 003,6,7,10,10,38,719dd9c9-9aa5-426d-981a-57f0ad3f1480,,3,7,8,6,3,120106fb-49b4-4bc0-b30c-50a59c5c6253,5
5,9,42,Avon Longitudinal Study of Parents and Children,7,7,2,10,9,71b8569c-b582-499c-85aa-909b825f6ea6,ALLIANCE > AVON LONGITUDINAL STUDY OF PARENTS AND CHILDREN,3,7,0,0,1,255d70c6-9a50-4b62-adc0-44216606a216,0
5,9,42,"Hospitalised and ventilator acquired pneumonia severity, treatments, outcomes",6,7,10,10,38,71f9cf07-0560-42b4-a0fe-5de725dacd31,,3,7,8,6,3,99dc4159-00d0-4874-b158-fe30244b53a1,5
5,9,42,NIHR BioResource: SNP imputation data,7,7,10,10,38,7257d45c-6697-4c49-bbce-de0d456c0678,,3,7,8,6,3,39d7ad29-be30-4e12-a7c8-d8757141de85,5
5,9,42,National Paediatric Diabetes Audit - survey of diabetes-related technologies,6,7,10,10,38,72eb9599-aa37-4c17-bc56-a7833e8038db,,3,7,8,6,3,eecbdd8d-92a0-4dfd-a216-1cf7f1f8c98f,5
5,9,42,Infoflex Cancer Registry,7,7,10,10,33,72fe91de-b0c0-423a-ad68-bd7067b20ad8,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,3,7,9,0,3,5505e91d-9e0a-4969-87d5-00f256d91306,5
5,9,42,"Deeply-phenotyped hospital COVID patients: severity, acuity, therapies, outcomes",6,7,2,10,13,730b3e54-1f59-4c07-b5d6-e6b63e4dda35,HUB > PIONEER,3,7,3,1,0,16a09f1b-3654-4ec3-9913-fb70cb1e2364,1
5,9,42,UK BiLEVE Consortium Dataset,7,7,0,10,7,73462506-32c5-43a0-963e-06d67e967b97,HUB > BREATHE,3,7,0,0,0,b8bcda0b-3c90-4382-aeb7-b01fc27e58fa,1
5,9,42,Critical Care Minimum Dataset,6,7,10,10,38,73941d19-6fcd-40e9-a7bd-ef0d91f93de9,,3,7,8,6,3,c71fbdc3-0311-4b3f-a9ff-7d2f2c0ba993,5
5,9,42,HIC Hepatitis v2,6,7,0,10,6,73f54071-62bf-48f5-8be1-569208b18ab8,NIHR Health Informatics Collaborative Viral Hepatitis Theme,3,7,0,0,0,66be725a-b950-4bf8-9a35-7e33ce765a25,0
5,9,42,Myeloma XII clinical trial samples,7,7,2,10,11,74241b17-23b7-4233-b7b9-1a484aa053b0,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,576fbcf8-ff25-4230-ae69-e72ca02b95f1,2
5,9,42,NIHR IBD BioResource: Contact detail,6,7,10,10,38,747d57aa-a02b-411c-9403-2e3ec9d3e5b5,,3,7,8,6,3,02ddc5c9-03d4-40e4-9934-e60817ec8f3e,5
5,9,42,NIHR BioResource: Metabolite data,7,7,10,10,38,74b54e34-0e01-4447-be1d-e9da3e03cd2e,,3,7,8,6,3,dec09f2e-a93f-41e2-8217-72431ea4a19e,5
5,9,42,National Audit of Dementia Round 4 - casenote audit,7,7,10,10,38,74be1c67-ab42-4716-a63b-be3f5de0d489,,3,7,8,6,3,587a94e6-48a4-4e5e-8230-4018897bc7c7,5
5,9,42,National Paediatric Diabetes Audit - core clinical dataset,6,7,10,10,38,75dabfb3-69b7-4192-b257-d0d814e5872d,,3,7,8,6,3,e355c9b9-44f0-4ba3-a872-645aa88f4f2b,5
5,9,42,National Exercise Referral Scheme,6,7,10,10,38,76535d6e-ce0c-407c-ba22-1b2420a1e654,,3,7,8,6,3,131784c0-769d-4f7b-b7d0-b5f4b89886d4,5
5,9,42,Hospital Episode Statistics Outpatients,6,7,10,10,38,76ac3c66-8c3f-41c1-8de2-2b56dd5512dc,,3,7,8,6,3,d4362d41-0838-4f41-bba3-c3268312c444,5
5,9,42,Moorfields DMO Dataset Release 001,6,7,10,10,38,77422eb1-7bdb-4205-b3d0-57d1add35317,,3,7,8,6,3,120106fb-49b4-4bc0-b30c-50a59c5c6253,5
5,9,42,The National COVID-19 Chest Imaging Database,6,7,0,10,6,77824298-ef3b-40f7-a0a4-b6dedb2e7a02,NHSX,3,7,0,0,0,31f0148b-f965-4136-ab39-6c5bbbf8c2d9,0
5,9,42,Leeds Multidisciplinary Research Tissue Bank,7,7,2,10,10,7793f54e-73be-4c97-a941-ba105b1b0480,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,7e60a651-b3d6-40ef-93dc-1f87dabee7be,2
5,9,42,UK Longitudinal Linkage Collaboration (UK LLC),7,7,10,10,38,77adbbe0-6cc7-426d-b485-4ac1f05a746b,,3,7,8,6,3,d858cd90-9a2f-4330-9bbe-46e047a5d0a2,5
5,9,42,Lifelong Learning Wales Record (LLWR),6,7,10,10,38,77b48222-3a00-4dcc-b0ef-3f99dfae697e,,3,7,8,6,3,cba62a8d-5917-4912-ad4d-340472f7b904,5
5,9,42,1958 National Child Development Study - Pain data,6,7,10,10,38,77dc7118-443c-4c85-a18c-e7bbe01e9e7a,,3,7,8,6,3,33092502-12ef-4bc0-8400-5f63915cbf33,5
5,9,42,Maternity Indicators Dataset (MIDS),6,7,10,10,38,77f4f3ec-31aa-4eb9-8896-a063ce831c9b,,3,7,8,6,3,a0c27454-8cbe-418f-bdae-a85d5e92e9d4,5
5,9,42,Systemic Anti-Cancer Treatment (SACT) data for CPRD Aurum,6,7,10,10,38,783184b6-e8f4-4768-a3eb-442a7f044aaa,,3,7,8,6,3,f8af632e-442d-4931-a370-b7fa2fa4b896,5
5,9,42,NHS Tayside and Fife Haematology Biochemistry (Lab Data Restructured),6,7,9,10,31,7858978f-30e8-42e7-abe4-d9af5447c278,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,3,7,8,0,3,10ffac16-d0c2-4d53-ab6a-69a38e283223,5
5,9,42,UCL / UCLH Biobank for Studying Health and Disease,7,7,2,10,10,7862c1c2-d4d6-4b3c-aea1-1f15a5b3b5ea,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,ce533c67-5565-4010-bedf-dca3863a9084,2
5,9,42,COVID-19 Symptom Tracker Dataset,6,7,0,10,6,78ce070c-84db-4676-81c5-0c672f4e12e3,ALLIANCE > SAIL,3,7,0,0,0,594cfe55-96e3-45ff-874c-2c0006eeb881,0
5,9,42,Mental Health Minimum Dataset v4.1 (Sensitive) Episodes,6,7,4,10,19,78fe2e13-7f40-406f-a584-04909d0ce060,ALLIANCE > NHS DIGITAL,3,7,1,0,3,efecbe58-4822-4f17-bf5c-92113d143db9,5
5,9,42,CAPS,6,7,10,10,38,7964fc83-017a-4786-918e-bab61f7ddd99,,3,7,8,6,3,a4c595a6-cb41-4743-bea3-feb4d4c72091,5
5,9,42,SACT - systemic anticancer treatment  for QResearch,6,7,10,10,38,7966a272-a2ba-4763-904b-f7d1e00bcfcd,,3,7,8,6,3,c7219fcb-cf19-474c-bdbf-8d72b84c9f0e,5
5,9,42,Synthetic Dataset - Patients at risk of sudden death: hypertrophic cardiomyopathy,6,7,10,10,38,796d97b4-6f3d-4ee8-8966-9238efdcac2d,,3,7,8,6,3,7b1c1f1a-4fb2-452d-9a3c-7748992b1fa4,5
5,9,42,Central England Haemato-oncology and oncology Research Biobank (CEHRB),7,7,2,10,10,79b02690-798b-462d-9ced-f53c9e39d624,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,314953f6-58e7-49c0-adfd-c60e623eba74,2
5,9,42,SCI Diabetes,6,7,10,10,38,79dfcffd-3f50-4fa2-bd3a-8ef1464e7589,,3,7,8,6,3,e179bd5b-0153-46d4-9e1b-4febd3f1153f,5
5,9,42,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Records,6,7,4,10,19,7aa02796-787a-42c2-b97e-d008fa77e4b8,ALLIANCE > NHS DIGITAL,3,7,1,0,3,1a8fc23c-b67b-4171-b5e1-1b650fce1ef4,5
5,9,42,Education Wales (EDUW),6,7,10,10,38,7aa38c5c-771c-4157-a008-32051a5aed4b,,3,7,8,6,3,204fa806-071d-4410-9c2c-143017d32d24,5
5,9,42,NIHR BioResource: Contact detail,6,7,10,10,38,7ada943a-083d-44c5-a147-32e581e3ed20,,3,7,8,6,3,fc2fcaec-bd5b-4d43-9e0c-2fed36eff0e4,5
5,9,42,NIHR BioResource: Whole Genome Sequencing,7,7,10,10,38,7b922498-1757-418d-96ca-64980a50b647,,3,7,8,6,3,ecb90b4a-6f4f-4398-a4f6-d64891c4a137,5
5,9,42,GPES Data for Pandemic Planning and Research (COVID-19),6,7,10,10,38,7d313fa6-941f-48ca-93e1-05d912d183ac,,3,7,8,6,3,696cfc9f-090d-4328-94ac-140760a77c73,5
5,9,42,Children In Need Census Wales (CINW),6,7,10,10,38,7d414fa8-565b-451b-bc9c-fe2965c2bc5b,,3,7,8,6,3,e4f6d9a8-88d0-4781-b192-cd165451b272,5
5,9,42,National Early Inflammatory Arthritis Audit - clinical dataset,6,7,10,10,38,7d98182a-18f8-4f2e-a59c-5048580557b5,,3,7,8,6,3,b0797c05-352f-455f-8d27-150b6f6354cc,5
5,9,42,COVID-19 Vaccination,6,7,10,10,38,7daacbe5-082d-4c12-b801-0fb08932dada,,3,7,8,6,3,b0049073-3335-433d-bdb9-de22547698f8,5
5,9,42,Effect of personal air pollution exposure on asthma control in children,7,7,4,10,20,7df79ee6-e67d-4ad9-89f3-23bee6cb0ec5,HUB > BREATHE,3,7,5,1,2,57efab41-65fc-4069-8b9d-e5ced13cb4d3,2
5,9,42,At-Risk Registers Integrated into primary care to Stop Asthma crises in the UK,7,7,5,10,21,7e780260-e8d3-4541-b51e-213233dfc349,HUB > BREATHE,3,7,5,1,2,36a5da45-772c-4c67-8ec3-84c9e67332d3,2
5,9,42,Next Steps,7,7,10,10,38,7ec7c8c4-770b-41f0-87d0-38ea232ae5bd,,3,7,8,6,3,0ad7a3dd-e720-49ef-9d27-c394a32b0326,5
5,9,42,Outpatient Appointments and Attendances - Scottish Morbidity Record (SMR00),6,7,10,10,38,7ed08209-f22e-4cdf-b8b5-e1d58b0bcaf9,,3,7,8,6,3,04cb9964-54fb-4529-b09b-735c3daa1c7b,5
5,9,42,COVID Therapeutics data for QResearch,6,7,10,10,38,7ed274f8-c30f-4f97-af5f-808d212de7e8,,3,7,8,6,3,891150d2-85b5-4bed-88a8-7d65f75bb020,5
5,9,42,UHB Eye Image Dataset Release 001,6,7,2,10,9,7f4fb30c-2a09-4d75-bed2-114751e06723,HUB > INSIGHT,3,7,0,0,0,21fb56d1-726f-40e3-a998-e4b34ba3e46f,1
5,9,42,CDE Encounter,6,7,10,10,38,7f7860ee-6235-4e7d-95f3-df692f5d9630,,3,7,8,6,3,3598723f-62fb-4377-9a8b-b264ced1aabd,5
5,9,42,National Community Child Health Database (NCCHD),6,7,10,10,38,7fd81823-ee92-49d3-9147-d56515ca2831,,3,7,8,6,3,20fe153c-a5e5-4991-900e-8fa9988e771a,5
5,9,42,GENOMICS ENGLAND 100K CANCER & COMMON,6,7,0,10,6,7fdb684d-bb7a-4d0b-8666-9f10510f071f,GENOMICS ENGLAND,3,7,0,0,0,702f0198-bdfe-401e-97f2-35f5d26357ad,0
5,9,42,COVID-19 Test Trace and Protect [CTTP],6,7,4,10,14,80a7208f-c174-42bd-9127-e8f006de7c95,ALLIANCE > SAIL,3,7,2,1,0,c0fc84af-aeab-4c7e-aa0b-8264baff55d9,1
5,9,42,Non-invasive assessment of portal hypertension using quantitative MRI (MRQuee),7,7,10,10,38,80c05b85-685e-49c7-8d78-dff6d131ed2f,,3,7,8,6,3,c2ced850-e75c-4428-8cc2-5338c34d138a,5
5,9,42,Cervical Screening Wales,6,7,0,10,6,80e9c439-4909-4534-8bfe-6f01fdec7de7,ALLIANCE > SAIL,3,7,0,0,0,b32325d7-7f00-4d20-9935-dd02e1bc6932,0
5,9,42,Outpatient Database for Wales (OPDW),6,7,10,10,38,80fc6c81-dd24-4f5f-870e-6c1cb7a1766d,,3,7,8,6,3,d331159b-b286-4ab9-8b36-db39123ec229,5
5,9,42,Outpatient Dataset,6,7,10,10,38,8193e951-2ed8-4ccf-9fe5-5c2e6f933d60,,3,7,8,6,3,d331159b-b286-4ab9-8b36-db39123ec229,5
5,9,42,Weekly SUS Outpatients Dataset,6,7,10,10,38,81c28c63-7cbb-49ce-86b4-c83e1c15fdba,,3,7,8,6,3,572cd3e2-9119-40ff-ab2e-49e8a0a02ab8,5
5,9,42,Risk and outcomes of coagulopathies in acutely unwell adults,6,7,2,10,14,81c54c5a-ceb1-487c-820a-437b4dd002ca,HUB > PIONEER,3,7,3,1,1,bf3fe16c-5377-4571-b5a5-7aa7e796594c,1
5,9,42,Inflammatory Bowel Disease datasets - Data profiling GWM,7,7,10,10,38,81d82bed-37f3-4975-ac21-5fcc1090853f,,3,7,8,6,3,c3a75213-e310-4d32-81bb-fe9cff43ef2e,5
5,9,42,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Episodes,6,7,4,10,19,8226b6fa-d815-4f15-9064-b56beb0fddb1,ALLIANCE > NHS DIGITAL,3,7,1,0,3,a27400b0-0efb-4af8-a7bc-e2c7e59796e3,5
5,9,42,Research Donors Ltd,7,7,2,10,8,826114ca-2563-4c0c-b023-3417ead32956,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,fcb62cb3-c876-47a3-961e-fb27c6f718fa,0
5,9,42,NHS Tayside and Fife Immunology (Extractable),6,7,10,10,38,8286eef9-0533-488e-bf19-8fc0fa1dd00b,,3,7,8,6,3,39055449-c074-4b58-adb2-b1c0d2441c4d,5
5,9,42,Reasons for delay in seeking care for pneumonia in children under five,7,7,10,10,38,828bc515-6b42-4492-a77e-cf20226ba041,,3,7,8,6,3,46f50b9b-b8e2-4ff1-a1b3-779174c3d032,5
5,9,42,Northern Ireland Biobank (NIB),7,7,2,10,10,82f4cf19-9e6a-4c31-8cc3-085f3d44ba44,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,c6e1ea88-f5bf-4a57-953f-688f313fcb04,2
5,9,42,Hypertonic saline nasal irrigation and gargling for suspected COVID-19,7,7,10,10,38,830c22bb-4321-4fa3-ba04-be9b30518877,,3,7,8,6,3,574cf7bc-dd70-4508-a66d-ac59d8d06639,5
5,9,42,Covid-19 Tests,6,7,10,10,38,83e2e155-1845-4bfd-a0c0-9e81b0a41397,,3,7,8,6,3,53585c9c-f588-41f8-b493-3d271a2794a8,5
5,9,42,Deriving and validating a clinical prediction rule for the diagnosis of asthma in primary care,7,7,2,10,14,842e8c5c-a298-4942-9ac4-f95d1a5f87b3,HUB > BREATHE,3,7,3,1,0,b0a68ee7-742d-45dc-aae9-4be4e1655fc0,2
5,9,42,HIC Acute Coronary Syndromes,6,7,0,10,6,844f3be0-f50d-4a88-9783-0928ad1c2aad,NIHR Health Informatics Collaborative Cardiovascular Theme,3,7,0,0,0,869a9b4e-3537-449f-9a59-a0eac523c4e4,0
5,9,42,"Oncology Clinical Trials Office, University of Oxford",7,7,2,10,11,8466ec6f-8a4c-4286-8138-04c35e12b1f8,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,4a65f6d6-f2e4-4d98-a3a4-94a32206836d,2
5,9,42,National Audit of Psychosis - Audit on Early Intervention in Psychosis services -  patient experience survey,7,7,8,10,28,849d46e6-49a6-4456-a5ae-990c02012bf2,ALLIANCE > HQIP,3,7,7,0,3,c3e63860-bd61-4154-ab5f-ca927fb029c4,4
5,9,42,COMPARE,7,7,3,10,21,84b6d047-2a05-4fc0-8537-809dbb3d18ed,OTHER > The University of Cambridge,3,7,5,1,2,8cbb73e2-a2c4-4caf-8dcd-6ac3795bb996,4
5,9,42,CRIS,7,7,10,10,33,84de0d13-f5bd-4c22-83d3-e1adb00d5a72,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,3,7,9,0,3,67cea834-33f5-4ed7-9dc2-072ad077de07,5
5,9,42,North West London Coordinate My Care (NWL CMC),6,7,1,10,7,850f99cb-f091-4f10-86ee-06a3eaa7df53,HUB > DISCOVER NOW,3,7,0,0,0,c853b41b-fbd1-4896-b0fb-85303109fec4,0
5,9,42,Hospitalised Community Acquired Pneumonia granular pathway and outcome data,6,7,10,10,38,8559e83d-ba93-4c98-af86-286f87f54a14,,3,7,8,6,3,6225bc5d-ace2-498f-8a90-2d671771bc65,5
5,9,42,Cystic Fibrosis Patient Tendon Rupture,6,7,0,10,6,8638e095-a609-463f-b36e-c4cac4519660,ALLIANCE > CYSTIC FIBROSIS TRUST,3,7,0,0,0,4fcc8b11-2b9b-4f68-b51a-978749d89acc,0
5,9,42,Oxford Musculoskeletal Biobank,7,7,2,10,11,865f0e79-f862-493b-b863-b39b777d60ca,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,ccd6e59d-3582-4f47-a4cd-f5845192d75c,2
5,9,42,Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS),7,7,1,10,7,8665b36e-f9a5-4062-ba56-d33fecfe3376,HUB > BREATHE,3,7,0,0,0,cc6f926a-90cf-4083-84e7-131d1e63813b,0
5,9,42,HES:Civil Registration (Deaths) bridge,6,7,4,10,19,86d7088b-7a15-4e9a-b2b0-857a67e04650,ALLIANCE > NHS DIGITAL,3,7,1,0,3,21aec912-444f-447d-b3c4-6791a6c82667,5
5,9,42,Quality of Life of Cancer Survivors: Pilot Patient Reported Outcomes (GOLD),6,7,10,10,38,86e4b1ad-e63c-4ab1-80f3-5c136ce7e94e,,3,7,8,6,3,83059be4-071b-4a36-8ab1-9fde1e32e75e,5
5,9,42,EMEP4UK Pollution,7,7,3,10,20,8821748d-9d8b-4787-91cc-0a58c5ab890d,HUB > BREATHE,3,7,5,0,2,eb76598f-e228-413c-82f3-231809062611,4
5,9,42,University of Southampton Faculty of Medicine Tissue Bank,7,7,2,10,11,88576066-fb5f-43e2-8af4-0904630b2f1b,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,786563e9-5377-4d18-8d32-65ff14d53987,2
5,9,42,HES Patient Reported Outcomes Measures (PROMs) data for CPRD Aurum,6,7,10,10,38,88bf4a0e-28ea-4124-8121-f20aed9147de,,3,7,8,6,3,7958450d-bd25-42c4-b79e-0e3d0806ac21,5
5,9,42,CPRD GOLD CHESS,6,7,10,10,38,88dced95-f51d-4207-91ae-9e506195a419,,3,7,8,6,3,1b677d33-8e87-4951-9658-e99ae73d963b,5
5,9,42,Mental Health Minimum Dataset v2.6 (Non-Sensitive),6,7,4,10,19,895e5c2f-e484-4d08-91c6-35ac2f85c231,ALLIANCE > NHS DIGITAL,3,7,1,0,3,702201ff-e729-4e29-a428-32953c9a0332,5
5,9,42,Human Biomaterials Resource Centre,7,7,2,10,11,89aac17d-f8a1-4ddc-9495-4adc278234a9,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,2f085ac6-d33d-4b9b-8a99-624cc51c3f17,2
5,9,42,CPRD COVID-19 Symptoms and Risk Factors Synthetic Dataset,6,7,10,10,38,89fe9e07-0d2f-4363-83fe-bad3c732eb20,,3,7,8,6,3,a48c65e2-a4e0-4d05-9e9c-fc84e050dea0,5
5,9,42,"Studies Supported by NIHR CRN, ICD10 Coded, with Summary Site Recruitment Data",6,7,10,10,38,8a0d67e2-6daa-4ebe-913b-eb5ede8801ba,,3,7,8,6,3,02397c83-62e6-4ec2-8366-89d211739564,5
5,9,42,National Joint Registry - Primary Knee Replacement dataset,6,7,10,10,38,8a4d097a-3ef2-4452-b6e0-98e2baebb427,,3,7,8,6,3,d517e6fc-9a88-4647-b787-dcbed3635885,5
5,9,42,COVID-19 Consolidated Deaths,6,7,0,10,6,8bbcf9f4-a3c4-4f26-aa0e-c5c46457afa3,ALLIANCE > SAIL,3,7,0,0,0,70e37f44-5c3e-4c83-a42a-89b3476d1d45,0
5,9,42,National Joint Registry - Revision Ankle Replacement dataset,6,7,10,10,38,8bbfbc8c-dad2-4a0b-b255-4aae3687a371,,3,7,8,6,3,b4f076d2-c9a3-49ba-84f4-94148dc8511a,5
5,9,42,A dataset of monitored patient safety indicators in 3 acute hospital settings,6,7,10,10,38,8bffc58f-c78c-43c4-b74b-c94479a76f91,,3,7,8,6,3,4985feee-3c91-47be-a122-2e13073bdac9,5
5,9,42,Sectra PACS,7,7,10,10,32,8c7abca7-4292-4d1f-b311-c132a7adf109,ALLIANCE > BARTS HEALTH,3,7,8,0,3,10bf4c08-6702-44fe-8faa-1280dea6b0c9,5
5,9,42,Falls and Fragility Fracture Audit Programme Fracture Liaison Service Database clinical dataset,7,7,8,10,28,8c8cf129-e87c-46b3-8812-19e07578ee89,ALLIANCE > HQIP,3,7,7,0,3,d94a604c-5733-4f07-93bb-e77b6ea2313f,4
5,9,42,Cancer Patient Experience Survey (CPES) for CPRD Aurum,7,7,10,10,38,8d00d72e-d10a-4cbc-8f81-95339b25c517,,3,7,8,6,3,fded6e24-8fef-47a4-a65e-9455bed043d3,5
5,9,42,Quality of Life of Cancer Survivors: Pilot Patient Reported Outcomes (Gold),6,7,2,10,12,8d06cb09-640c-40db-8387-adf7fab54c3b,ALLIANCE > CPRD,3,7,1,0,2,83059be4-071b-4a36-8ab1-9fde1e32e75e,1
5,9,42,Quality of Life of Cancer Survivors: Pilot Patient Reported Outcomes (Aurum),6,7,2,10,12,8d24889c-ac3c-4b9d-a8bd-cf9effd64370,ALLIANCE > CPRD,3,7,1,0,2,3bc43876-507b-4dff-bd2b-7df147322e15,1
5,9,42,Deaths – Date of Death,6,7,10,10,38,8d33b7a7-151a-4e2e-b87f-b14371e0cb37,,3,7,8,6,3,faf2fc49-d09f-4ea2-a2cb-b1d30fffa406,5
5,9,42,Bridge file: Hospital Episode Statistics to Mental Health Minimum Data Set,6,7,4,10,19,8d3f80d4-aeae-46f0-809b-cd6c51e24f75,ALLIANCE > NHS DIGITAL,3,7,1,0,3,31bb8022-f8b1-405a-a22f-140f7c4b4fa6,5
5,9,42,Developing and evaluating interventions to improve asthma care: HEAL ASTHMA,7,7,10,10,38,8da6766c-df44-4414-a858-4415e473ea76,,3,7,8,6,3,216924f0-585e-4842-a165-78cf9e0af0aa,5
5,9,42,National Asthma and COPD Audit Programme (NACAP): Wales primary care dataset,7,7,10,10,38,8daf5886-4813-465d-9145-3585a8c584bb,,3,7,8,6,3,8a3ec96a-0600-4c6d-8761-9d277f07b9da,5
5,9,42,Evaluating the Genetic Factors Associated with Non-Alcoholic Steatohepatitis.,7,7,10,10,38,8e2a9ef9-bc60-4743-be2d-af453b091b38,,3,7,8,6,3,c0e3e61c-000c-43bb-9dd1-55698198a8b6,5
5,9,42,REal-time Assessment of Community Transmission (REACT-2),6,7,3,10,20,8e5e3ebe-c0ae-458f-bc75-a5a3368d4c2d,ALLIANCE > IMPERIAL COLLEGE LONDON,3,7,6,1,3,25003f25-384c-4264-9c8f-dd8734ee5595,1
5,9,42,Children Receiving Care and Support Census (CRCS),6,7,10,10,38,8e75e0f9-40ed-4505-a8e8-20f21c69ddea,,3,7,8,6,3,fb3fac03-a428-4b3f-8058-5622e1fd57d8,5
5,9,42,Mental Health Services Data Set - Inpatients,7,7,5,10,20,8eace3c2-1dc8-4708-9350-ad129b7d2bc9,ALLIANCE > NHS DIGITAL,3,7,1,0,3,275ac6a4-798b-4f49-a25e-008245050bbc,5
5,9,42,Welsh Longitudinal General Practice Dataset (WLGP) - Welsh Primary Care,6,7,10,10,38,8f2cb486-6a3b-418e-8fb4-b85bc454eaf3,,3,7,8,6,3,33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2,5
5,9,42,Unscheduled Care Data Mart,6,7,10,10,38,8f54b1ad-b8cd-44a3-94d7-c98133ca913d,,3,7,8,6,3,a265af2e-40fc-4759-af61-eab293cdad5a,5
5,9,42,The impact of hospitalised patients with COPD: from admission to outcome,6,7,2,10,14,8fac682b-96be-4e21-a2a9-5fe66c3b35ff,HUB > PIONEER,3,7,3,1,1,780bf7d0-9ee1-4641-a74f-dc148e361970,1
5,9,42,Eye images and retinopathy grades in diabetic eye screening,6,7,10,10,38,8fc6bf25-df25-429f-be41-b7d5ffd4ff15,,3,7,8,6,3,3b1bb176-e22f-402a-b863-730d05b22021,5
5,9,42,Rural-Urban classification for CPRD Aurum,6,7,10,10,38,90671a93-53ba-44fe-90f5-b1e138a6819b,,3,7,8,6,3,b7d24b82-f8a4-4838-844c-ecd86ddf5db2,5
5,9,42,COVID-19 COG-UK Viral Genome (variant strain data),6,7,10,10,38,90ace555-da01-4940-a3ef-78bb83976ff0,,3,7,8,6,3,9a36f3f8-3b7e-4e61-8993-b9cc2734fcb8,5
5,9,42,RAPID (Hospital Stay Level Data),6,7,10,10,38,90db47a7-d082-4778-884c-78f9b6c7e57f,,3,7,8,6,3,1fc57971-5af5-499e-a500-4ffbb087f0c4,5
5,9,42,Prescribing Information System (PIS),6,7,10,10,38,90f44ae7-8394-4fe5-8c1e-c9aa5bf0edf1,,3,7,8,6,3,22e3943e-edb5-44a1-9e4e-22b0f7a31767,5
5,9,42,Bloodwise Childhood Leukaemia Cell Bank,7,7,2,10,10,914321d0-1d86-4974-a38d-97469f9ff2cd,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,93baeb13-cc4b-47fd-9dae-5ae5277cba54,2
5,9,42,"Demographic risk factors, biomarkers, physiology for Acute Compartment Syndrome",6,7,10,10,38,9147f060-0210-40a6-a557-ce744a63f912,,3,7,8,6,3,60c1557a-4541-429f-bbe5-f9edbdb34f8a,5
5,9,42,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - clinical audit,7,7,8,10,28,91b2fdab-1d0e-41a1-a9cc-1ebb536c7ee5,ALLIANCE > HQIP,3,7,7,0,3,3afbb83d-d47b-43b3-a202-0d3081e5d294,4
5,9,42,NHS Tayside Virology,6,7,10,10,38,91f116fc-07f5-47cd-bdbd-f8b68629f98f,,3,7,8,6,3,855a84b2-9d58-4b2b-a450-b6c6d534e403,5
5,9,42,Seasonal Influenza Vaccine Effectiveness II,7,7,3,10,15,91f1aef1-7dfe-4cb3-86ab-15e09f91e969,HUB > BREATHE,3,7,4,1,0,50b47298-d935-4990-a002-e26b6bb26d30,1
5,9,42,"Estimate the cost of care, quality of life and wider societal burden due to COPD",7,7,10,10,38,922f72c0-e3cb-4d89-a56f-50d938a87630,,3,7,8,6,3,ee6013d6-5584-4275-b124-3113ee5ad37d,5
5,9,42,National Joint Registry - Revision Elbow Replacement dataset,6,7,10,10,38,925feb2c-195f-460c-bae7-f17ea652fd5d,,3,7,8,6,3,12babf2b-42e8-4b1e-9143-3475a07bb343,5
5,9,42,Omega 3 Cohort,7,7,10,10,38,927beb63-f650-4972-a3ad-af8e29dc26a5,,3,7,8,6,3,a1bcea4c-89dd-4cdb-978c-43db676ed73c,5
5,9,42,Yorkshire Specialist Register of Cancer in Children and Young People,6,7,1,10,7,931efe47-04eb-4ff3-aa62-97e2e4007aed,HUB > DATA-CAN,3,7,0,0,0,93582beb-e45a-47b6-aeab-d26f583e4c3b,0
5,9,42,National Survey for Wales,6,7,0,10,6,9360bc6c-2a7d-4415-869d-3e853c558f4d,ALLIANCE > SAIL,3,7,0,0,0,bcca421a-9077-4c47-9daa-b1bc030d3dee,0
5,9,42,HES Maternity for QResearch,6,7,10,10,38,93a11fe9-c616-4964-9452-fdf736ec8f11,,3,7,8,6,3,30ec0315-5242-40cb-93ad-2c6f244caad4,5
5,9,42,South West Primary Care Dataset,6,7,2,10,12,93aeac00-2e6d-44d7-8643-092c587c241a,HUB > DATA-CAN,3,7,2,1,0,a47a8c77-3ced-43a0-acf0-3997c4eb5a29,1
5,9,42,Exploring psychological issues of primary care teams in Malaysia amidst COVID-19,7,7,10,10,38,94188672-a44d-4ae3-8bb3-f249891a5af7,,3,7,8,6,3,64f78a5f-268f-4951-9c91-f7e7130baffa,5
5,9,42,National Unified Renal Translational Research Enterprise (NURTuRE),7,7,2,10,11,9445e723-655a-43d0-a4e5-50313d98eac0,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,15f07cef-f4cc-4a50-90bc-9fd40f8b6327,2
5,9,42,Covid Vaccination Dataset (CVVD),6,7,10,10,38,94c7dca9-a96f-4e77-b156-96676a701834,,3,7,8,6,3,471f101c-a45e-4620-8710-be3036a46fba,5
5,9,42,BioDock,7,7,2,10,11,94e28efd-a976-4748-81fd-956a598c26cb,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,ecb82441-286f-408d-880c-9239a25fb5cd,2
5,9,42,Unscheduled Care Datamart,6,7,1,10,12,94f983ec-af41-451a-af5d-657ac58207c6,ALLIANCE > PUBLIC HEALTH SCOTLAND,3,7,2,0,2,a265af2e-40fc-4759-af61-eab293cdad5a,1
5,9,42,RAPPER,7,7,2,10,10,94fab6d3-9753-4ffd-ade2-02d199d93f94,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,76d26f0f-0136-4ae5-8be9-37782a70bac5,2
5,9,42,GP dataset - Welsh Primary Care,6,7,10,10,38,953f6cc1-bd69-4fbc-a91b-d33f6c7aa6ca,,3,7,8,6,3,33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2,5
5,9,42,"4 Country ChrOnic Respiratory Disease study: PILOT PHASE, Islamabad",7,7,10,10,38,95b26238-3379-4188-ad6c-a09657b77648,,3,7,8,6,3,a6ea6185-2e2e-4738-b7f1-dc052eae902e,5
5,9,42,VIVALDI 2,6,7,4,10,21,96c73136-da1b-43de-9fd1-9d5e63631b14,OTHER > UNIVERSITY COLLEGE LONDON,3,7,6,1,3,12f1ffbc-0ddd-4d6e-b126-2cccf6738658,1
5,9,42,SAIL Dementia e-Cohort,6,7,2,10,11,9709ee81-c5f1-4c01-a1ac-51ae2a0a60f3,ALLIANCE > SAIL,3,7,1,1,0,f48b7c05-6a44-480c-84c6-4f7a684f29f8,1
5,9,42,FFFAP -  National Hip Fracture Database Facilities Survey 2019,7,7,10,10,38,97771ec7-2abb-4d6e-b630-77c61a5e314a,,3,7,8,6,3,025c9e8a-938b-4886-9e03-fcad90fe7157,5
5,9,42,"Resilience, Ethnicity & Adolescent Mental Health (REACH)",7,7,10,10,38,97a5f21e-c0a9-4a04-978b-9f054d7b6bcf,,3,7,8,6,3,0f754b8b-353e-4e8d-9ff0-03d5e0817e02,5
5,9,42,Mental Health Minimum Dataset v4 (Sensitive) Records,6,7,4,10,19,97fa09e6-5ea5-41cd-baf8-20366db13a3f,ALLIANCE > NHS DIGITAL,3,7,1,0,3,eab996ed-b268-439a-bff4-19925698336a,5
5,9,42,Characterisation of hospitalised COPD exacerbations using real world data,6,7,10,10,38,9836e0e1-5ea2-4dc4-be5a-24e390b7fa33,,3,7,8,6,3,f6f2978d-4a49-4dd9-8615-78d28e6dc83c,5
5,9,42,RATHL Trial,7,7,2,10,9,99812cec-ea1c-4979-8e00-32df5bad000b,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,e5ec63dd-4da5-4119-99c8-5cc79045618c,0
5,9,42,Clinical characteristics of hospitalised primary biliary cholangitis patients,6,7,10,10,38,9991ac9c-0aab-4588-a862-eaab2e60a1f7,,3,7,8,6,3,ee315149-c131-4b7c-b88a-9d4a3e1f7948,5
5,9,42,Sars-CoV-2 Immunity & REinfection EvaluatioN (SIREN),6,7,10,10,38,99b505ee-44c6-497d-b30b-3ce80eba4047,,3,7,8,6,3,8e0221d4-dcfa-4580-834b-f44421fca3b5,5
5,9,42,The EPIC-Norfolk Study,7,7,10,10,38,99bc7b04-5c5b-4e3d-baba-2f7ca4b9d802,,3,7,8,6,3,fe610510-fe78-461e-9c73-54dae67cade4,5
5,9,42,MR measures of liver fibrosis (MRker),6,7,10,10,38,9a18a460-e6d8-405e-84b1-d50c3fb74316,,3,7,8,6,3,335905f0-4b94-451e-96f1-5b44f45ea923,5
5,9,42,Quality of Life of Colorectal Cancer Survivors: Patient Reported Outcomes (Gold),6,7,2,10,12,9a5fdb85-7bd6-4073-9058-e45667d497a8,ALLIANCE > CPRD,3,7,1,0,2,61a607a9-b404-41e0-a52e-0c6d0ce8c2be,1
5,9,42,Blended learning for primary care physicians on COPD in Bangladesh,7,7,10,10,38,9a836aa8-60c7-4911-943e-477b0ae8bbb8,,3,7,8,6,3,3907a55f-104b-4533-ba21-69bd5f08ce8f,5
5,9,42,Systemic Anti-Cancer Therapy Dataset [SACT],6,7,10,10,38,9abb8804-de89-4aba-8877-0e9a405870fe,,3,7,8,6,3,6c4ed998-0f05-415c-a3e4-42430bb62d24,5
5,9,42,Neovascular age related macular degeneration at University Hospitals Birmingham,6,7,10,10,38,9b356432-2650-4ded-aa75-657871b38fe3,,3,7,8,6,3,89c2c798-2e0f-4235-9cd9-e2347f2dfc50,5
5,9,42,National Cardiac Audit Programme - National Congenital Heart Disease Audit (NCHDA),7,7,8,10,28,9b7d2306-35e2-44a3-a97d-0b0e03a15336,ALLIANCE > HQIP,3,7,7,0,3,2b640175-725a-465f-9aec-6794e6d27791,4
5,9,42,Mental Health Services Data Set - Currencies,7,7,5,10,20,9b7f7994-0b9c-4809-b67d-45ae1f04ec5c,ALLIANCE > NHS DIGITAL,3,7,1,0,3,add485fa-4c54-4a3e-8676-abe2ff4725a5,5
5,9,42,PHM and Cancer Outcomes in the WYH Cancer Alliance,6,7,3,10,13,9bfba8a4-43c3-4356-93a5-3eb3b7bc247a,HUB > DATA-CAN,3,7,1,1,1,bc839e9c-e303-4c3c-9c2c-9975602376e2,1
5,9,42,Domiciliary Social Care Worker (DSCW),6,7,10,10,38,9c2356fe-409f-4a34-9fbf-663d2add3902,,3,7,8,6,3,0e38bbf4-c788-4a1a-9af8-a24821250154,5
5,9,42,Optimum Patient Care Research Database (OPCRD),6,7,10,10,38,9c31bd50-e999-4d4d-bb9d-545c00fcf23e,,3,7,8,6,3,ac755244-4143-4629-9170-a9e8fc98bb1e,5
5,9,42,"Extended Cohort for E-health, Environment and DNA (EXCEED)",6,7,0,10,6,9ca6e8d2-98d2-4757-84e1-287585400e55,HUB > BREATHE,3,7,0,0,0,e22ddf52-7f9e-4072-ae61-cb722461b37d,0
5,9,42,National Survey for Wales Dataset (NSWD),6,7,10,10,38,9cb83fb7-e8d7-436b-b847-e4759b9589c5,,3,7,8,6,3,bcca421a-9077-4c47-9daa-b1bc030d3dee,5
5,9,42,UK Renal Registry - Kidney PREM dataset,6,7,10,10,38,9cc82b97-d508-4cb9-98ca-0105aa897bb6,,3,7,8,6,3,ea068fd4-1a96-4ed5-a010-8930afb968bb,5
5,9,42,IBD NIHR BioResource: Sample holding,6,7,2,10,8,9d4f445e-f81e-45d7-bd83-7e9f68199b4f,HUB > GUT REACTION,3,7,0,0,0,f2af20f9-af84-40ce-8a07-7d095948653e,0
5,9,42,National Vascular Registry -  Abdominal Aortic Aneurysm Repair clinical dataset,6,7,10,10,38,9da5acec-1749-46a6-bf93-51457bbaa52c,,3,7,8,6,3,fbe1ae63-0c12-48e5-be16-87d6bc7bd179,5
5,9,42,Respiratory social media database,7,7,4,10,18,9de20d42-8e9b-45c8-8574-52a49fba826c,HUB > BREATHE,3,7,5,1,0,43fc768a-9d2c-4c6d-952f-d8570c487b4a,2
5,9,42,Annual District Death Daily,6,7,0,10,6,9e67001e-7c77-4bc0-9af2-5138b5d638e4,ALLIANCE > SAIL,3,7,0,0,0,584bf8c8-d58f-44c6-9b65-e1611144fd54,0
5,9,42,Radiotherapy Dataset (RTDS),6,7,10,10,38,9ea7a624-ce4c-460e-b68f-0655dac36765,,3,7,8,6,3,f102ca50-d1e4-44ec-924e-be89446652af,5
5,9,42,Granular ICU data focussing on the impact of lactate readings on outcomes,6,7,10,10,38,9fe99176-1cbf-41f7-901d-245051dbe410,,3,7,8,6,3,edfc20b7-5a5e-40c4-afd0-a7a5bba77003,5
5,9,42,Pregnancy Register for CPRD GOLD,6,7,10,10,38,9fff31ef-f927-4832-97cb-edcbb0a19839,,3,7,8,6,3,14aaf184-5922-4459-affb-6c9e55c12176,5
5,9,42,Outpatient Referral (OPRD),6,7,10,10,38,a0292641-9e1a-495d-a7f2-d9ce87ff0b88,,3,7,8,6,3,7465c65e-c321-42e9-a2f4-6bc664caf1fc,5
5,9,42,National Joint Registry - Revision Shoulder Replacement dataset,6,7,10,10,38,a03b66c6-f56d-40f8-bb9b-06751d97864c,,3,7,8,6,3,9623e62b-3c50-44aa-8923-0bbb94e7ad61,5
5,9,42,National Neonatal Research Database (NNRD),6,7,10,10,38,a04b16f3-dd24-47de-8c20-699b88eb4da0,,3,7,8,6,3,67020745-9def-4c6e-b5ac-bb273bd0a20e,5
5,9,42,UK CLL Trials Biobank,7,7,2,10,11,a06afa88-caba-4354-ac70-d05c67b34dfc,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,636e216a-072b-4c8b-b867-23b7666d2cb2,2
5,9,42,HIC Transplantation,6,7,0,10,7,a0e0c0c2-072a-47ac-9252-e27b37ac024f,NIHR Health Informatics Collaborative Renal Transplantation Theme,3,7,0,0,1,359a322e-3781-4796-b6b2-81962fa19b7a,0
5,9,42,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Events,6,7,4,10,19,a1a67182-e81b-4144-ac51-92a86f277eb2,ALLIANCE > NHS DIGITAL,3,7,1,0,3,7b31b427-b447-432e-9a6c-ad2099343491,5
5,9,42,National Paediatric Diabetes Audit - Spotlight survey of diabetes-related technologies,7,7,8,10,28,a1d41f64-76e1-4576-a906-f64a7fe664c4,ALLIANCE > HQIP,3,7,7,0,3,eecbdd8d-92a0-4dfd-a216-1cf7f1f8c98f,4
5,9,42,Brecon dataset,6,7,0,10,6,a1e1ec62-d78c-40ac-9f90-66ef1dd865b2,ALLIANCE > SAIL,3,7,0,0,0,9c6e891f-6449-48d2-a1c3-8dd236e34bbd,0
5,9,42,National Asthma & COPD Audit:COPD and adult asthma organisational dataset,6,7,10,10,38,a25181ec-a00c-4031-9f35-5cb072477e64,,3,7,8,6,3,1982d9ef-890a-41ff-a86a-de61d65aaa09,5
5,9,42,Enhanced Prescribing Database,6,7,10,10,38,a2a324f8-ccd3-405b-a146-34bbb85cc34a,,3,7,8,6,3,2843087f-23a4-4cfe-8e72-53f2b9562cc3,5
5,9,42,Comprehensive Patient Records for Cancer Outcomes,6,7,0,10,6,a337845e-1dde-445b-90cf-91d8b825e3a5,HUB > DATA-CAN,3,7,0,0,0,ce4582a8-0985-46c6-b95f-29a5de862d4a,0
5,9,42,HDR UK Papers & Preprints,6,7,10,10,38,a34797cd-4ee8-4f79-8c90-cda08b48bf3d,,3,7,8,6,3,fd8d0743-344a-4758-bb97-f8ad84a37357,5
5,9,42,"Peer-led, Professionals Assisted Pulmonary Rehabilitation (PLPAPR): pilot study",7,7,10,10,38,a41cfa11-ee7f-4ebe-be2a-f1235e34951d,,3,7,8,6,3,dec5d8da-2d63-4ab8-927e-4a5a659dc541,5
5,9,42,Care Home Dataset,6,7,0,10,6,a45acd02-82d7-4bfe-9845-6b4df683bba8,ALLIANCE > SAIL,3,7,0,0,0,aae02f9e-1bad-415d-9730-c46a07a990aa,0
5,9,42,NIHR IBD BioResource: Demographic,6,7,10,10,38,a4936ec2-002e-4927-9a46-29ae9b5d695f,,3,7,8,6,3,b4121feb-f91b-4e20-a19b-fa49c7a5c1c1,5
5,9,42,Health & Attainment of Pupils in a Primary Education Network [HAPN],6,7,4,10,14,a4eb97a6-6a61-415b-9dfb-65503675ed00,ALLIANCE > SAIL,3,7,2,1,0,464d8653-4e69-406b-93fd-d68c29d5dfdc,1
5,9,42,Paediatric Intensive Care Audit Network - core dataset (referral),7,7,8,10,28,a513dd3b-7e58-4d7f-8164-0a4dbe0a96c0,ALLIANCE > HQIP,3,7,7,0,3,79ae4881-6223-471a-a278-6b2d3b84f971,4
5,9,42,UK ME/CFS Biobank,7,7,2,10,10,a5163bce-7c03-4e61-8ebc-024939c047a8,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,d0694e15-b6ba-4a95-962a-dbf627ca207c,2
5,9,42,ISARIC4C COVID-19 Clinical Information Network (CO-CIN),6,7,10,10,38,a5a4a55c-c311-445d-a21f-0e4acb42f227,,3,7,8,6,3,84336be3-23bd-466e-b29b-df48db897665,5
5,9,42,Air Quality Study: An ecological analysis of asthma health outcomes in Malaysia,7,7,10,10,38,a5b41636-a112-4631-aaee-215bc4cf200e,,3,7,8,6,3,95f385b1-4f5c-4a88-8e79-9613acc66938,5
5,9,42,The Primary-Secondary Care Partnership to Improve Outcomes in Chronic Kidney Disease,7,7,8,10,28,a5c088cd-dae6-4c58-b381-a0d273585f4d,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,3,7,7,0,3,d472a895-8587-4503-956e-3bd66d990979,4
5,9,42,Patient Medical Card Registration (NI),6,7,10,10,38,a5d1a44f-9e9d-4c6d-9ce0-53889d579781,,3,7,8,6,3,4e5ba567-c452-4979-8e2e-865f7df20252,5
5,9,42,Scottish Stillbirth and Infant Death Survey,6,7,10,10,38,a6252de5-4fc3-4dc7-950b-2f2528f58533,,3,7,8,6,3,e54d35a6-2e7c-422d-a4a5-a7da930b08f2,5
5,9,42,plasmaMATCH,7,7,2,10,11,a6472a29-17db-477c-bb6e-264686c8fc26,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,5618f65d-23fc-4bd5-9a4c-73e4b330c3a6,2
5,9,42,Child Health Systems Programme - First Visit,6,7,10,10,38,a69493b6-991d-40b5-ba81-2f70c424c557,,3,7,8,6,3,dec04153-f595-41ce-9d7e-5ef0c3fe8289,5
5,9,42,National Records of Scotland (NRS) - Births Data,7,7,10,10,38,a7447f01-c3fd-43f1-8fc4-3e6f3b6e59ef,,3,7,8,6,3,3b87eef0-bfb6-4bf4-84b9-29880197fec9,5
5,9,42,LIMS,7,7,10,10,33,a74f72ad-bf70-42e4-8933-069c7b53c7f9,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,3,7,9,0,3,df70b490-3c00-458e-a6dd-ea3242a3ebac,5
5,9,42,The 1970 British Cohort Study (BCS70),7,7,10,10,38,a8364fd6-2247-4ef0-af8c-51c7b3ec24cd,,3,7,8,6,3,929186f3-e230-4b52-a9f5-0c20af7f5ce2,5
5,9,42,NIHR BioResource: NHS Trust data,7,7,10,10,38,a889651d-a26e-4907-86a3-a06d100d13f5,,3,7,8,6,3,3731006a-ee7c-4d15-bc07-4eeb29a3d031,5
5,9,42,Healthcare Workers Risk Assessment,6,7,1,10,7,a8bb670a-b45b-48a6-8e4d-9e8f61de4f5b,ALLIANCE > SAIL,3,7,0,0,0,ed131fee-0635-4613-a453-a383d5dd7cec,0
5,9,42,Paediatric Intensive Care Audit Network - core dataset (transport),7,7,8,10,28,a8bfd0c4-1aec-47cc-9e45-00a713482fa2,ALLIANCE > HQIP,3,7,7,0,3,45310176-6331-4bdd-bc53-d9194e212a35,4
5,9,42,Scottish Immunisation Recall System (SIRS),7,7,10,10,38,a8c8978f-b5dc-448c-9a03-4d961d79a863,,3,7,8,6,3,c027d0ca-7c7d-4864-b4dd-8040f4020fbb,5
5,9,42,Salford Lung Study,7,7,2,10,14,a8f5117e-7523-452f-abf3-ced72f03cb2e,HUB > BREATHE,3,7,2,2,1,86838cad-d5d3-4b65-9c37-29b0c8c36309,1
5,9,42,"Demography, interventions & outcomes of patients with Cerebrovascular Disease",6,7,2,10,15,a9b50e33-9974-4635-8e52-9c9b3cb87eb2,HUB > PIONEER,3,7,3,1,2,ddf7f82f-b453-442d-b562-bb0157593831,1
5,9,42,North West London Primary Care Events Data (NWL PCE),6,7,1,10,7,a9f4a852-a1f2-4041-bb33-3a50e6c43f8d,HUB > DISCOVER NOW,3,7,0,0,0,0f930154-0a0e-4bef-9464-59e657b904d6,0
5,9,42,Mental Health Minimum Dataset v3_3.5 (Non-Sensitive),6,7,4,10,19,aa019da2-0f2f-493c-95e8-7263ee735f46,ALLIANCE > NHS DIGITAL,3,7,1,0,3,348b12fb-7718-477e-a572-4fc3c716152d,5
5,9,42,ONS 2011 Census Wales (CENW),6,7,2,10,12,aa1fe6a9-79cc-4afc-bd38-ec0d5e4fc195,ALLIANCE > SAIL,3,7,1,1,1,fc24482c-0f9b-445f-af7a-8598627c3b15,1
5,9,42,Death Registration Data - Provisional Monthly Extracts,6,7,10,10,38,aa25e5e4-9d53-4f7b-a7fb-228835f6bfd8,,3,7,8,6,3,487222b7-5c13-4a92-8b41-044796048720,5
5,9,42,Critical Care Dataset (CCDS),6,7,10,10,38,aabb918b-b15f-4c1e-a50a-8ceee6993d70,,3,7,8,6,3,1789286a-deaf-49df-88cd-660e92934af6,5
5,9,42,Assessing the eDPSEEA model in seasonal pollen induced asthma in Islamabad,7,7,10,10,38,aad2340a-ab87-40ee-bfbe-c56adb01fd47,,3,7,8,6,3,bfa012ad-e609-4d15-a824-6d143758ca4d,5
5,9,42,Weekly SUS ECDS Dataset,6,7,10,10,38,ab0f56e2-681f-4e43-b798-94685ddc3c4a,,3,7,8,6,3,f75b02f0-a45f-433a-a669-420c8bd40720,5
5,9,42,Developing Patient and Public Involvement in Research in Malaysia,7,7,10,10,38,ab2dafd8-b513-4b33-9365-5eb74f32f9d1,,3,7,8,6,3,153c0ba6-f2ec-4fb4-b5a7-33e11cbdf7fc,5
5,9,42,GOAL,7,7,10,10,38,ab7f482c-42ea-4ddb-8c92-5ecc1be868ce,,3,7,8,6,3,563c0bfc-437e-4c10-b144-b392d983017c,5
5,9,42,Walker Study Data,6,7,10,10,38,ac057e24-22d8-478e-8988-89fe4ee67b6c,,3,7,8,6,3,245bffa9-07c3-40b6-916b-161062cdf674,5
5,9,42,Tayside Bowel Screening Dataset,6,7,10,10,38,ac7927ca-ef8b-47d7-abce-33a03baaac5c,,3,7,8,6,3,00201dde-1faf-41d3-b282-5c24c0ca3697,5
5,9,42,Mental Health Minimum Data Set,6,7,5,10,20,acafb160-b18a-436e-90f1-dc4530a90267,ALLIANCE > NHS DIGITAL,3,7,1,0,3,285ae0ae-196b-4a75-b1f1-78b07162acfa,5
5,9,42,COVID-19 SARI-Watch (formerly CHESS),6,7,2,10,14,ad376d74-4f12-4fb4-8d34-a9e7d0b45b3b,ALLIANCE > NHS DIGITAL,3,7,2,1,2,f61f116d-f732-450e-9d34-c6ae00e3fd1e,1
5,9,42,2019 UK Parkinson's Audit - Elderly care and neurology,6,7,10,10,38,ad5dd22c-f6e1-4338-9d4e-80e4b9ec8f26,,3,7,8,6,3,0cac3870-dd13-44fc-97c2-4bdb67550b39,5
5,9,42,IBD NIHR BioResource: Contact detail,6,7,2,10,9,ad638da8-366b-481f-995e-fc326301eb16,HUB > GUT REACTION,3,7,1,0,0,02ddc5c9-03d4-40e4-9934-e60817ec8f3e,0
5,9,42,Cardiff School of Dentistry Tooth Bank,7,7,2,10,11,adbee090-9634-455e-9be1-62843158fb08,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,0d4f0103-82d8-43f4-8058-4aec80ea562f,2
5,9,42,North West London Admitted Patient Care Data (NWL APC),6,7,1,10,7,adce90ad-d576-4c98-9de9-dca19f7f4d41,HUB > DISCOVER NOW,3,7,0,0,0,788857b5-6a5b-4ec2-825e-d965e291cf45,0
5,9,42,Biobank for patients with retinal degenerations & dystrophies,7,7,2,10,11,ae2022bc-2083-4e57-b825-1fb610d910ee,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,cee932f8-151c-4834-ac6d-61d842f9d170,2
5,9,42,COVID antigen testing - Pillar 2,6,7,10,10,38,ae68c3c8-7930-40bd-86e8-7ca1aa6ce57d,,3,7,8,6,3,c8f2ee14-2831-445d-a207-2f7f932f4735,5
5,9,42,Cystic Fibrosis Patient NTM culture,6,7,0,10,6,ae788191-69e5-4a03-b11b-bd25574b0e4f,ALLIANCE > CYSTIC FIBROSIS TRUST,3,7,0,0,0,69bdac5f-bb70-4ca5-a5ce-51a6106ad00b,0
5,9,42,Community Services Dataset,7,7,10,10,32,ae9e8a9f-533f-4823-8e00-84e39ad2c266,ALLIANCE > BARTS HEALTH,3,7,8,0,3,cae0a9a5-1bf2-49c3-b8d1-c315d3239074,5
5,9,42,Manchester Cancer Research Centre (MCRC) Biobank,7,7,2,10,10,af2b3e6d-718e-464a-8c0d-5882fa1d869f,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,095d805c-4b62-4726-b968-bb2f1c463701,2
5,9,42,Cardiff University Biobank,7,7,2,10,10,af2ecff2-398c-437f-8c45-adef2406ce43,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,097540aa-a0ed-492e-853b-9ebcfd061dea,2
5,9,42,NIHR Exeter Clinical Research Facility,7,7,2,10,11,af4af5cc-a9eb-4e0e-b50a-3cab4ac2daf9,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,df9b7bb1-1b26-4e67-b885-df2dcb8e3450,2
5,9,42,Welsh Ambulance Services NHS Trust (WAST) - Legacy,6,7,10,10,38,af6db86a-b901-442e-adf5-f29f6c1dc16e,,3,7,8,6,3,d415a5c5-8432-4a81-937f-12135ade6de7,5
5,9,42,National Audit of Care at the End of Life - organisational level audit,6,7,10,10,38,afc74c32-efdf-4aab-a0bb-fe5586f4af78,,3,7,8,6,3,a290592c-a6f5-4874-b283-1d33e923c487,5
5,9,42,Childhood Pneumonia Governance in Bangladesh,7,7,10,10,38,b009b68f-730a-4d72-9a3c-c917b1ff715d,,3,7,8,6,3,5df03d24-ad95-4d64-96df-0684a4f26e58,5
5,9,42,COVID antigen testing - Pillar 1,6,7,10,10,38,b0319b9b-14ba-4e23-86ff-89363d4d69a7,,3,7,8,6,3,3abc20ce-3dc6-4715-9de0-56aa97a6f5ec,5
5,9,42,Emergency Care Dataset (ECDS),6,7,10,10,38,b04e89c3-3c56-4ad9-b929-d3937874df52,,3,7,8,6,3,57fa56f2-78d1-49af-ab8d-e8146d711868,5
5,9,42,National Audit of Care at the End of Life - case note review,6,7,10,10,38,b05cb16b-80dc-4e16-8d86-8ee741a5e051,,3,7,8,6,3,d8c67899-2d81-48c2-8482-31cd33973a36,5
5,9,42,SICSAG Episodes (Scottish Intensive Care Audit Group),6,7,10,10,38,b07485ca-2d45-483d-9336-32cca4504712,,3,7,8,6,3,6f8182d2-2993-400d-829d-b52cdb324bf3,5
5,9,42,HIV-POGO,6,7,10,10,38,b132812c-7a5c-4d2d-aca2-fdcdb890283a,,3,7,8,6,3,e171a080-a4cd-4e64-9c2b-e72beb7cac78,5
5,9,42,CPRD Aurum CHESS,6,7,10,10,38,b24500e6-4078-43ee-989c-1d425b9d3906,,3,7,8,6,3,0c67a669-7a19-4cb8-b7b0-42a19f84d56d,5
5,9,42,Lothian Birth Cohort 1936 (LBC1936),7,7,10,10,38,b2f48da1-d3c6-4126-a74b-e87c2f629ef8,,3,7,8,6,3,e63613a9-92e9-4147-8a76-40e4a87ec131,5
5,9,42,Cystic Fibrosis Patient Transplants,6,7,0,10,6,b2fb79c5-26db-484b-8e93-1c56d7654f57,ALLIANCE > CYSTIC FIBROSIS TRUST,3,7,0,0,0,bea354e8-c552-41ef-80c2-a76ca5767e4b,0
5,9,42,Fife Microbiology: Tests,6,7,10,10,38,b3004f9b-11a0-482b-9cec-791b28fd492e,,3,7,8,6,3,0c43c0b6-de3a-478b-8190-4da37fbe5ff5,5
5,9,42,Covid 19 Accident and Emergency Statistics,6,7,10,10,38,b32322b4-edd9-48ed-9204-de1259f0dfc1,,3,7,8,6,3,c319c402-7ca7-4e2b-bd17-a1abacf9f84c,5
5,9,42,HIC ICU 8.3.2,6,7,0,10,6,b40777a2-468b-4b45-8b7d-2f62f912e950,NIHR Health Informatics Collaborative Critical Care Theme,3,7,0,0,0,4f546f1e-433c-4884-a090-2a4520c878ac,0
5,9,42,UK Cystic Fibrosis Registry (CYFI),6,7,2,10,12,b43309eb-7860-49b7-9f11-1a7a0fd5532e,ALLIANCE > SAIL,3,7,1,1,1,0628fb77-057d-4838-b80e-18245a8f535d,1
5,9,42,Cystic Fibrosis Patient Chronic Medication,6,7,0,10,6,b5033be2-0744-49c5-a398-a4d3ed4e1deb,ALLIANCE > CYSTIC FIBROSIS TRUST,3,7,0,0,0,0ad31772-0893-4cf7-bab0-683e80302201,0
5,9,42,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Episodes,6,7,4,10,20,b53f716d-a5c3-4ad8-a2aa-cae09c12ac18,ALLIANCE > NHS DIGITAL,3,7,2,0,3,ef22c16c-c294-46e1-abf9-5204212e9053,5
5,9,42,Radiotherapy Dataset,6,7,2,10,11,b589b19b-b43f-4344-affb-5d7ea328c909,ALLIANCE > SAIL,3,7,1,1,0,f102ca50-d1e4-44ec-924e-be89446652af,1
5,9,42,National Vascular Registry - Lower Limb Angioplasty clinical dataset,6,7,10,10,38,b63aadf4-da85-478e-a171-05714ef9057e,,3,7,8,6,3,c8b6c319-239b-4792-9898-644a63d07ab5,5
5,9,42,DataLoch Core,7,7,10,10,38,b670cfe7-d4e2-46e5-b3e9-dccfd05c02d2,,3,7,8,6,3,d62939c4-e4a8-4fca-91ed-54f7f87fb89e,5
5,9,42,Development of spirometry predictive values for Indian population,7,7,2,10,11,b6a60be1-5d94-41f9-a426-5f9523a98d50,HUB > BREATHE,3,7,2,0,1,59521b01-6adb-4dd3-8b40-dbeb51171e4f,0
5,9,42,Welsh Demographic Service (WDSD),6,7,10,10,38,b6f26b11-da8d-402a-91c7-3b7122be274c,,3,7,8,6,3,8a8a5e90-b0c6-4839-bcd2-c69e6e8dca6d,5
5,9,42,Welsh Longitudinal GP Dataset - Welsh Primary Care (WLGP),6,7,10,10,38,b6fe3b50-aff3-435d-9c57-8b46eaa34671,,3,7,8,6,3,33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2,5
5,9,42,Cafcass England,6,7,0,10,6,b70900e9-85e9-4dd2-ae4b-02523be4219d,ALLIANCE > SAIL,3,7,0,0,0,8ee61578-e298-423a-be22-cb0438023e5c,0
5,9,42,UHB 100K Genomics patient clinical data including their acute care contacts,6,7,10,10,38,b789c975-7042-445c-bfa6-c24e5ca8a983,,3,7,8,6,3,ceae4fe0-4e98-4e3c-85db-e86539aade81,5
5,9,42,Public Health England Seroepidemiology Unit,7,7,2,10,11,b7a352ee-6306-4bd8-b9bc-f2a69fe17d70,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,89497432-17e0-49f4-96a4-65ef57d07701,2
5,9,42,CPRD Aurum SGSS,6,7,10,10,38,b8a46533-aa49-49d9-a0a2-7326e37f958e,,3,7,8,6,3,981b8787-45be-4f61-8625-3e3aae6ef10a,5
5,9,42,COVID-19 Detection from Chest X-Rays using Deep Learning,7,7,10,10,38,b95a3ebd-f1f2-4f5f-a598-1eaa60dd1790,,3,7,8,6,3,57526718-0a9a-42ad-8b7a-582d9ef96d13,5
5,9,42,ESPAC-TPlus,7,7,2,10,11,b9642fb3-3bee-491b-8d83-22f9de0fd77f,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,47f979bc-da9d-4e9e-9f2b-15e09366db04,2
5,9,42,2019 UK Parkinson's Audit - Patient Reported Experience Measure (PREM),6,7,10,10,38,b97ff350-f84d-4739-a4d6-f3a607063799,,3,7,8,6,3,6a6c4568-59e9-4760-89d6-07558a24944c,5
5,9,42,Hospitalised patients with diabetic emergencies & acute diabetic health concerns,6,7,10,10,38,b988b8bc-fbc5-40a7-8123-76ea5286b8c7,,3,7,8,6,3,0d556d7e-be27-4979-a09e-d419b2e838f3,5
5,9,42,Paediatric Intensive Care Audit Network - customised data collection,7,7,8,10,28,b9b4ee9a-3ffa-483d-8e46-16f862c83740,ALLIANCE > HQIP,3,7,7,0,3,6c78af2c-3898-435e-b1f4-e6a44682dc71,4
5,9,42,Pneumonia case management practices in selected communities in Pakistan,7,7,10,10,38,b9ffcd6b-cabd-4875-ac5c-5cb878f7290f,,3,7,8,6,3,cf190350-74c6-45f2-8ede-69ace62eb88d,5
5,9,42,Mental Health Minimum Dataset v4 (Non-Sensitive) Events,6,7,4,10,19,ba071b0b-5ef4-457b-b194-3a69c2c71a06,ALLIANCE > NHS DIGITAL,3,7,1,0,3,3adeb2f4-a924-49cb-9537-84a9a4242a62,5
5,9,42,National Joint Registry - Primary Elbow Replacement dataset,6,7,10,10,38,ba0bf718-05ab-4a6c-9419-1d04991d9ee9,,3,7,8,6,3,b06415af-9151-4ccc-83a1-ab859943fb2b,5
5,9,42,Emergency Department (Symphony),6,7,10,10,38,ba30a8b6-bfc7-4105-b094-11f187c7b293,,3,7,8,6,3,8002b4d7-ff3b-4402-b805-a6a0022836fd,5
5,9,42,BathTAP Updating Cohort 1,6,7,10,10,38,ba936454-e65e-491d-a16d-79115a4da09a,,3,7,8,6,3,90131a34-3cc8-4a74-b72f-d9600cfa2808,5
5,9,42,COVID-19 Symptom Tracker Dataset (CVST),6,7,10,10,38,bb04212f-0626-4cbe-8863-a2cc1df40683,,3,7,8,6,3,594cfe55-96e3-45ff-874c-2c0006eeb881,5
5,9,42,Patient postcode linked deprivation measures for CPRD Aurum,6,7,10,10,38,bb3152a1-aaef-4c0e-b0da-0fa94503b9da,,3,7,8,6,3,bd85a09c-fe4a-41b8-81d2-77feadcd1a0a,5
5,9,42,IBD NIHR BioResource: Case report form,6,7,10,10,38,bb61567b-431f-4e30-b906-654490ea14c7,,3,7,8,6,3,877a7275-b99d-4ed4-9691-de577e0ab49e,5
5,9,42,CDE Clinical Events,6,7,10,10,38,bb833f51-bc38-4489-b693-6658ea772393,,3,7,8,6,3,e3b36044-e1fb-418b-946a-b83626bf2e3f,5
5,9,42,Labour Force Survey (Longitudinal),6,7,10,10,38,bbd0a590-f4ee-4133-abe0-696cb247b3e0,,3,7,8,6,3,4ac15572-fe9a-46d3-860d-a46b616181f7,5
5,9,42,1958 National Child Development Study (NCDS),7,7,10,10,38,bbed7a4e-0c38-48b8-b4f8-b617ec307f59,,3,7,8,6,3,0ceaaedc-4904-4820-8b74-d6a8e679fb11,5
5,9,42,National Cardiac Audit Programme - National Audit of Percutaneous Coronary Interventions (PCI),7,7,8,10,28,bc236fba-2935-4406-aaa9-0006cbbf693d,ALLIANCE > HQIP,3,7,7,0,3,ac7016ce-f7a9-4c71-bebb-6af6efa27844,4
5,9,42,"Urinary tract infections acute presentations: microbiology, treatment, outcome",6,7,10,10,38,bd18eb49-9789-4ed3-a6c1-7b4f851ec2e7,,3,7,8,6,3,ae2192ce-7d75-4cec-8ebd-e07c2eacb7c3,5
5,9,42,Education Daily Attendance Dataset,6,7,2,10,11,bd87cdf4-ec39-41f6-bb07-c19f10372840,ALLIANCE > SAIL,3,7,1,1,0,17056e83-ee5a-4fe7-86e1-f09563256be1,1
5,9,42,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Events,6,7,4,10,19,bdc17b2c-8b0f-4959-ab9b-e2de32d8a5f9,ALLIANCE > NHS DIGITAL,3,7,1,0,3,3d348613-2d66-4814-a294-7e0c365f43f8,5
5,9,42,Referral to Treatment Times (RTTD),6,7,10,10,38,bdc4999c-71f6-4e94-aabc-e232ff423f10,,3,7,8,6,3,0bf54842-c1db-4bdb-9f55-c5be490bf758,5
5,9,42,Oxford Healthcare Workers,6,7,3,10,21,be1368c6-c97f-4ce0-8322-f97ccb28b9c3,ALLIANCE > OXFORD UNIVERSITY HOSPITALS,3,7,7,1,3,9de2f365-4c5d-4252-acee-6270b113aa93,1
5,9,42,Barts CTU,7,7,2,10,11,be77a483-2eff-4c05-8091-035fe79b3c8a,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,22aa219f-f3c8-4a25-822e-aa2504f6f29a,2
5,9,42,2011 Census - COVID19 Research Database Subset,6,7,10,10,38,be8ec01c-20ea-4863-ba7c-6d103df85a42,,3,7,8,6,3,a05aef07-c3fa-4331-905a-6b6f58eac3d5,5
5,9,42,Practice postcode linked deprivation measures for CPRD Aurum,6,7,10,10,38,bf36d50c-111e-462a-be66-9ef586df1afb,,3,7,8,6,3,9f689ef4-26c6-4f85-80ff-5116974f315a,5
5,9,42,TheatreEvents,7,7,10,10,33,bf83ada4-b72e-4789-b177-12a53aa763ea,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,3,7,9,0,3,2c6adf80-f30b-46c9-b9d4-fe3e68622469,5
5,9,42,EU Farm Structure Survey Wales (EUFS),6,7,10,10,38,bfbd3c63-8902-4242-97d5-ca935591e8cb,,3,7,8,6,3,cc7aa34f-81df-42f8-ad69-80e136c48bf1,5
5,9,42,"Ventilatory strategies, medications and outcomes for patients with COVID",6,7,10,10,38,c01fbdae-33e3-4839-b842-3b61a722a925,,3,7,8,6,3,55a744c4-a2d4-4ea0-b0eb-1af6e1465383,5
5,9,42,Daisy Tumour Bank,7,7,2,10,10,c03468f4-ba51-4d9f-a785-f041adb84724,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,b3ec5c18-e339-4bd8-8a59-5a3445a81f16,2
5,9,42,Hospital Episode Statistics Accident and Emergency,6,7,10,10,38,c13ee365-cc04-4512-b371-7908fb717525,,3,7,8,6,3,3ddfccc3-ba32-4653-a999-966b8d6c412f,5
5,9,42,Cystic Fibrosis Patient Demographics,6,7,0,10,6,c1682cb7-8f43-49fa-b66a-0a4a205885d3,ALLIANCE > CYSTIC FIBROSIS TRUST,3,7,0,0,0,19bc55c2-13d7-4488-a52c-35287483ea4e,0
5,9,42,National Radiotherapy Dataset (RTDS) for CPRD GOLD,6,7,10,10,38,c22e5f4e-02e2-4b54-b895-5e31b75a1f44,,3,7,8,6,3,56a66de8-3470-4a36-ac71-4d5471e72654,5
5,9,42,COVID-19 Vaccination Status,6,7,10,10,38,c230a8d8-bf78-4713-8f2f-312162e92e55,,3,7,8,6,3,98372a87-f3e6-475d-be12-46c0f9587413,5
5,9,42,NICAM: Nilotinib treatment for c-KIT mutated advanced AMM,7,7,2,10,11,c2c77d1a-d4d8-40cd-95f3-31912d4bd561,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,ba0edcaf-854d-4907-851a-280b56128b3b,2
5,9,42,Outpatient Referral,6,7,0,10,6,c2ddca9f-f144-437b-ac7a-0a628a50ba1a,ALLIANCE > SAIL,3,7,0,0,0,7465c65e-c321-42e9-a2f4-6bc664caf1fc,0
5,9,42,National Diabetes Audit,6,7,3,10,12,c2e112a0-a198-46b0-9a0c-ec91edfb6839,ALLIANCE > NHS DIGITAL,3,7,1,0,1,9a434a5c-563b-4da1-9133-9994960ade54,1
5,9,42,Covid Lateral Flow Test (CVLF),6,7,10,10,38,c303bdc0-fa5d-4c22-84ca-83577446062d,,3,7,8,6,3,ce60d677-6263-4d41-9d45-d3c7ebb3ee36,5
5,9,42,University College London - Edinburgh-Bristol (UCLEB) multi-omics consortium,7,7,10,10,38,c34e6ba2-f857-43e9-9cf5-372a44347833,,3,7,8,6,3,cd8f4e44-0228-4abd-9286-0509afe9427e,5
5,9,42,TRICON8,7,7,2,10,10,c3b4f4f2-953e-4470-bedd-9d09fd30a508,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,85113a93-89ed-40e3-a479-33b461b91858,2
5,9,42,2011 Census variables (and variable breakdowns),6,7,2,10,13,c4426ec2-fbf0-45b2-9f68-0477527257a0,ALLIANCE > PUBLIC HEALTH SCOTLAND,3,7,2,1,1,a05aef07-c3fa-4331-905a-6b6f58eac3d5,1
5,9,42,Diagnostic and Therapy Services Waiting Times (DATW),6,7,10,10,38,c474492c-1c9d-4e94-bc85-270aab69a74d,,3,7,8,6,3,97896866-ab5e-408a-ac5a-072802db9faf,5
5,9,42,National Waiting List Open Pathways,6,7,10,10,38,c47f463f-6e7e-4abb-b9bc-010ae68156b7,,3,7,8,6,3,c7b1e328-f2d7-4d11-b38f-ce9930b95ca0,5
5,9,42,PANTHER study,6,7,3,10,22,c66f943f-4307-4486-817c-49f6d8b9fd6b,ALLIANCE > UNIVERSITY OF NOTTINGHAM,3,7,7,2,3,596077a9-298b-44cc-aa7a-81f04cf5dcb3,1
5,9,42,Child Health Systems Programme - 4-5 year review,6,7,10,10,38,c6859b1b-4d5b-46bd-8532-089cff743be7,,3,7,8,6,3,5844bde6-628d-4e76-bb56-3534e2728eb6,5
5,9,42,Exogenous sex steroid hormones and asthma in females of reproductive age,7,7,4,10,17,c6e2fffb-4817-462e-ba7e-ff546728f3d1,HUB > BREATHE,3,7,4,1,0,bc5d6d69-ec03-42fe-a63b-638c25c5258c,2
5,9,42,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Episodes,6,7,4,10,19,c713773c-e961-400e-b44a-947002deb073,ALLIANCE > NHS DIGITAL,3,7,1,0,3,334afc50-a05a-43b9-aa1e-a012a22733e0,5
5,9,42,SCOT translational sample collection,7,7,2,10,8,c78122ae-8be1-40d7-8567-b83059941c16,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,b3b790a7-a455-4efb-9c68-60e7131cb836,0
5,9,42,UHB Linked Diabetic Eye Disease in Acute Diabetic Hospital Admissions,6,7,10,10,38,c8654ef8-585c-4ac4-ac0e-33a875d407a1,,3,7,8,6,3,865c99c4-bbe9-45de-83b9-290fb54d5470,5
5,9,42,Admissions and Discharges,6,7,10,10,38,c8edcbd8-40e6-4c34-b138-307a94c19cc0,,3,7,8,6,3,1d5b9205-dae4-4b0e-a3d3-04707875edf8,5
5,9,42,HES Accident and Emergency data for CPRD Aurum,6,7,10,10,38,c8f36174-aaa7-4388-bea9-48fffb2c441c,,3,7,8,6,3,c43501ec-08b4-4d33-a7dd-d19fca821925,5
5,9,42,Emergency Department Dataset Daily (EDDD),6,7,10,10,38,c9322345-9fe2-404e-8dcb-0b4d8856459b,,3,7,8,6,3,fa257aa8-51fc-4eb7-a448-e473fa54686d,5
5,9,42,Annual District Death Extract (ADDE),6,7,10,10,38,c93ff611-458c-4fc8-bb94-5274988f7f7f,,3,7,8,6,3,15cf4241-abad-4dcc-95b0-8cd7c02be999,5
5,9,42,National Diet and Nutrition Survey (NDNS),7,7,2,10,11,c960ffab-a94c-45e3-96a0-598719acfbf5,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,f86400cb-7cab-4e34-aab6-57138b6a96c2,2
5,9,42,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Records,6,7,4,10,19,c97b8058-a6a4-4c8d-92e1-6e9f4cddd301,ALLIANCE > NHS DIGITAL,3,7,1,0,3,01c88a30-b14d-401e-82bb-165cbde81942,5
5,9,42,COVID-19 Test Results (PATD),6,7,10,10,38,c9809e56-5b29-4ab4-a5f3-f72a2d6419fc,,3,7,8,6,3,f5f6d882-163d-4ef1-a53e-000fba409480,5
5,9,42,CPRD Aurum,6,7,10,10,38,c9c2f711-00a0-4b5a-abf8-2d1353d7cd67,,3,7,8,6,3,1d574c14-1af0-490d-9c4e-be88cfd0e345,5
5,9,42,Secondary Uses Services Payment By Results,6,7,3,10,15,ca05a688-c305-4ebd-967f-facb010c29bf,ALLIANCE > NHS DIGITAL,3,7,2,1,2,2004c512-f7c9-4995-b820-55f36aa3fad2,1
5,9,42,Cystic Fibrosis Patient Annual Review Encounters,6,7,0,10,6,ca2c6ec0-00ce-42fc-a077-88911259576c,ALLIANCE > CYSTIC FIBROSIS TRUST,3,7,0,0,0,11360490-8da3-4a25-bb87-4fcc249b9af5,0
5,9,42,NHS Tayside and Fife Haematology (Lab Data Restructured),6,7,10,10,38,ca8c912d-82c4-481e-b17a-b567e3bf3c72,,3,7,8,6,3,c294bb01-062b-494e-942b-1efe8cbac3dc,5
5,9,42,Cystic Fibrosis Patient Liver Enzyme,6,7,0,10,6,caa644b6-a50d-455b-bee1-96232443e2b9,ALLIANCE > CYSTIC FIBROSIS TRUST,3,7,0,0,0,f72e80fc-dcd3-4457-ae91-dd14449002dd,0
5,9,42,The Million Women Study,7,7,10,10,38,caab69a0-b560-4320-ac61-557f81f37ae3,,3,7,8,6,3,97ac8a7d-30b9-4fa6-84db-b4f9430fc1d6,5
5,9,42,Northern Ireland Regional Maternity system (NIMATS),6,7,10,10,38,cace4854-a8de-4487-9c43-fe580b341d26,,3,7,8,6,3,be7efa4f-e500-4a54-8157-6c4442a7e8a8,5
5,9,42,ECHO,6,7,10,10,38,cb0b4506-8c28-4cad-abf0-1abaf59c6a2c,,3,7,8,6,3,b54d9224-a03f-4d53-8de8-c253b65a8172,5
5,9,42,UKCTOCS Longitudinal Women's Cohort (UKLWC),7,7,2,10,10,cb7370a6-a1b0-4473-a32f-ec85ec0155a5,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,e0b951ba-0f7d-4743-9374-b965042accdd,2
5,9,42,Congenital Anomaly Register and Information Service (CARIS),6,7,10,10,38,cbab40e4-9e61-4466-b706-db47771d2512,,3,7,8,6,3,6fe7e004-eb51-4c7b-9905-1ec9a4827dca,5
5,9,42,Falls & Fragility Fracture Audit  Fracture Liaison Service  clinical dataset,6,7,10,10,38,cbb0568c-510e-49de-af43-edb9345535a8,,3,7,8,6,3,d94a604c-5733-4f07-93bb-e77b6ea2313f,5
5,9,42,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - Scotland,6,7,10,10,38,cc1a15ea-1bca-42c5-9915-8e6bfd733d6e,,3,7,8,6,3,69a356d6-599e-4d02-8241-066ce3c297bd,5
5,9,42,Mental Health Minimum Dataset v4.1 (Sensitive) Records,6,7,4,10,19,cc383a3f-1c47-4b7d-99cf-be8ee0afe401,ALLIANCE > NHS DIGITAL,3,7,1,0,3,c00d5ad2-d5d2-4318-8849-4c2fe52aabd0,5
5,9,42,RIO,7,7,2,10,9,cde234d0-748b-4df6-a59d-3268cc7e8c1d,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,18bc81e3-7d99-4152-bd7a-3c90ee7e489d,0
5,9,42,Postponed Admitted Procedures,6,7,0,10,7,ce192e2e-4f31-4bb0-9c1f-5c4173c03011,ALLIANCE > SAIL,3,7,0,0,1,bff94600-a254-4111-82f7-6167084d81ca,0
5,9,42,Maternity Services Dataset,7,7,10,10,32,ce1bcddb-a6af-4511-84c6-2a252d3eb202,ALLIANCE > BARTS HEALTH,3,7,8,0,3,173d07ab-5930-4d19-b3de-dcca193e62fd,5
5,9,42,CAFCASS Wales (CAFW),6,7,10,10,38,ce251255-cef6-4963-9ca5-ec798ab157d2,,3,7,8,6,3,29a714e1-5289-4362-be24-2848c954344e,5
5,9,42,North West London Community Data (NWL COM),6,7,1,10,7,ce896b89-5f4a-407c-bb10-7eec51089458,HUB > DISCOVER NOW,3,7,0,0,0,65dad445-ed81-4005-9f5a-4f8a7164043e,0
5,9,42,Welsh Demographic Service (WDS),6,7,0,10,6,cea328df-abe5-48fb-8bcb-c0a5b6377446,ALLIANCE > SAIL,3,7,0,0,0,8a8a5e90-b0c6-4839-bcd2-c69e6e8dca6d,0
5,9,42,4 LMIC Asian Country ChrOnic: estimating respiratory disease burden in adults,7,7,1,10,10,cf64602c-7703-4f29-bd90-e0d511e2b24e,HUB > BREATHE,3,7,2,0,1,490747bf-b268-41f3-8f35-f6bc4a4bdbfa,0
5,9,42,Referral to Treatment Times,6,7,0,10,7,cfdb9fbd-9f67-435c-b257-6b51430451bb,ALLIANCE > SAIL,3,7,0,0,1,0bf54842-c1db-4bdb-9f55-c5be490bf758,0
5,9,42,Labour Force Survey (Household),6,7,10,10,38,cfea1343-daea-43cf-b73c-c4eebecee182,,3,7,8,6,3,0b630200-1e7c-4b19-ad53-bcc8863f7ade,5
5,9,42,Cancer Group CTR Cardiff trials,7,7,2,10,11,d006821e-a507-4699-b560-b5d023e09d4b,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,cd833805-f0a8-4ddb-a50d-b12695c92120,2
5,9,42,Child Health Systems Programme - 6-8week review,6,7,10,10,38,d07f2709-ccc7-410b-9b73-a45918e21fed,,3,7,8,6,3,f9cf4be7-fbc9-4601-8beb-5d3c3596bf04,5
5,9,42,National Vascular Registry Audit - Carotid Endarterectomy Clinical Dataset,6,7,10,10,38,d094b10a-b1b4-4805-9424-33547e9c46ba,,3,7,8,6,3,f857055b-c29e-4c7f-99ce-65f4ed59648e,5
5,9,42,National Audit of Psychosis - Early Intervention Psychosis Audit patient experience survey,7,7,8,10,28,d15b6d4a-a5de-4df4-8f29-4a8926af8024,ALLIANCE > HQIP,3,7,7,0,3,a464c126-8591-4af6-a10f-99c020f59527,4
5,9,42,Welsh Dispensing Dataset,6,7,1,10,7,d27f265d-8931-4f76-83a2-cb47189a53f0,ALLIANCE > SAIL,3,7,0,0,0,50ef6443-ed4b-40f9-97fb-1cfd53be6579,0
5,9,42,NIHR IBD BioResource: Case report form,6,7,10,10,38,d2981964-3ff7-47e2-91e1-ac5812227a80,,3,7,8,6,3,877a7275-b99d-4ed4-9691-de577e0ab49e,5
5,9,42,Patient Reported Outcome Measures,6,7,9,10,32,d2af6a29-291b-4444-a17c-40f4208f1e1b,ALLIANCE > NHS DIGITAL,3,7,8,2,3,55614ed3-2484-4408-a4e9-e5fffed9e8e4,4
5,9,42,Education - Wales,6,7,0,10,6,d2da2750-7482-4ce9-ae5c-2ab393408a67,ALLIANCE > SAIL,3,7,0,0,0,204fa806-071d-4410-9c2c-143017d32d24,0
5,9,42,Cancer Network Information System - CNIS / CANISC,6,7,10,10,38,d3010e1b-09ea-49e5-a5fb-3cf5a030fda6,,3,7,8,6,3,da91f0eb-1761-485b-8b7f-9121b6a1d004,5
5,9,42,HES Critical Care data for QResearch,6,7,10,10,38,d3e74665-3555-4955-823f-37295862e4b6,,3,7,8,6,3,87966461-0162-4649-84e3-76adc5cd0274,5
5,9,42,JANUS,7,7,10,10,33,d3fd4dac-2d15-401c-8185-905ee108d9ce,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,3,7,9,0,3,6590f79d-cfea-4695-9fe0-dc5f85e6d273,5
5,9,42,Annual District Birth Extract (ADBE),6,7,10,10,38,d42aa93a-ecc3-480b-a55b-d089dbc11413,,3,7,8,6,3,12a77014-4a77-4eb1-8b26-f49689352d1b,5
5,9,42,National Neonatal Audit Programme - clinical audit,6,7,10,10,38,d4683e8d-9c3f-4e5e-874c-80333a1ef719,,3,7,8,6,3,49b67625-4c9a-4101-a982-e733e7db20ca,5
5,9,42,Follow-COVID,6,7,10,10,38,d524cd6b-14be-44a5-868c-f3e187d4e5d8,,3,7,8,6,3,e50d2b20-ef95-43fe-bbf0-83224d88e480,5
5,9,42,OUH Patient Master Index,7,7,10,10,33,d57a096a-4fa3-4529-b508-0b9df0f1893c,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,3,7,9,0,3,5d7465f6-ced8-434b-9907-d357ad125024,5
5,9,42,INTERVAL,7,7,3,10,20,d58d02f1-47c2-44fc-b16e-4f6cbbb46e62,OTHER > The University of Cambridge,3,7,4,1,2,c1fa9b47-a954-4587-a0c2-bae0f3ec2b9b,4
5,9,42,Use of digital auscultation to improve diagnosis of paediatric pneumonia,7,7,10,10,38,d5af13e0-cbcc-47f9-8d85-21867f198051,,3,7,8,6,3,198bd2cc-ca40-4dff-992c-a9480703fc37,5
5,9,42,TRACK-COVID,6,7,5,10,24,d614f4fc-fae9-4775-86d9-4d4710017cf4,OTHER > UNIVERSITY OF CAMBRIDGE,3,7,7,2,3,9e89af6b-bfa8-43dc-a2d4-5540c899a670,1
5,9,42,UNIRAD UK Sample collection,7,7,2,10,11,d6296f3e-ccd9-46a5-acc9-50eb5aa41c56,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,a1d16f3f-c7e7-41c5-a071-07889bf49ab1,2
5,9,42,NACAP Pulmonary rehabilitation - clinical audit,6,7,10,10,38,d6d1588d-b65c-479d-8f15-7fddf5ed4cc0,,3,7,8,6,3,3afbb83d-d47b-43b3-a202-0d3081e5d294,5
5,9,42,UK BioLAM,6,7,10,10,38,d7b7faa1-e8c5-4c0b-8dc0-a9af1ec659da,,3,7,8,6,3,5345e2b8-13f3-41ce-9f56-87aaa9f3f55e,5
5,9,42,HES Admitted Patient Care data for CPRD GOLD,6,7,10,10,38,d7eeb562-2433-47c9-8b3f-72d55c24bb45,,3,7,8,6,3,4bcf64a6-f404-4ef4-ae6e-172512ab5f43,5
5,9,42,Research on use of an online learning platform on under-five pneumonia,7,7,10,10,38,d7f1b4ab-ae3c-4318-afc9-1b561d46d442,,3,7,8,6,3,a3d85fd2-9df3-4f6e-9035-0830a3488ddb,5
5,9,42,BathTAP Headache Cohort 1,6,7,10,10,38,d864c698-b98c-4a1e-9c6a-7b941d61a35c,,3,7,8,6,3,9cff3fc9-25d6-49fe-8218-dbbc3b3bc1ab,5
5,9,42,HIV PiNS,6,7,10,10,38,d89732fc-1bc3-4bd6-a634-9e9d03f3fea4,,3,7,8,6,3,1abc859e-4ac6-431a-b550-af1afb36df1b,5
5,9,42,COG-UK Viral Genome Sequences,6,7,10,10,38,d8fddd9b-56f2-44a5-9bf9-9efd8d727a8a,,3,7,8,6,3,1fe02b65-7b77-43bf-93c8-4f0743fee672,5
5,9,42,Generation Scotland: Scottish Family Health Study,7,7,10,10,38,d95be3ed-f767-4ea5-9e4d-295446f68eb5,,3,7,8,6,3,f4f0ef1a-46cf-4734-8516-3adb0b62ae6d,5
5,9,42,National Vascular Regsitry - Oragnisational Audit dataset,6,7,10,10,38,d977abd8-a966-4b4c-99f0-7a4c368f9934,,3,7,8,6,3,3c661240-e4d2-456c-a809-133c23f9c469,5
5,9,42,CDE Documentation,6,7,10,10,38,d9fc7ff7-6de4-4757-a2e3-d49f222ea1dd,,3,7,8,6,3,f866b225-10b8-4df4-9c32-072411f816d8,5
5,9,42,Deeply phenotyped clinical data for hospitalised Atrial Fibrillation patients,6,7,10,10,38,da139725-1b1e-4ccd-83ab-2951d2fedca5,,3,7,8,6,3,572b3ccd-4213-4a41-9255-3096952a2954,5
5,9,42,Child Health Systems Programme - School,7,7,10,10,38,da191840-9037-4e1f-8e6c-ec66eb80b798,,3,7,8,6,3,2c31cb1c-2b3d-40c5-b8d4-bf0b81f089b4,5
5,9,42,Looked After Children Wales,6,7,0,10,6,da5098df-414f-48e0-aaa7-7e2277f80eb7,ALLIANCE > SAIL,3,7,0,0,0,cfdafacb-48f0-4ad8-9f20-193a5eec2da4,0
5,9,42,King's Health Partners Cancer Biobank,7,7,2,10,11,da9cdc4c-2790-47f4-b4b5-76e87ce450ae,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,a218d0b4-0273-4a04-ba17-c01dae6dcf33,2
5,9,42,Mental Health Minimum Dataset v4.1 (Sensitive) Events,6,7,4,10,19,db113fcd-69a0-4357-9c6d-250085deb3f5,ALLIANCE > NHS DIGITAL,3,7,1,0,3,a1154967-a80e-41da-a9ae-6183584ecf6b,5
5,9,42,National Vascular Registry Audit  - Lower Limb Amputation clinical dataset,6,7,10,10,38,db53c086-db48-4f7e-9264-ed44a9154753,,3,7,8,6,3,03e77b9d-57b8-44d5-8d64-9b1325958b22,5
5,9,42,UK Lung Volume Reduction Surgery,7,7,0,10,6,db89a123-0402-4962-8a8f-78557ba4d84f,HUB > BREATHE,3,7,0,0,0,9f98a674-12f6-42f4-b1a5-322b3b75eef1,0
5,9,42,"NHS Tayside, A&E Drugs given during an A&E visit",7,7,9,10,31,dba474a3-90c4-423d-beb0-5ef79c490d24,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,3,7,8,0,3,acfbef89-344c-49a5-8079-7344f4316e0f,5
5,9,42,The Consequence of Respiratory Syncytial Virus (RSV) Infection in Young Infants,7,7,10,10,38,dbcf49c1-f23c-4bb8-8c4f-6fc4e996ff97,,3,7,8,6,3,51d41006-727e-43d4-bdb6-f8b427c295c6,5
5,9,42,Outpatient Dataset (OPDW),6,7,10,10,38,dc5507d0-807e-4981-906b-731690a5e085,,3,7,8,6,3,d331159b-b286-4ab9-8b36-db39123ec229,5
5,9,42,NHS Greater Glasgow & Clyde Bio-Repository,7,7,2,10,10,dcb4c87b-5884-41c0-b9af-d7d094dd0922,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,762976cc-83d0-4b31-a879-37f87f947406,2
5,9,42,NIHR BioResource: Health and Lifestyle Questionnaire,6,7,10,10,38,dcb8a41b-f2ac-4ee1-9520-b7ef7214e9d6,,3,7,8,6,3,321e3ad6-96b9-4f19-bbc4-d06dfe2a59d5,5
5,9,42,Prescribing,6,7,10,10,38,dcd6f957-1fcc-481a-bbd2-89abfe933449,,3,7,8,6,3,6d044471-62d2-4190-b315-503f77d33ef2,5
5,9,42,Decode-ME,7,7,10,10,38,dd6e4344-9cee-41f3-8062-6bb9cdfda012,,3,7,8,6,3,a71d0b2a-620c-4c04-b7bb-45843461db9f,5
5,9,42,MesobanK,7,7,2,10,11,ddbc149a-db56-41de-bd2c-3624149f6e7e,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,b03835b7-7408-49a0-a9aa-ea405f9855c9,2
5,9,42,NIMRAD-TRANS,7,7,2,10,11,ddd49721-ff49-4f68-b3f5-e95a417fb0ac,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,039b55f7-d416-49ab-9bdb-4ff7dbc733df,2
5,9,42,VIKING GENES,7,7,10,10,38,ddf35f0d-ca89-4f74-bbdd-65d1a84b38ca,,3,7,8,6,3,43636f80-27fd-43d0-8556-d0a2de0cd819,5
5,9,42,Children's Health in London and Luton (CHILL),7,7,1,10,9,de4b46f5-1591-442d-a896-6e0d91657c01,HUB > BREATHE,3,7,0,0,0,722be723-04bd-48b4-923b-e7d393f0c22b,2
5,9,42,UK Renal Registry - COVID-19 dataset,6,7,10,10,38,de8d0b95-b968-45f2-8cd4-2c87d72ff729,,3,7,8,6,3,2a3dba77-34ff-4781-b273-1b3d54d11f32,5
5,9,42,Children’s Kidney Cancers - Great Ormond Street Hospital,6,7,0,10,6,df23aabd-3e5f-4fc2-aad6-af990cff6f19,HUB > DATA-CAN,3,7,0,0,0,3f71bef5-c5a2-400c-a482-2ad30b29a240,0
5,9,42,IBD NIHR BioResource: SNP chip data,6,7,2,10,8,df3cc57d-08ae-4e81-ae79-283d71cf8d95,HUB > GUT REACTION,3,7,0,0,0,3c749cfc-4008-4916-b64f-969d6a754c0f,0
5,9,42,Welsh Health Survey Dataset (WHSD),6,7,10,10,38,df55c56f-b081-45f4-b265-ed1b2c6d94cd,,3,7,8,6,3,e4d8edb3-6e8e-435d-9732-60c83027d8f9,5
5,9,42,National Paediatric Diabetes Audit - core clinical dataset (care processes and outcomes),7,7,2,10,14,dfba178f-ce67-4c2d-8693-b23110aeecae,ALLIANCE > HQIP,3,7,2,0,3,e355c9b9-44f0-4ba3-a872-645aa88f4f2b,1
5,9,42,MATCH,6,7,10,10,38,dfc16033-7620-4002-aa3b-e5bbc400bbfd,,3,7,8,6,3,5429fc2a-3d72-414d-9393-4079c4c6c0fa,5
5,9,42,Generation Scotland,7,7,2,10,11,dfc3205c-3079-4e95-93e2-8a3a3beeea5a,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,019fad36-65ea-4d47-8d6d-a47240eeb801,2
5,9,42,NIHR BioResource: Demographic,6,7,10,10,38,dfd65358-d5a4-40f1-873a-c8c304799cbf,,3,7,8,6,3,d2c486bb-b95b-4093-bb58-b196cfc08c7b,5
5,9,42,National Asthma and COPD Audit Programme (NACAP): secondary care workstream – children and young people asthma (organisational),7,7,8,10,28,dfedefac-c389-4d07-a8a3-eb2e4ff34587,ALLIANCE > HQIP,3,7,7,0,3,3efd9b30-1f84-48c0-a3e0-402ecb5c7724,4
5,9,42,COVID Tests,7,7,10,10,38,e00284e3-439b-4a6d-9781-679c539404f8,,3,7,8,6,3,607b17d6-74de-466a-a377-238444707abb,5
5,9,42,Laboratory turnaround times processing electronic blood test orders in the NHS,6,7,10,10,38,e05de62a-91be-46b8-8c1d-c9ed89d8c740,,3,7,8,6,3,971e2827-3aa4-4af3-bdce-3c8419897654,5
5,9,42,UK Renal Registry - Your Health Survey dataset,6,7,10,10,38,e096053e-b028-4487-a6d0-6958cbb5f388,,3,7,8,6,3,14ed4ab3-470b-45c8-b48f-27fd382a912e,5
5,9,42,Beta-blocker Stratification using MRI to assess portal pressure (B-SMaRT),7,7,10,10,38,e09e1735-a54a-49cd-81f1-484040d76a5a,,3,7,8,6,3,d602ca39-b287-4047-81c1-d635d3ceed5a,5
5,9,42,SpiroMeta Consortium Dataset,7,7,0,10,7,e172870f-37c4-4103-afae-8a60cae43ccb,HUB > BREATHE,3,7,0,0,0,fb6d98c5-e41d-4804-bb28-839556e0f657,1
5,9,42,Patient postcode linked deprivation measures for CPRD GOLD,6,7,10,10,38,e17b9566-76e9-47b4-9cf9-26704e232992,,3,7,8,6,3,f5c9ba01-a9cb-4a85-9850-d9466b2ff4fb,5
5,9,42,Cancer registry data for QResearch,6,7,10,10,38,e17fbbfa-72e8-4642-8ec5-0fa25dd56a51,,3,7,8,6,3,fd876055-ab0f-4562-9e8a-35efa3928b02,5
5,9,42,Coagulopathies & arterial/venous thrombosis in COVID patients: an OMOP dataset,6,7,2,10,13,e22f93fb-bc08-44eb-b292-dc2baf0ad343,HUB > PIONEER,3,7,3,1,0,dd4629c0-14b6-4cba-8dcf-31ec5fea68bb,1
5,9,42,"Leeds Dental Institute/School of Dentistry Leeds, Skeletal Tissues Bank",7,7,2,10,11,e3373d01-48c6-49bc-8c9b-827831e525b3,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,f94168a1-cab8-4211-90e0-38a241609697,2
5,9,42,Quality of Life of Cancer Survivors: Pilot Patient Reported Outcomes(Aurum),6,7,10,10,38,e37a86dc-8544-46aa-8f91-923ced92e263,,3,7,8,6,3,3bc43876-507b-4dff-bd2b-7df147322e15,5
5,9,42,The impact of multimorbidity on care pathways during COPD hospitalisations,6,7,10,10,38,e38ceae6-1ef7-4a26-90c9-9b0c920b3df7,,3,7,8,6,3,76167567-9221-4024-bccf-dfdfb9e4bb07,5
5,9,42,eLIXIR - Early Life Data Cross-Linkage in Research,7,7,2,10,10,e443bc67-bc8a-430b-88a9-d3380cd2ae38,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,c8cd0645-b728-4c62-84b8-036c1d8763be,2
5,9,42,IBD Registry,7,7,10,10,38,e4a1be81-8f3c-4731-ae8a-7cbd594c78f5,,3,7,8,6,3,a406d06b-350e-4392-ab4e-b1012e422a34,5
5,9,42,Care Home Dataset (CARE),6,7,10,10,38,e4a745d6-f44c-481a-b337-aae4cfe72594,,3,7,8,6,3,aae02f9e-1bad-415d-9730-c46a07a990aa,5
5,9,42,NHS Scotland General Practice (GP) Contact Data - Subset,6,7,10,10,38,e5a0c70c-7429-487d-8dc7-04cf073191cc,,3,7,8,6,3,8f486c3d-9504-4a0e-8e24-ab96f057fc9e,5
5,9,42,National Asthma and COPD Audit Programme (NACAP): COPD secondary care clinical dataset,7,7,8,10,28,e6433c92-8439-4e2e-a3e7-016e7812dcfb,ALLIANCE > HQIP,3,7,7,0,3,85b4dc84-88f4-4740-80fa-fa1eb04a0ae6,4
5,9,42,National Emergency Laparotomy Audit - Patient Audit Dataset,7,7,10,10,38,e70f4e13-440b-4dec-a13c-c17d9d9da553,,3,7,8,6,3,25b93812-191f-49bb-bbd0-782fb85b2bd2,5
5,9,42,IDRIS Trial,7,7,2,10,10,e7979d81-708d-4657-857c-4ca95d05cda2,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,8437b207-c925-4dd1-9478-5af329cd736e,2
5,9,42,COVID-19 Staff Testing of Antibody Responses Study (Co-STARS),6,7,3,10,20,e79c5f26-deb0-4531-834d-58912c9fe663,ALLIANCE > GREAT ORMOND STREET HOSPITAL,3,7,7,2,1,435bfcda-f378-44f6-9387-042d959eb945,1
5,9,42,BathTAP Headache Cohort 2,6,7,10,10,38,e7b615a0-2867-47ff-bb40-0d459b41226c,,3,7,8,6,3,2d79feab-3046-4735-a4ec-a4c11c9c1aa8,5
5,9,42,Air Pollution Exposure Estimates,6,7,10,10,38,e8932b23-ed21-40f4-8fb1-00ef186e6ee1,,3,7,8,6,3,584cbecc-43ef-4015-adf7-ff70178d7abe,5
5,9,42,Strategy introducing Pulmonary Rehabilitation for COPD management in rural India,7,7,2,10,14,e8c3b66d-f06b-4e3f-944d-f65235133f00,HUB > BREATHE,3,7,2,0,2,e8afaf39-86fa-4085-a075-6118cc25fae0,2
5,9,42,Brecon Dataset (BREC),6,7,10,10,38,e956a7a4-896b-47dc-8d98-f48385d110f7,,3,7,8,6,3,9c6e891f-6449-48d2-a1c3-8dd236e34bbd,5
5,9,42,HES Diagnostic Imaging Dataset for CPRD GOLD,6,7,10,10,38,e97f2bd0-48c1-4cd8-9d18-780f21a52b45,,3,7,8,6,3,a1bef3a6-9700-43a5-8f3e-dad44ce1fe10,5
5,9,42,IBD NIHR BioResource: Health and Lifestyle Questionnaire,6,7,10,10,38,e9820518-54e3-46d1-a63f-c5da867dcd82,,3,7,8,6,3,18bfe765-5733-41f3-8114-0a1ec2524b5b,5
5,9,42,National Asthma and COPD Audit Programme - Pulmonary rehab organisational audit,6,7,10,10,38,e9902b10-84ca-495f-a4d9-a9948d0d64ca,,3,7,8,6,3,4b33fc6d-3cac-4404-adac-d693328456fa,5
5,9,42,Hospitalised Community Acquired Pneumonia before & during the COVID-19 pandemic,6,7,10,10,38,e9cdc12c-6938-4c18-b45c-e0a77df6de56,,3,7,8,6,3,1861b3dd-4969-490e-9faf-c57809f56bc1,5
5,9,42,Children Receiving Care and Support Census,6,7,0,10,6,ea9fa5fb-928d-4736-8fbf-e3b58a49c6d6,ALLIANCE > SAIL,3,7,0,0,0,fb3fac03-a428-4b3f-8058-5622e1fd57d8,0
5,9,42,Sunquest,7,7,10,10,33,eaca9ed1-30b6-4157-8894-8e53efc84849,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,3,7,9,0,3,a80b2567-4755-46f1-bd2a-f3817ce4f10c,5
5,9,42,HES Outpatient data for CPRD GOLD,6,7,10,10,38,eacd1a6e-6060-4843-ac9b-ff01e1dfe9c3,,3,7,8,6,3,21dc2345-3983-4a46-960c-f17974bc7b71,5
5,9,42,Scottish Birth Record (SBR),6,7,10,10,38,eaec06fa-a27e-46d1-9be9-6e1f9a16fb5d,,3,7,8,6,3,81c53293-ef64-4507-8fcf-2a254dc19936,5
5,9,42,English Longitudinal Study of Ageing (ELSA),7,7,10,10,38,eb030592-7f5d-4969-abde-c4a962251406,,3,7,8,6,3,f12cb023-1402-49d1-aa27-e0fe4ed19fd7,5
5,9,42,ICT-based intervention for adult asthma with limited health literacy,7,7,10,10,38,eb376dc5-1abb-4d06-a39a-e479078bcf9d,,3,7,8,6,3,1d6b02f1-47b8-42ad-919d-f738b545cff7,5
5,9,42,Quality of Life of Colorectal Cancer Survivors:Patient Reported Outcomes (Aurum),6,7,10,10,38,eb62e466-f199-43ea-b07a-3aa468be5076,,3,7,8,6,3,bfb90d2b-746d-44a6-a896-4979d73d9276,5
5,9,42,Annual District Death Extract,6,7,0,10,6,eba50bb1-e971-4062-8ece-81be39ceca5b,ALLIANCE > SAIL,3,7,0,0,0,15cf4241-abad-4dcc-95b0-8cd7c02be999,0
5,9,42,Health & Attainment of Pupils in a Primary Education Network (HAPN),6,7,10,10,38,ebc7383b-000d-4d7b-a8db-7f7ce6b1a183,,3,7,8,6,3,464d8653-4e69-406b-93fd-d68c29d5dfdc,5
5,9,42,Community Services Data Set,6,7,10,10,38,ec121652-b3ab-4f90-8b93-ab5f6b1bc64c,,3,7,8,6,3,5616e0a6-22f1-43a5-a2bd-dcecfa2f3b70,5
5,9,42,NHS Grampian Biorepository,7,7,2,10,10,ece82228-9af1-4699-a763-b4608908b645,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,10d0def8-dc03-473f-b60b-4c0dc3642a25,2
5,9,42,The Fenland Study,7,7,10,10,38,ed8683b0-1745-47fe-b644-710e6b8dca33,,3,7,8,6,3,8ca5cc9c-bb4e-4fa4-b430-165720cd9634,5
5,9,42,Falls and Fragility Fracture Audit Programme National Hip Database Facilities Survey 2019,7,7,8,10,28,ee099373-8a72-4ec7-818f-3cbb9c8a793d,ALLIANCE > HQIP,3,7,7,0,3,025c9e8a-938b-4886-9e03-fcad90fe7157,4
5,9,42,The PEACE Study,7,7,2,10,11,ee4a73ef-fb4e-4926-9fcc-db6b44b1447e,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,33b1a989-5f61-412e-bdae-b551c92d1ed6,2
5,9,42,Hospital Episode Statistics Critical Care,6,7,10,10,38,eec9fec3-2257-4dd2-a3a9-8c164322fbaa,,3,7,8,6,3,80564a6b-1458-41de-a131-772eb93c0509,5
5,9,42,Scottish Covid-19 Vaccination Data,6,7,10,10,38,eee15509-f23a-441e-b5be-ee76bd2ba649,,3,7,8,6,3,bcfd3b49-f7f0-489e-bc1b-bcce0bd261f2,5
5,9,42,Understanding Society,7,7,10,10,38,ef478925-7612-4cd6-a10e-5e64ee8a0f4d,,3,7,8,6,3,932cecdf-65fb-4e3d-9454-7a2d0585e970,5
5,9,42,SGSS data for QResearch,6,7,10,10,38,ef4c90fc-03b6-4b21-a45f-bcd7cabb0857,,3,7,8,6,3,8a438697-7cdd-4716-8824-8685fa8eb314,5
5,9,42,Freetext Dataset,7,7,10,10,32,ef727724-6c38-483b-b28d-8e94b5a9d7ac,ALLIANCE > BARTS HEALTH,3,7,8,0,3,0f07f939-1265-4e8b-aaa6-d897d254c2f3,5
5,9,42,Mother-Baby Link for CPRD GOLD,6,7,10,10,38,efc0be66-e680-4166-ba58-d507f4c02d88,,3,7,8,6,3,b734a1b5-37d3-4859-85d4-bf011df2a951,5
5,9,42,Coronavirus and the Social Impacts on Great Britain,6,7,10,10,38,f0109da2-6452-45a9-928e-5376dcb78609,,3,7,8,6,3,e253257c-48c2-491b-b3b9-205161a16a7e,5
5,9,42,GP Out of Hours,6,7,10,10,38,f08bfb75-f2b8-4afb-9c3d-59cdd2b6b3ce,,3,7,8,6,3,731dc868-3e79-4722-9b79-6bb8dec9435b,5
5,9,42,Welsh Health Survey Dataset,6,7,2,10,11,f0fc13b4-f801-4647-82f3-07ed07f26ea0,ALLIANCE > SAIL,3,7,1,1,0,e4d8edb3-6e8e-435d-9732-60c83027d8f9,1
5,9,42,Welsh Results Reports Service (WRRS),6,7,10,10,38,f13d5f5a-08b3-49be-8d5e-48772a612cb0,,3,7,8,6,3,71d37610-ac55-432d-82a3-bdb04407acd8,5
5,9,42,Assessing acuity scores – NEWS2 in acute illnesses with component markers,6,7,10,10,38,f14341fe-2f15-48a7-bcd6-3c4d298375d1,,3,7,8,6,3,bc6a661a-4447-40ad-bc92-3007e89688c9,5
5,9,42,Child Health Systems Programme - 13-15 Month Review,6,7,10,10,38,f16f0b1b-650d-486b-bc89-946b1623103e,,3,7,8,6,3,e77af7a3-32fa-4a08-8455-4fb489e5b64a,5
5,9,42,NIMS - National immunisation data for QResearch,6,7,10,10,38,f19b7888-344d-47af-878a-82a270a30d22,,3,7,8,6,3,65b04cbe-1b5c-44d7-b640-ce63fb106401,5
5,9,42,North West London Acute Patient level Data (NWL Acute PLD),6,7,3,10,12,f2268d4e-0149-4913-9832-0399960eecd4,HUB > DISCOVER NOW,3,7,1,1,0,0d5a40e6-52c0-43c4-bd9f-f2a803cc8ff6,1
5,9,42,"Problems, Diagnosis and Procedures",7,7,10,10,32,f2b4211b-1af7-46ff-82a3-35b29d1d478e,ALLIANCE > BARTS HEALTH,3,7,8,0,3,51b41359-1558-48df-9950-88f75ca6ac4c,5
5,9,42,Emergency Department Dataset (EDDS),6,7,10,10,38,f2c2ea2f-f5e8-4297-8510-c2d430ff0946,,3,7,8,6,3,75c4dcb8-33bf-43f4-b2bb-db51b6621b2c,5
5,9,42,Identification of Medical Admissions suitable for Same Day Emergency Care (SDEC),6,7,10,10,38,f3957e36-25eb-4e0a-a69a-a1c0ce85cb4f,,3,7,8,6,3,7af96f17-5ab6-4275-b8ef-61a3e053d342,5
5,9,42,Capture-24: Activity tracker dataset for human activity recognition,6,7,10,10,38,f3f24eff-a21b-45e4-92a2-71c162426f53,,3,7,8,6,3,5713fd1a-4358-4485-bed5-83fb25ec2fce,5
5,9,42,HES Emergency Care (Accident & Emergency) data for QResearch,6,7,10,10,38,f55f5b6d-bc40-4fd9-924c-79a2fed5c270,,3,7,8,6,3,9fc11eb5-3e64-491d-9b50-43a84bd76fee,5
5,9,42,ONS Death Registration data for QResearch,6,7,10,10,38,f563f791-c2e4-426b-97be-a91ea82c4e40,,3,7,8,6,3,0d9db5af-972a-4597-ae5b-f9c2fdeddeff,5
5,9,42,UHB Linked Diabetic Eye Disease and Cardiac Outcomes,6,7,10,10,38,f58a3c47-44aa-4815-aeab-e19a4a330926,,3,7,8,6,3,4385ed4c-1c42-4ba5-b57f-9ab18e5ffbe1,5
5,9,42,Epilepsy 12 - National organisational audit and Trust profile,6,7,10,10,38,f635894a-61b8-40ad-bfa2-4c31ef23ad34,,3,7,8,6,3,2c737d63-69f4-4a02-8df9-54c1e65e845f,5
5,9,42,National Cardiac Audit Programme - Myocardial Ischaemia National Audit (MINAP),7,7,10,10,38,f636abcd-91b1-4408-b44b-5f6274bc98d6,,3,7,8,6,3,3558f8a1-6d52-4b59-b513-51c068095bc2,5
5,9,42,Substance Misuse Dataset,6,7,0,10,6,f6aa8836-b437-40b6-bd1e-ae20010048dd,ALLIANCE > SAIL,3,7,0,0,0,291c0dd4-0988-42d2-8e0b-878a892add57,0
5,9,42,North West London Integrated Care Record (NWL ICR),6,7,1,10,7,f6e25ba4-4f7a-436e-a5f9-f0257d45a612,HUB > DISCOVER NOW,3,7,0,0,0,602d8093-6a1e-42cf-a89c-8bf0d47ecc8c,0
5,9,42,PHOTO Translational bladder cancer biorepository,7,7,2,10,10,f71e0f89-edf6-4070-9045-6024b00f79ca,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,07d1b768-78f6-41e8-995a-66afd2549b34,2
5,9,42,Suspected Cancer Pathway Monthly (SCPM),6,7,10,10,38,f76d0428-f93c-41ba-9ebb-08e4211bf17a,,3,7,8,6,3,fcf5a844-f48d-428e-aa06-abe64e66185e,5
5,9,42,Medicines dispensed in Primary Care (NHSBSA data),6,7,3,10,14,f80940e8-0ee1-46be-876b-46fb4bbbc4d2,ALLIANCE > NHS DIGITAL,3,7,2,0,2,f201b68f-d995-4a70-a9ee-aa3510232777,1
5,9,42,Hospital Episode Statistics Admitted Patient Care,6,7,10,10,38,f82b398a-7e53-4851-ab7b-07508f810ebc,,3,7,8,6,3,2b6409db-a669-4bef-9fd5-39c2b6f8d5e9,5
5,9,42,Ventilation strategies for patients on intensive care,6,7,2,10,14,f8a268c1-831c-4c80-b62c-e254a572b9a0,HUB > PIONEER,3,7,3,1,1,1a66dbc1-4f06-455c-85fc-68b372575cad,1
5,9,42,Growing up in Bradford (BiB),6,7,10,10,38,f98965a8-1ff3-4981-8462-fbc8005775b6,,3,7,8,6,3,fe1684ef-69ee-4490-9ab8-b26e990c9060,5
5,9,42,2019 UK Parkinson's Audit - Speech and language therapy,6,7,10,10,38,f98d83ec-ad27-46d7-9786-7a0f2749aa11,,3,7,8,6,3,c7f7541b-5030-40b9-962a-4aba44af7e1a,5
5,9,42,Bowel Screening Wales (SBSW),6,7,10,10,38,f98f9578-a4a3-4d93-b32e-f30ff75888b7,,3,7,8,6,3,9f29d47e-4e9a-41b8-b7bc-5ef3570294ef,5
5,9,42,Real-time Assessment of Community Transmission (REACT) Study 2: COVID antibody,7,7,3,10,23,f9959c00-c063-4fbf-933d-755e3b6ecedc,ALLIANCE > IMPERIAL COLLEGE LONDON,3,7,7,1,2,70656016-c1c9-4bc2-93d1-c66341fcdf36,4
5,9,42,Tommy's National Reproductive Health Biobank,7,7,2,10,10,f99d82da-13eb-42db-ad0d-348be2173535,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,20639743-9a28-43dd-a8af-7571ece2a7f8,2
5,9,42,PHOENIX DDR-Anti-PD-L1 Trial,7,7,2,10,10,f9c40294-92d8-45cd-b11a-70eb0fc09004,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,df94730b-374b-4d91-8116-1c10a7c77c4e,2
5,9,42,National Vascular Registry Audit - Lower Limb Bypass clinical dataset,6,7,10,10,38,fa07a8df-4584-4dc1-87f9-f03ff8d31861,,3,7,8,6,3,d357be1e-27fe-4b2f-9174-3a2a03ecc12b,5
5,9,42,Genvasc Primary Care Data,7,7,8,10,27,fa179e24-2068-4c34-b73c-230003010e9f,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,3,7,7,0,3,f397acff-a7af-4062-8e8b-c85889cc41df,3
5,9,42,Scottish Cancer Registry (SMR06),6,7,10,10,38,fa45c071-1852-4c02-bddc-fda4517bffa8,,3,7,8,6,3,ad36dc03-1856-44de-99b0-1af6f312d86b,5
5,9,42,Breast Test Wales,6,7,0,10,6,fb4a069b-fd74-47b2-bbb1-9cde6b590d66,ALLIANCE > SAIL,3,7,0,0,0,8b9efd45-f56d-4aa3-b2b8-c66ff3813a2b,0
5,9,42,Idiopathic Pulmonary Fibrosis (IPF) Genome-wide Association Study,7,7,0,10,6,fb50af29-4aa6-4071-9300-bd2d57c850b0,HUB > BREATHE,3,7,0,0,0,b850e56c-5c5b-413e-b829-743772053978,0
5,9,42,NHS Tayside and Fife Immunology,6,7,10,10,38,fb65ff7c-fc02-402e-ab55-59765d7b0d43,,3,7,8,6,3,39055449-c074-4b58-adb2-b1c0d2441c4d,5
5,9,42,Asymptomatic COVID-19 in Education (ACE) Cohort,7,7,10,10,38,fba3b66d-8d3a-473f-bb3d-537a6ab1fa7a,,3,7,8,6,3,48adf432-9b66-4d03-a25e-008fbbb24f56,5
5,9,42,National Asthma and COPD Audit Programme (NACAP): secondary care workstream – children and young people asthma (clinical),7,7,8,10,28,fbb5d74c-802a-4888-9452-3e0faf257f82,ALLIANCE > HQIP,3,7,7,0,3,33b36393-3760-40d8-bb98-61806fea5398,4
5,9,42,National Vascular Registry Audit Carotid Endarterectomy Clinical Dataset,7,7,8,10,28,fc08ad6a-3e94-44db-a122-945c4c875616,ALLIANCE > HQIP,3,7,7,0,3,f857055b-c29e-4c7f-99ce-65f4ed59648e,4
5,9,42,Systemic Anti-Cancer Treatment (SACT) data for CPRD GOLD,6,7,10,10,38,fc4b3dea-b56b-4beb-87f0-921fb9d8836a,,3,7,8,6,3,014e7973-b43e-4a4a-91b4-de3f353b71b9,5
5,9,42,North West London High Cost Drugs Data (NWL HCD),6,7,1,10,7,fc704af0-368b-4dd0-866f-753b6d1dccf8,HUB > DISCOVER NOW,3,7,0,0,0,75638d2c-556a-46b6-afcc-7ab425b34679,0
5,9,42,CellPath,7,7,10,10,33,fc7b44f0-eb69-4257-8c07-7516c1210c46,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,3,7,9,0,3,c4538af4-505f-45df-aeae-788ddfd7cb54,5
5,9,42,National Bowel Cancer Audit - clinical dataset,7,7,10,10,38,fc7ea07b-d60f-4be9-a840-89b17d4c2414,,3,7,8,6,3,c8a28f0b-a5f8-4dbb-8d71-5b89c7cb3111,5
5,9,42,Infectious Diseases BioBank at King's College London,7,7,2,10,11,fd2317ea-c729-433b-b578-309118118b78,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,47b544f4-301c-43e0-b347-fc623ea1a8b3,2
5,9,42,MSDS (Maternity Services Data Set),6,7,3,10,12,fd296ed6-6e12-49ab-9e5f-f40428a47b02,ALLIANCE > NHS DIGITAL,3,7,1,0,1,11d3cf0f-ae5d-42f4-a756-b98c3eff46bc,1
5,9,42,"Projections of global, regional and national prevalence of asthma from 2018-2040",7,7,6,10,21,fdb053d7-375a-4422-aa16-c899661d72b1,HUB > BREATHE,3,7,5,1,2,0911f991-6c0f-4412-b805-1ee0ded93a12,1
5,9,42,CPRD GOLD SGSS,6,7,10,10,38,fdb46c60-780a-47fa-bc7e-e367c2f64900,,3,7,8,6,3,7325c42d-6974-4f1b-acd6-5a3c9d22f4a1,5
5,9,42,National Joint Registry - Revision Knee Replacement dataset,6,7,10,10,38,fe168c6f-7533-413e-94fd-066fd845d7c0,,3,7,8,6,3,6664317b-39b9-4133-b6c7-ec4bddf78c76,5
5,9,42,Bristol Biobank,7,7,2,10,11,fe3f2246-aec4-4be4-8f51-3e5bde80931d,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,9d56ae46-5955-4f03-a93c-a4a6d9f641ab,2
5,9,42,Healthcare Workers Risk Assessment (HWRA),6,7,10,10,38,fe8852b2-9d0b-4145-8f5c-531378731d39,,3,7,8,6,3,ed131fee-0635-4613-a453-a383d5dd7cec,5
5,9,42,Emergency hospital admissions in patients from care home settings,6,7,10,10,38,feb9a877-2e22-4a5b-a260-5c5186224028,,3,7,8,6,3,6009f720-3cd5-449d-b36b-e2ccf3fbc73a,5
5,9,42,Falls and Fragility Fracture Audit Programme National Hip Database clinical dataset,7,7,8,10,28,fed22efe-8a84-4b1e-a642-2412a1420ce8,ALLIANCE > HQIP,3,7,7,0,3,e06b951b-e9d8-4a2c-a51f-1d819f669205,4
5,9,42,REQUITE,7,7,2,10,11,fede80e2-aea9-4229-8024-39b09110be7b,ALLIANCE > TISSUE DIRECTORY,3,7,1,0,0,b5217dcb-582f-4914-ae45-9eb3899add30,2
5,9,42,UK SARS-CoV-2 viral sequencing data (COG-UK data)-Lineage/Variant Data-Scotland,6,7,10,10,38,fee7f039-99d6-4eab-951d-b35e0ae71a75,,3,7,8,6,3,69a356d6-599e-4d02-8241-066ce3c297bd,5
5,9,42,The impact of COVID on hospitalised patients with COPD and hospital services,6,7,10,10,38,ff0750c4-2765-4bf6-a294-33215f1ced77,,3,7,8,6,3,a1c4dda9-d34b-443f-aaaf-231f2e0c31fa,5
5,9,42,Enhancing access to pulmonary rehabilitation through implementation research,7,7,10,10,38,ff0ee5d5-aeb4-4dc0-bddf-79336e0ab004,,3,7,8,6,3,6265a41f-9444-457b-b401-1d0978f5c58a,5
5,9,42,Mortality (Death registration),6,7,10,10,38,ff10d5c4-42a2-4a06-b6af-a2f7393c62e0,,3,7,8,6,3,59fb436a-f8c3-4d4a-bc76-d4a02904b078,5
5,9,42,Mental Health Minimum Dataset v4 (Non-Sensitive) Records,6,7,4,10,19,ff2c6982-00f3-4483-9fc2-19b3a7211d8d,ALLIANCE > NHS DIGITAL,3,7,1,0,3,b9f24f81-bcf2-4e47-8909-0d5414e2d7a4,5
5,9,42,Oxford Carpal Tunnel Syndrome (CTS) Cohort,7,7,10,10,38,ff727b8e-4805-424a-ba34-acc9b90225fe,,3,7,8,6,3,cd3555b0-514a-4693-8f68-c8267a8e9939,5
5,9,42,IMPORT HIGH trial blood samples,7,7,2,10,10,ff8231e5-3ede-4844-a21b-b1d05120e07e,ALLIANCE > TISSUE DIRECTORY,3,7,0,0,0,edafebac-9479-4d2c-b44e-349091d5b35b,2
